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Background 
This PhD thesis presents the research work of the Swiss National Science Foundation (SNSF) 
funded project (#147022) entitled “Physical activity as a life style component of aggressive 
decrease of atherosclerotic modifiers (ADAM) in elderly subjects: the SAPALDIA Cohort 
Study.” The study has been performed against the background that a physically active 
lifestyle is linked with decreased risk of cardiovascular disease (CVD) and CVD events, such as 
myocardial infarction or stroke, at all ages among others through improvements in arterial 
stiffness reflecting arterial remodeling. Arterial stiffness proved to be an independent 
predictor of all-cause and cardiovascular mortality. However, arterial stiffness in association 
with physical activity of different intensities has insufficiently been studied in Caucasian 
cohorts of older adults and not at all concerning the change of physical activity over time in 
older Caucasian adults. 
Aims: 
The research program realized the following aims: (1) evaluation of the measuring 
characteristics of the novel cardio-ankle vascular index (CAVI) and the brachial-ankle pulse 
wave velocity (baPWV) as marker of arterial stiffness for the first time in a Caucasian cohort 
of older adults and analyses of the (2) cross-sectional and (3) longitudinal association 
between physical activity as a preventive life style component of aggressive decrease of 
atherosclerotic modifiers and CVD assessed as arterial stiffness in this ageing Caucasian 
clientele. 
Methods: 
The PhD thesis comprised a large nested study of the second follow-up of the Swiss Cohort 
Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA 3) including 3026 
participants aged 50-81 years. SAPALDIA is a multi-center cohort study in eight distinct areas 
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representative of the environmental diversity of Switzerland geared to the investigation of 
respiratory and cardiovascular health (including morbidity and mortality) in its ageing 
cohort. Mixed central and peripheral arterial stiffness was measured oscillometrically and 
simultaneously by CAVI and baPWV using a non-invasive VaSera VS-1500N vascular 
screening system (Fukuda Denshi, Tokyo, Japan). The self-reported International Physical 
Activity Questionnaire (IPAQ) long version was administered to classify the physical activity 
level in 3072 individuals for the cross-sectional analyses. The IPAQ long form asks for the 
frequency and duration of moderate and vigorous physical activity in different domains 
performed during the last seven days (leisure time, domestic and gardening activities, work-
related, transport-related). Furthermore, we assessed physical activity in SAPALDIA 2 (2001-
2003) and SAPALDIA 3 (2010-2011) using a short questionnaire with a cut-off of at least 150 
minutes of moderate-to-vigorous physical activity per week for sufficient activity for the 
longitudinal analyses. We used multivariable mixed linear and logistic regression models 
adjusted for several potential confounders to analyze associations between physical activity 
and arterial stiffness. 
Results: 
Measuring characteristics of arterial stiffness indices (CAVI, baPWV) 
The first aim was to determine the measuring characteristics in terms of the reproducibility 
of the novel arterial stiffness measure CAVI together with baPWV in a Caucasian clientele 
within the SAPALDIA cohort. These two arterial stiffness indices are derived from an 
oscillometric measurement with the VaSera VS-1500N vascular screening system. This work 
resulted in one publication showing the high reproducibility of these indices (Milestone 1).1 
This could be done for the first time in a Caucasian cohort, since both of these newly 
emerging arterial stiffness indices reflecting early CVD risk have so far mainly been studied in 
Asian populations or only in small studies with Caucasians. Valid markers of CVD are 
essential and highly important for CVD risk stratification on the population level. The 
analyses of the association of CAVI with blood pressure in comparison with baPWV has been 
conducted but could not been integrated in a publication so far. The association between 
CAVI and carotid intima media thickness as a traditional and well established marker of 
cardiovascular risk is pending. However, we have analyzed associations of CAVI and baPWV 
with age and sex as the main determinants of arterial stiffness in the SAPALDIA cohort 
proving the high quality of these indices. 
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Cross-sectional association of physical activity and arterial stiffness 
In the next step, we have focused on the second aim targeting the analyses of the cross-
sectional association between physical activity and arterial stiffness reflecting CVD risk in 
multilevel models including several confounding factors. Physical activity is regarded as an 
important health promotion measure with protective impact on the cardiovascular system 
and, thus, as one component of aggressive decrease of atherosclerotic modifiers. The main 
focus of the second aim was the question how a physically active lifestyle is cross-sectionally 
associated with arterial stiffness in the SAPALDIA cohort. Up-to-date this question has been 
insufficiently studied in older adults in population based studies. Furthermore, there is no 
comparable cohort in which a measure of arterial stiffness could be analyzed in association 
with a detailed questionnaire of physical activity like the IPAQ. During the data collection of 
SAPALDIA 3 the IPAQ has been consulted to classify the subjects’ physical activity level. We 
hypothesized that a sedentary lifestyle is associated with increased arterial stiffness assessed 
by CAVI and baPWV. We found that in this general Caucasian population of older adults 
higher levels especially of vigorous physical activity were associated with lower arterial 
stiffness reflecting lower cardiovascular risk. These data support the importance of physical 
activity for improving cardiovascular health in older adults. These results are included in a 
manuscript published in the European Journal of Epidemiology (Milestone 2).2  
Longitudinal association of physical activity and arterial stiffness 
To add on this from a longitudinal point of view we have extensively worked on the third aim 
analyzing the association between change in physical activity between the first and second 
follow-up of SAPALDIA (SAPALDIA 2 to 3) and CVD risk using CAVI and baPWV as marker in 
multilevel models including several confounding factors. We hypothesized that an increase 
in physical activity between SAPALDIA 2 and 3 is associated with lower cardiovascular risk 
assessed by arterial stiffness. This is the first longitudinal population based cohort study 
showing that keeping up or adopting a physically active lifestyle was associated with lower 
arterial stiffness in older adults after a follow-up of almost a decade. Increasing the 
proportion of older adults adhering to physical activity recommendations incorporating also 
vigorous physical activity may have a considerable impact on vascular health at older age 
and may contribute to healthy ageing in general. These findings will strengthen physical 
activity recommendations within CVD prevention guidelines in older adults with respect to 
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the prevention of manifest CVD and related health outcomes. A manuscript presenting these 
findings have been published in the journal Age and Ageing (Milestone 3).3 
Conclusions: 
Consequently, the aims of the PhD research plan could be fulfilled within the proposed 
timeline, except the pending analyses of the association between CAVI and baPWV with 
carotid-intima media thickness. We could show that CAVI and baPWV are non-invasive 
arterial stiffness indices that are easy-to-apply and reproducible for population wide CVD 
risk stratification in Caucasians. Because arterial stiffness receives growing significance for 
examinations of asymptomatic subjects in research our cohort study results will lead to 
improvements of early stage diagnosis and treatment of CVD. Risk stratification is essential 
for goal-oriented and area-wide primary and secondary care. Early detection of CVD and 
cardiovascular risk factors is crucial besides promotion of prevention and early treatment for 
diminishing the increasing health and economic impact of CVD. CAVI and baPWV could be 
implemented in this epidemiological cohort study to assess the cardiovascular risk related to 
increased arterial stiffness and associated with insufficient physical activity. Besides, a long-
term physically active lifestyle was shown to be beneficially associated with vascular ageing 
and therefore decreased CVD risk on the population level in the long-term. Since there are 
few population based studies in Caucasians concerning this topic and the growing 
acknowledgement of physical activity in population health interventions this study presents 
highly relevant and unique results in line with current epidemiological, medical and sports 
science research trends. In conclusion, physical activity may play a major role in long-term 
healthy cardiovascular ageing at the population level and should be emphasized in CVD 
management and prevention guidelines. Increasing the proportion of older adults adhering 
to physical activity recommendations incorporating also vigorous physical activity may have 
a considerable impact on vascular health at older age and may contribute to healthy ageing 
in general. 
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Chapter 1 Introduction 
1.1 Physical Activity  
1.1.1 Physical Activity Epidemiology in Adults 
The current European Guidelines on cardiovascular disease prevention in clinical practice of 
the European Society of Cardiology4 and global physical activity guidelines5 recommend a 
minimum of 150 minutes per week of at least moderate intensity physical activity for adults 
to beneficially affect population health and cardiovascular mortality. Adherence to physical 
activity guidelines is suggested to reduce the mortality rate by 25%6 and an increase of 
physical activity by 10% or 25% could prevent more than 533’000 or 1.3 million deaths, 
respectively, per year worldwide.7 According to the 2013 Hypertension Guidelines of the 
European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) 
physical activity is one lifestyle measure of health promotion besides smoking cessation, 
weight reduction in the overweight, moderation of alcohol consumption and balanced diet 
concerning all populations.8 Nevertheless, physical activity is underrepresented in the daily 
life of the majority of the worldwide population. As pointed out at by the Lancet Physical 
Activity Series 31.1% of the world population does not meet current physical activity 
recommendations.9 In the US only 28% of women and 31% of men meet the current 
guidelines, and 41% of women and 39% of men are not physically active during their leisure 
time at all.10 According to the Special Eurobarometer 412 of 2014 54% of the interviewed 
European Union citizens did not perform any vigorous physical activity in the previous week 
and 44% any moderate physical activity, respectively.11 In this European survey 13% 
reported on no bouts of ten minutes walking in the past week at all. In other words, two 
thirds of Europeans do not meet current physical activity guidelines.12 In Switzerland 72% 
(65% in 2007) of the population (69% in women and 76% in men) achieve at least 150 
minutes of moderate intensity physical activity and, therefore, are sufficiently active 
according to the 2012 Swiss Health Survey.13,14 One third of the Swiss population still has to 
be categorized as insufficiently active. However, as pointed out in the 2013 Health Enhancing 
Physical Activity Core Document this comparably high proportion of Swiss people being 
sufficiently active can be explained by the new physical activity guidelines that do not take 
into account the frequency of performed physical activity.14 According to the former physical 
activity guidelines not only the amount of 150 minutes of moderate-to-vigorous physical 
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activity had to be fulfilled to be categorized as sufficiently active, but also a frequency of 3-5 
of activities of at least 10 minutes had to performed throughout a week on a regular basis. 
The 24% irregularly active Swiss adults of the 2007 Swiss Health Survey would therefore also 
be insufficiently active according to the previous recommendations, amounting to a total of 
59% insufficiently active Swiss adults in 2007 instead of 35%. 
1.1.2 Health Benefits of Physical Activity 
A physically active lifestyle is linked with decreased risk of cardiovascular disease (CVD) and 
CVD events, such as myocardial infarction or stroke, at all ages among others through 
improvements in arterial stiffness reflecting arterial remodeling.15–18 Besides beneficial 
effects on CVD development and progression physical activity has been shown to be 
beneficially associated with the primary and secondary prevention of various diseases such 
as diabetes, cancer, hypertension, obesity, depression, dementia and osteoporosis.19,20 In a 
recent cohort study in 334’161 European men and women it has been shown, that in the 
general population being at least moderately physically active compared to inactive reduces 
the number of deaths by 7.35% and would increase life expectancy at birth by 0.70 years.21 
These results were independent of body mass index and waist circumference. Comparably 
Wen et al. have found among 416’175 Taiwanese aged 20 years or older, that 15 minutes of 
daily moderate physical activity could decrease mortality risk by 14% and increase life 
expectancy by 3 years compared to inactive persons.22 This suggests that a substantial public 
health benefit may arise from efforts to promote moderate-to-vigorous physical activity and 
to reduce physical inactivity.  
1.1.3 Physical Inactivity 
In contrast, physical inactivity is regarded as one of the main risk factors for both non-
communicable diseases in general and CVD in particular.23 Physical inactivity accounts for 
about 6% of all deaths worldwide and, thus, is the fourth leading risk factor for premature 
mortality.24 According to the same report of the World Health Organization (WHO) physical 
inactivity is associated with around 1 million deaths per year in Europe. Physical inactivity 
has to be distinguished by sedentary behavior. According to the current definition sedentary 
behavior refers to activities with an energy expenditure of 1-1.5 metabolic equivalents (one 
MET is the energy cost of resting quietly, equivalent to an oxygen uptake of 
3.5 mL*1/kg*1/min), namely especially sleeping, sitting, reclining or watching TV.25 In 
contrast there are light physical activities with an energy expenditure of 1.6-2.9 METs such 
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as slow walking, sitting in combination with writing or cooking. Physically inactive are 
persons who are not meeting current physical activity guidelines and, thus, perform less 
than 150 minutes of moderate physical activity or an equivalent of 75 minutes of vigorous 
physical activity per week.14,26 
Influences of the environment are supposed to be very important determinants for physical 
activity in a public health context.27 These include influences such as the design of public 
spaces and parks, the nearness and availability of sports and retail facilities, and especially 
transport (roads, walking and cycling paths, subways) and occupation settings related to 
physical activity or sedentary behavior.27 In the last decades with an increasing level of 
technology the environment has become less requiring of physically strenuous activities and 
less stimulating for being physically active at all. Likewise daily amounts of physical activity 
show a distinct decline, with increasing time spent being sedentary, especially sitting.9 In the 
past ten years scientific knowledge has been accumulated presenting the adverse health 
effects of sedentary behavior, most often studied concerning daily sitting time.28 In this 
context it has been shown, that time spent viewing television29, time spent sitting in cars30 or 
prolonged sitting in general31 is associated with increased CVD and all-cause mortality. A 
recent systematic review came to the same conclusions summarizing that there is strong 
evidence for an association between sedentary behavior and all cause and CVD mortality.32 
This association has been shown to be independent of leisure time physical activity 
suggesting, that even complying with current physical activity recommendations cannot 
counterbalance the adverse health effects of prolonged sitting.33 There is growing evidence 
that efforts to reduce prolonged sitting time, while increasing time being physically active 
have to be pursued in view of population health.33,34 Up-to-date interventions are therefore 
targeting to reduce sitting bouts of more than 30 minutes such as within workplace 
settings.35 On this scientific basis both prolonged sitting and too little moderate-to-vigorous 
physical activity have to be considered as separate risk factors for cardiovascular and other 
non-communicable diseases.26 
1.2 Cardiovascular disease 
Within the European Union 41% of all deaths in 2003 were explained by diseases of the 
circulatory system including ischemic (coronary) heart diseases, other heart diseases and 
cerebrovascular diseases.36 Myocardial infarction and stroke as the main CVD are the first 
and second leading death causes worldwide and are solely responsible for one third of the 
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deaths in the world.37,38 More than half of the deaths on account of non-communicable 
diseases (16.7 million of 32 million) are directly connected to CVD.38 A recently published 
report of the American Heart Association highlighted that the prevalence rate for any form 
of CVD will increase to 40.5% of the US population and future costs of patients suffering 
from CVD will triple.39 Therefore, CVD represents a major cause of morbidity and mortality 
and, hence, a major global health problem for both the society and the health care system. A 
recently observed decline in the rates of CVD mortality in developed countries is strongly 
attributed to improved treatment37,40 and augmented attention to risk factor identification, 
stratification and modification especially regarding smoking cessation, physical exercise, and 
control of weight.41 Obviously, the potential of lifestyle prevention has not exhausted its 
potential even though preventive approaches are still “undervalued and underused around 
the world” (p.657).37 The progression of CVD is directly related to the long-term 
asymptomatic process of atherosclerosis, which often already begins in adolescence.42 
Atherosclerosis is the main form of arteriosclerosis, which comprises every arterial 
hardening and thickening.43 According to the most common explanatory approaches 
atherosclerosis is an inflammatory process characterized by pathophysiological 
modifications of the endothelial layer.43,44 Thereby, lipid and lipoprotein particles 
accumulate beneath the endothelium in the initial stage, by what immunoactive cells 
(peripheral blood monocytes and T-lymphocytes) are chemotactically attracted, move to the 
intima, where they result in the formation of fatty streaks.44 If the traditional cardiovascular 
risk factors, such as high blood pressure, tobacco use, alcohol consumption, cholesterol, and 
obesity or overweight,38 remain unchanged at this point, an atherosclerotic plaque (fibrous 
plaque, atheroma) as an accumulation of fibrous tissue, cells, and lipid originates from this 
first lesion of atherosclerosis.44 In the case of fissures, erosion, ulceration or rupture because 
of “hemodynamic trauma, local attachment and activation of platelets and blood cells, 
inflammatory processes in the plaques, and cytotoxic effects of plaque contents” (p. 596)45 
the formation of an arterial thrombus and dynamic coronary vasoconstriction is likely to 
occur as starting points of further worsening.46 This may lead to serious cardiovascular 
events such as angina pectoris, myocardial infarction, sudden cardiac death or chronic 
coronary heart disease, summed up by the clinical term coronary heart disease.47  
The described atherosclerotic alterations impair the two functions of the arterial system 
both the conduit of blood to the periphery and the cushioning of the pulsatile blood-flow 
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into an almost smooth flow in the microcirculation,48 in order to protect arterioles and 
capillaries from pressure-induced damages.49 The structural and functional properties of the 
arteries in terms of compliance characteristics facilitate these functions. Already at an early 
stage of atherosclerosis the aorta and major arteries stiffen and steadily lose their elastic 
and distensible abilities.50 From this it follows that atherosclerosis is closely related to 
arterial stiffness.51,52 Especially in arterial regions with high shear stress one can find with 
higher probability stiffer vessels and more often atherosclerotic altered vascular walls.53 
Wang & Fitch state that this vascular stiffening process is associated with foam cell-induced 
medial thickening, elastin degradation, and endothelial dysfunction.50 Finally, the 
impairment of the buffer capacity on account of the arterial stiffness may lead to elevated 
left ventricular afterload followed by left ventricular hypertrophy, heart insufficiency, 
worsening of coronary ischemia and an increased risk of stroke, dementia and renal failure 
due to damages of the microcirculation.49,54 Thus, arterial stiffness is an early, subclinical sign 
of grave cardiovascular alterations and different techniques of diagnosis need to be 
elucidated and enhanced to accomplish an application-oriented basis of primary and 
secondary medical care and prevention.  
1.3 Arterial Stiffness 
Arterial stiffness is a generic term for structural and functional properties as well as 
alterations of the arterial vessel system.54 Stiffness is inversely associated with compliance as 
“a change in volume or cross-sectional area for a given change in pressure” (p. 159)49 and to 
distensibility as “a fractional change in volume or cross-sectional area for a given change in 
pressure”49, wherefore arterial stiffness needs to be differentiated from these concepts. 
Within the current research perspective arterial stiffness is regarded as a structural 
biomarker for early vascular ageing signalizing increased cardiovascular risk.55,56 The concept 
of early vascular ageing (EVA) recently proposed by Nilsson et al. shows that arterial stiffness 
as a structural biomarker of cardiovascular risk is more reliable and consistent over a long 
period of time compared to circulating biomarkers like C-reactive protein or homocysteine.55 
This is because arterial stiffness reflects the accumulated vascular damage over the 
lifespan.57 Arterial stiffness strengthens the significance of cardiovascular risk stratification 
at an early stage and therefore improves the diagnosis, treatment and cessation of 
subclinical arteriosclerotic process.55 This is needed to implement early stage interventions 
targeted at the vascular health summed up by the term aggressive decrease of 
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atherosclerosis modifiers (ADAM).55 Arterial stiffness proved to be an independent predictor 
of all-cause and cardiovascular mortality in patients with essential hypertension58 and 
demonstrated its significance for estimating CVD prognosis.59 As reviewed by Safar, Levy and 
Struijker-Boudier arterial stiffness is a marker for increased CVD risk, including myocardial 
infarction, heart failure, and total mortality, as well as stroke, dementia, and renal disease.60 
In this regard a recent prospective cohort study has shown that aortic stiffness adds 
significant information to the prediction of cardiovascular events and to the risk 
stratification of populations at intermediate risk.61 Thus, arterial stiffness is recognized as a 
surrogate end point for cardiovascular events.15,62 Different non-invasive surrogate 
measures are known (pulse wave velocity, pulse pressure, pressure pulse waveform analysis) 
that are marker of arterial stiffness and the underlying cardiovascular risk.63 In a very recent 
position paper by the European Society of Cardiology Working Group on peripheral 
circulation several vascular biomarkers have been scrutinized for their ability of being a 
surrogate end point of cardiovascular events.56 The consensus was that carotid 
ultrasonography, ankle-brachial index and carotid-femoral pulse wave velocity (cfPWV) meet 
the most criteria, and brachial-ankle pulse wave velocity (baPWV), central 
hemodynamics/wave reflections and C-reactive protein at least part of the criteria.  
PWV expresses the velocity of the pressure pulse wave that is generated by the systolic 
contraction of the left ventricle and spreads out along the arterial tree.15 In the same 
manner as arterial stiffness, PWV correlates inversely with the distensibility of the arteries 
that is PWV increases in accordance with the stiffening of the vessels.54 PWV is not only 
strongly dependent on age64 but also linearly related to blood pressure.15,65,66 Arterial 
stiffness increases non-linearly with age, especially detectable after the age of 55-60.67 Out 
of this growing rigidity of the vessel walls results a distinct greater disproportion of systolic 
blood pressure and diastolic blood pressure in the elderly, leading to a curtailment of the 
significance of cardiovascular risk analyses using blood pressure measurements.67 Thus, 
Benetos et al. state that pulse waveform and PWV analyses can be advantageous compared 
to common blood pressure assessment.64  
Recent overview publications demonstrated that PWV > 10 m/s can be considered as 
cardiovascular hazardous and as target organ damage.15,65,68 Therefore, in the current 2013 
Hypertension Guidelines of the European Society of Hypertension (ESH) and the European 
Society of Cardiology (ESC) compared to the 2007 Guidelines the threshold of cfPWV for an 
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abnormal, high-risk cardiovascular status has been changed from 12 m/s to 10 m/s.8,69 This 
lower threshold for cfPWV takes into account that the true distance covered by the pulse 
wave is 20% shorter than measured superficially with a tape measure from the carotid to the 
femoral artery and this method has therefore been recently recommended by an expert 
consensus.70 Especially in middle-aged and older adults travel distance measured 
superficially multiplied by 0.8 has been shown to result in a closer approximation to invasive 
aortic PWV compared with other travel distance estimations.71,72  
PWV measurements vary depending on the vessel regions included. They can provide 
predictions about different regions of the vascular system and therefore have only limited 
significance concerning the vascular system on the whole. cfPWV is commonly 
acknowledged as the ´gold-standard´ method for assessing central/ aortic arterial stiffness.15 
The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) 
recommend cfPWV as a tool for the assessment of subclinical target organ damage.69 
Besides, measuring of baPWV is widespread applied in Japan.68 Since baPWV has revealed a 
reliable correlation to left ventricular mass and diastolic function,65,66,68,73 has proven a 
considerable high validity, reproducibility, and good correlation with aortic PWV,74 baPWV 
also features a reasonable tool for clinical use. A recent systematic review and meta-analysis 
by Vlachopoulos et al. strengthens the predictive ability of baPWV regarding critical 
outcomes in 8169 participants with a mean follow-up of 3.6 years.62 The authors highlight 
the good association of baPWV with cardiovascular events, cardiovascular mortality and all-
cause mortality with pooled relative risks of 2.95, 5.36 and 2.45, respectively, comparing two 
groups of high versus low baPWV. Thereby an increase of 1 m/s in baPWV was associated 
with an increase of 12%, 13%, and 6% in total cardiovascular events, cardiovascular 
mortality, and all-cause mortality, respectively. However, none of these methods allow 
assessing arterial stiffness quantitatively and independently of blood pressure and the 
arterial segments included in the baPWV calculations are rather virtually derived, wherefore 
Vlachopoulos et al. prefer to use the term brachial-ankle elasticity index (baEI) than 
baPWV.62  
1.4 Cardio-ankle vascular index (CAVI) and brachial-ankle pulse wave velocity (baPWV) 
To overcome these methodological problems Shirai et al.75 and Yambe et al.76 proposed the 
cardio-ankle vascular index (CAVI) for non-invasive stiffness assessment of the arterial tree 
including the aorta, femoral artery, popliteal and tibial artery by using a device based on a 
Introduction 
9 
convenient volume plethysmographic method. CAVI is methodologically based on the 
measurement of baPWV with improvements regarding the length calculation of the included 
vessels, the pulse wave propagation time and the correlation with blood pressure.75 CAVI 
clearly reflects the arterial stiffness between the heart and the ankle, by precise 
determination of the time point of the systolic aortic valve opening.75 CAVI and baPWV are 
combined estimates of the central and peripheral arterial stiffness, thus systemic arterial 
stiffness indices.75,77 CAVI’s great advantage compared with other arterial stiffness 
parameters like cfPWV and baPWV is the lower correlation with blood pressure on account 
of an inclusion of a mathematical relationship to the mechanical properties of the arterial 
wall and the stiffness parameter β.78,79 In a Japanese study with 135 hemodialysis patients 
baPWV and CAVI have been compared concerning their association with cardiovascular 
outcome.80 Thereby only the highest tertile of baPWV (≥16.6 m/s) was significantly 
associated with a lower survival rate and was a determinant of cardiovascular death. This 
could not be shown for CAVI, which should theoretically be advantageous in the prediction 
of cardiovascular outcomes. More data on the associations of CAVI with different 
cardiovascular events and mortality are still missing, owing to the fact that CAVI is rather 
new. However, it can be assumed that CAVI implies good correlations as shown by 
Vlachopoulos et al.62 for baPWV due to the methodological connection of both methods. 
CAVI is compatible with the PWV method, however, CAVI is mathematically derived from a 
modification of Bramwell-Hill´s formula and a substitution in the stiffness parameter β, and 
is adjusted for blood pressure (Fig. 1).75 CAVI is not only theoretically but also experimentally 
proven less dependent on blood pressure at the time of measurement and, therefore, may 
be more useful for the clinical assessment of arterial stiffness than PWV.79,81–83 For example, 
the diabetes and non-diabetes subjects of the study of Ibata et al. passed through CAVI and 
baPWV evaluations directly after exercise stress tests vigorous enough to influence blood 
pressure, whereby only baPWV was affected by the changes in blood pressure.81 The same 
effect could be shown when only CAVI remained unchanged during general anesthesia in 
contrast to a decrease of baPWV and systolic blood pressure.84 Yambe et al. confirmed this 
superiority of CAVI over baPWV after heart transplantation, when CAVI remained stable 
whereas baPWV increased rapidly.85 Different studies could demonstrate good 
reproducibility of CAVI as an index of both arterial stiffness and arterial distensibility without 
or distinct less dependency on blood pressure than PWV.75,81,86–88 For this reason serial 
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Stiffness Index β 
Bramwell-Hill  
equation 
CAVI 
examinations using CAVI as measurement of arterial stiffness are less affected by blood 
pressure fluctuations. This is especially important when measurements are done throughout 
the day like in the second follow-up of the Swiss Cohort Study on Air Pollution and Lung and 
Heart Diseases in Adults (SAPALDIA 3) because of known blood pressure variations and 
subsequent potential influences on PWV. 
Fig. 1. Deduction of CAVI from the stiffness index 
β and Bramwell-Hill’s equation. PS-systolic blood 
pressure; PD-diastolic blood pressure; D-artery 
diameter; ΔD-change of artery diameter 
according to blood pressure; PWV-pulse wave 
velocity between the heart and the ankle; ΔP=PS-
PD; ρ-blood density; a, b-constants; V-blood 
vessel volume; ΔV-change in blood vessel volume. 
 
CAVI showed good reliability and reproducibility86,89 with an interobserver correlation 
coefficient between 0.82 – 0.87 as reported by Wu et al.90 and a coefficient of variation 
(3.8%) below the threshold for clinical useful testing in Asian populations.75 However, there 
is lack of evidence concerning the reproducibility of CAVI and baPWV for arterial stiffness 
assessment in larger samples of Caucasians. Only one study with a small sample (n=7) 
showed a low variability of 2.9% expressed as coefficient of variation for CAVI on a week to 
week basis in Caucasians.91 So far most of the published research results concerning CAVI 
and baPWV are from the Asian region, within which especially from Japan. Thus, the clinical 
and scientific evidence, usefulness and reference values of CAVI and baPWV need to be 
proven in representative Caucasian populations such as within the SAPALDIA 3 study.56 
1.5 Physical Activity and Arterial Stiffness 
Physical inactivity is one condition that is associated with increased arterial stiffness, and 
consequently with an increased risk of cardiovascular events.15 The progression of CVD on 
account of insufficient physical activity is associated with long-term asymptomatic 
atherosclerotic processes that often already begin in adolescence with stiffening of the 
arteries.42 Physical activity can be regarded as one component of aggressive decrease of 
atherosclerosis modifiers (ADAM).55 Within the EVA-ADAM concept by Nilsson et al. early 
vascular ageing (EVA) is opposed by specifically targeted early stage interventions to 
positively influence the progression of cardiovascular risk associated with arteriosclerotic 
vessel modifications.55 In recent years besides aerobic (endurance) exercise also resistance 
training has found its way into health guidelines as an elementary component.92–94 Both 
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should be performed in a moderate intensity on a regularly, at the best daily basis.69 
Intervention studies with rather small sample sizes have demonstrated that arterial stiffness 
is modifiable by exercise training throughout life.95,96 Generally one can state that the 
association between arterial stiffness and physical activity and exercise training depends on 
the type, duration, intensity and frequency of the respective physical activity. In this regard 
we could show in a recent systematic review of randomized controlled trials that aerobic 
exercise is beneficially associated with arterial stiffness especially when performed at higher 
intensities (see Appendix A).95 In contrast, the results regarding resistance training are 
controversial ranging from negative to beneficial effects.95–97  
Up to date there are only few population-based studies concerning physical activity and 
arterial stiffness. Aoyagi et al. examined the association of habitual physical activity (>3 
metabolic equivalents; measured by step counts) and arterial stiffness in 198 women and 
men.98 They reported on a beneficial effect of physical activity at least for the stiffening of 
central arteries. Hence they state that the more physical active a person is the lower the 
PWV values and, thus, less stiff the vessels are. This beneficial association of physical activity 
with arterial stiffness was recently confirmed by two large scale studies.99,100 Thereby, higher 
walking speed was strongly associated with reduced cfPWV in older adults. In a population-
wide study on 373 female and male Netherlands van der Laar et al. found that the effect of 
habitual physical activity depends on its intensity and differs with the respective arterial tree 
segment.101 Accordingly, only vigorous but not light-to-moderate habitual physical activity 
provides favorable associations with compliance of peripheral arteries. In contrast, in one 
cross-sectional study in 538 healthy older adults longer time spent in light intensity physical 
activity was associated with lower cfPWV, independently of moderate-to-vigorous physical 
activity.102 There is only one longitudinal study performed in 274 young overweight adults 
showing that an average increase in moderate-to-vigorous physical activity of 12.7 min/day 
is associated with reduced baPWV of at least 0.71 m/s.77 
Arterial stiffness measured by CAVI and baPWV in association with physical activity of 
different intensities has insufficiently been studied in a Caucasian cohort of older adults and 
not at all concerning the change of physical activity over time in older Caucasian adults. 
SAPALDIA offers highly qualitative longitudinal cohort data in order to examine the 
association between short-term physical activity and change of physical activity over a 
period of almost a decade and markers of CVD like CAVI, baPWV, blood pressure, and 
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potential confounders. The association of the longitudinal physical activity from SAPALDIA 2 
to SAPALDIA 3 may indicate whether long-term change of physical activity has an impact on 
arterial stiffness and, thus, may have consequences for promoting physical activity.  
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Chapter 2 PhD Thesis Aims and Hypotheses 
On the basis of the presented scientific background this PhD thesis has targeted the 
following aims: 
 Aim 1: Determination of the measuring characteristics of oscillometrically measured 
arterial stiffness indices in a cohort of adults aged 50-81 years (SAPALDIA 3) in terms of 
analyses of the reproducibility of CAVI and baPWV (test-retest-reliability, age and sex 
association). 
 Aim 2: Cross-sectional analyses of the association between physical activity assessed by 
the International Physical Activity Questionnaire (IPAQ) long version and CVD risk using 
CAVI and baPWV as arterial stiffness marker in multilevel models including several 
confounding factors. 
 Aim 3: Longitudinal analyses of the association between change in physical activity 
between SAPALDIA 2 and SAPALDIA 3 and CVD risk using CAVI and baPWV as arterial 
stiffness marker in multilevel models including several confounding factors. 
 
In view of these aims this PhD thesis focused on the evaluation of the following specific 
hypotheses: 
 Hypothesis 1: CAVI and baPWV are reproducible measurements of arterial stiffness in a 
Caucasian cohort of adults aged 50-81 years. 
 Hypothesis 2: A physically active lifestyle is beneficially associated with arterial stiffness 
in older adults and, therefore, with decreased cardiovascular risk independent of several 
potential confounding factors. 
 Hypothesis 3: A long-term physically active lifestyle or the adoption of physical activity 
between SAPALDIA 2 and SAPALDIA 3 (almost a decade) is associated with lower 
cardiovascular risk assessed by arterial stiffness independent of several potential 
confounding factors. 
 
 
Methods 
15 
 
 
Chapter 3 
 
Methods 
 
 
 
 
Methods 
16 
Chapter 3 Methods 
3.1 Study Design and Population 
The data were derived from SAPALDIA 3, the second follow-up of this multi-center cohort 
study in eight distinct areas representative of the environmental diversity of Switzerland 
targeted at the investigation of the effects of air pollution on respiratory and cardiovascular 
health including morbidity and mortality in its ageing cohort.103,104 SAPALDIA is coordinated 
by the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel (Principal Investigator 
Prof. N. Probst-Hensch) and has been funded by the Swiss National Science Foundation 
(SNSF) and the Federal Office of Environment for over 20 years. The first survey (SAPALDIA 1) 
of 9651 randomly selected adults, 18 to 60 years of age, started in 1991, and included a 
questionnaire, lung function and atopy tests. The same measurements were conducted in 
the first follow-up (SAPALDIA 2) in 2002 with 8047 subjects (86% of survivors) of which 65% 
underwent physical re-examination. SAPALDIA 3 was expanded by high relevance in chronic 
disease research and focused more precisely on cardiovascular health assessment. Thus, 
besides sonographic measurements of carotid-intima media thickness, PWV measurement 
was implied in 3025 subjects as a marker of arterial stiffness reflecting cardiovascular 
modifications and cardiovascular risk. SAPALDIA has earned high relevance in environmental 
and chronic disease research with more than 100 publications listed in PubMed. The 
respective Swiss cantonal ethical committees have granted ethical approval and participants 
gave written informed consent. 
3.2 Physical Activity Assessment 
For cross-sectional analyses the self-reported International Physical Activity Questionnaire 
(IPAQ) long version was administered to classify each subject’s physical activity level.105 The 
IPAQ long form asks for moderate and vigorous physical activity in different domains 
performed during the last seven days (leisure time physical activity, domestic and gardening 
activities, work-related physical activity, transport-related physical activity).106 Moderate and 
vigorous intensities were associated with harder and much harder breathing, respectively. 
Total minutes per week of moderate physical activity (including walking), vigorous physical 
activity and total physical activity were calculated per domain and in total following the IPAQ 
guidelines.106 They were weighted by their energy cost as metabolic equivalents (MET) with 
one MET equating to around one kcal/kg/hour, which approximately corresponds to sitting 
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quietly. This leads to a MET-minutes per week score reflecting total energy expenditure.107 
For longitudinal analyses a short self-reported physical activity questionnaire was 
administered within the SAPALDIA main questionnaire to classify the subjects’ long-term 
physical activity from SAPALDIA 2 to SAPALDIA 3.108 Thereby four questions were asked 
concerning the frequency and duration of physical activities per week.  
- Do you participate in physical activities that make you a bit breathless; e.g. walking, 
dancing, gardening or other kinds of sport? How often do you participate in these 
activities each week?: Never/ Seldom/ 1 time a week/ 2 times a week/ 3 times a week/ 
4 times a week/ 5 times a week/ 6 times a week/ 7 times a week. 
- How long do you spend doing these activities each day? (minutes). 
- How often do you usually exercise so much that you get out of breath or sweat? every 
day/ 4-6 times a week/ 2-3 times a week/ once a week/ once a month/ less than once a 
month/ never. 
- How many hours a week do you usually exercise so much that you get out of breath or 
sweat? none/ about ½ hour/ about 1 hour/ about 2-3 hours/ about 4-6 hours/ 7 hours or 
more. 
Physical activities with episodes of getting a bit out of breath were categorized as moderate 
intensity and physical activities linked with getting out of breath and sweating as vigorous 
intensity, respectively. We calculated minutes per week of moderate-to-vigorous physical 
activity, whereby minutes of vigorous physical activity were taken twice.5 Subjects with less 
than 150 minutes of moderate-to-vigorous physical activity were categorized as insufficiently 
active (inactive), and subjects with at least 150 minutes as active, respectively, both in 
SAPALDIA 2 and SAPALDIA 3.5 
3.3 Arterial Stiffness and Hemodynamics 
Peripheral blood pressure and arterial stiffness was measured by means of the cardio-ankle 
vascular index (CAVI) and the brachial-ankle pulse wave velocity (baPWV) using a VaSera VS-
1500 vascular screening system (Fukuda Denshi, Japan) (Fig. 2.).75 CAVI is considered to be 
less dependent on the blood pressure at the time of measurement compared to common 
PWV measurements.75 After resting for at least 10 minutes two measurements were taken 
at 3-5-min intervals in supine position and averaged for analyses. Common blood pressure 
cuffs were placed directly above each ankle and at each upper arm. ECG leads were attached 
at each wrist and a phonocardiogram on the sternal border in the second intercostal space 
to assess PWV by a foot-to-foot method and mathematically derive CAVI as described 
previously.1  
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On the basis of these peripheral recordings, pulse wave analysis will be performed 
retrospectively for future analyses using the ARCSolver algorithm (AIT Austrian Institute of 
Technology GmbH, Vienna, Austria) in order to derive aortic pulse wave velocity as a 
surrogate marker of aortic stiffness as well as central systolic and diastolic blood pressure 
within the first aim. The ARCSolver method is a mathematical procedure for the calculation 
of aortic stiffness and central hemodynamic measures from peripheral pulse waves and 
blood pressure measurements at the brachial artery using a common occlusive cuff.109 We 
have recently proven the feasibility of this method in combination with the VaSera VS-1500 
device in a separate study.110 
 
 
Fig. 2. Arterial stiffness measured by means of the 
cardio-ankle vascular index (CAVI) and the brachial-
ankle pulse wave velocity (baPWV) with blood 
pressure cuffs at each upper arm and above each 
ankle, ECG leads at each wrist and a 
phonocardiogram on the sternal border in the 
second intercostal space using a VaSera VS-1500 
vascular screening system (Fukuda Denshi, Japan). 
 
 
 
 
 
 
 
 
 
 
3.4 Covariates 
Within SAPALDIA a broad range of possible covariates was available, such as detailed 
information on respiratory and cardiovascular health symptoms, doctor diagnosed diseases 
(e.g. cardiopulmonary and metabolic disease), anthropometric and socio-demographic 
characteristics, occupation, medication, smoking habits, and nutrition, either directly 
measured or assessed with questionnaires. 
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3.5 Statistical Analyses 
For the analyses of aim 1 reproducibility of the respective arterial stiffness indices was 
assessed in a representative subsample (N=105) of the SAPALDIA 3 cohort. Thus, arterial 
stiffness was measured twice at 3-5 min intervals on each of two separate days within 3 
months. Means of individual between-visit coefficients of variation and intraclass correlation 
coefficients using one-way analysis of variance were applied for statistical analyses. Mixed 
linear models were used to produce detailed information on the sources of variability of 
repeated arterial stiffness measurements including a fixed effect of time and random effects 
of subject, measurement day within subject, and fieldworker. We used Bland-Altman plots 
for graphical analyses.111  
We used mixed linear and logistic regression models as appropriate, with a random study 
area effect to account for the multi-center setting for the cross-sectional and longitudinal 
analyses of aim 2 & 3. Based on the literature and previous analyses in this cohort we pre-
selected potential confounding covariates. Covariates were considered as potential 
confounders if the p-value of their association with the respective outcome was <0.2. On the 
basis of prior knowledge a set of possible interaction terms between physical activity, age, 
sex and mean arterial pressure was tested to include in the final models. All identified 
covariates and interactions were added incrementally to the final model. For the cross-
sectional analyses 1908 individuals of the SAPALDIA 3 cohort with complete datasets of 
arterial stiffness, IPAQ and the covariates of interest were available and included in the 
analyses. Comparisons of the variables of interest by physical activity levels were performed 
by using t tests, nonparametric median tests (Kruskal Wallis test) or χ2 tests, as appropriate, 
age associations by linear regression and sex differences by t-tests or non-parametric 
Wilcoxon-Mann-Whitney tests. We analyzed the association between long-term change in 
physical activity from SAPALDIA 2 to SAPALDIA 3 and arterial stiffness in SAPALDIA 3 in 2605 
individuals with information on all variables of interest. All statistical analyses were 
performed using the statistical software Stata (StataCorp LP, USA) with P <0.05 defining 
statistical significance. 
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3.5.1 Power Analysis 
The power analyses have been performed with respect to CAVI as arterial stiffness outcome.  
3.5.1.1 Reproducibility of Oscillometrically Measured Arterial Stiffness Indices 
For the analysis of the reproducibility of CAVI and baPWV we calculated the coefficient of 
variation, expressing the standard deviation as a percentage of the mean, based on 
measurements which are either taken in the same session (intra-session variability) or 
between two sessions within 90 days (inter-session variability). A coefficient of variation 
below 5% is assumed to be acceptable for clinical purposes.88 Furthermore, the intraclass 
correlation coefficient has been calculated, which reflects the proportion of the total 
variance that is due to the true variance among subjects. Based on Asian reproducibility 
studies we could assume the intraclass correlation coefficient of CAVI to be around 0.8.75,86,88 
Besides, there is only one study in Caucasians with a small sample of seven healthy 
volunteers aged 28.8 ± 5.1 years showing a low variability of 2.9% expressed as coefficient of 
variation for CAVI on a week-to-week basis.91 In our reproducibility study, 105 subjects were 
measured twice, 90 days apart. Taking these factors into account, the 95%-confidence 
intervals for our reproducibility analysis has been assumed to be narrow (95%-CI 0.725-
0.86). Thus, this reproducibility analysis could produce a precise estimate of the true 
intraclass correlation coefficient. 
3.5.1.2 Association of Arterial Stiffness With Different Levels of Physical Activity 
We classified our study population according to three physical activity levels (low, medium, 
high) based on the IPAQ data. We could assume the distribution of physical activity levels to 
be similar to the one in a previous study with the SAPALDIA sample by Felber Dietrich et al., 
where 42% were categorized as having low, 33% as having medium and 22% as having high 
physical activity.112 Besides, the standard deviation of CAVI as the main outcome for these 
power analyses has been shown to be around 0.8.113 Under the given assumptions we 
estimated to have sufficient power (80%) to statistically detect, at the usual significance level 
of 5%, a slight average effect of physical activity on CAVI of 0.05 per additional physical 
activity level. If 50% of the variance in physical activity were explained by confounder 
variables, we estimated to be able to detect an average effect of 0.08 per level of activity 
with the same power.  
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3.5.1.3 Association of Arterial Stiffness With Change in Physical Activity Between 
SAPALDIA 2 and 3 
For the analysis of the association of arterial stiffness with change in physical activity the 
participant’s change of physical activity from SAPALDIA 2 to 3 was categorized as follows: a) 
as remaining inactive if the participant was inactive in both assessments, b) as becoming 
inactive if active in SAPALDIA 2 but inactive in SAPALDIA 3, c) as becoming active if inactive in 
SAPALDIA 2 but active in SAPALDIA 3, and d) as remaining active if active in SAPALDIA 2 & 3. 
Based on repeated surveys in the Swiss household panel, we assumed the distribution of the 
four groups to be remaining inactive: 30%, becoming inactive: 20%; becoming active: 20%, 
remaining active: 30%.13,14 As an example, we calculated the power for the comparison of 
the most extreme groups (remaining inactive vs. remaining active). With a standard 
deviation of CAVI of 0.8113 and an overall N=3000 we calculated to be able to statistically 
detect, at the usual significance level of 5% and with a power of 80%, a clinically small 
difference of 0.11 between the mean values of CAVI of these two extreme groups. This also 
shows that the study population of this PhD thesis was large enough for comparisons 
between subgroups. 
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Chapter 4 
Publication 1: Reproducibility of Arterial Stiffness 
Indices 
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 Abstract 
 Background . There is an increasing interest in oscillometric arterial stiffness measurement for cardiovascular risk strati-
fi cation. We assessed reproducibility of the cuff-based arterial stiffness measures cardio-ankle vascular index (CAVI), bra-
chial-ankle pulse wave velocity (baPWV) and peripheral augmentation index (pAI) in a subsample of the second follow-up 
of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA 3).  Methods . CAVI, 
baPWV and pAI were measured twice within 90 days in a representative subsample ( n    105) of SAPALDIA 3 with a mean 
age of 63 years (52.4% female).  Results . The mean coeffi cient of variation for CAVI was 4.4%, baPWV 3.9%, and pAI 
7.4%. The intraclass correlation coeffi cient ranged from 0.6 for pAI to 0.8 for CAVI, and 0.9 for baPWV. The mixed linear 
model revealed that 68.7%/80.1%/55.0% of the CAVI/baPWV/pAI variance was accounted for by the subject, 5.2%/8.1%/ 
   0.01% by the fi eldworker, 6.7%/7.8%/28.5% by variation between measurement days, and 19.4%/4%/16.5% by measure-
ment error. Bland-Altman plots showed no particular dispersion patterns except for pAI.  Conclusions . Oscillometric 
arterial stiffness measurement by CAVI and baPWV has proved to be highly reproducible in Caucasians. Results of the 
pAI showed lower reproducibility. CAVI and baPWV can be implemented as easy-to-apply arterial stiffness measures in 
population wide cardiovascular risk assessment in Caucasians. 
 Key Words:  Cardiovascular disease , oscillometry , pulse wave analysis , reproducibility , vascular stiffness 
 Introduction 
 There is an increasing scientifi c interest in oscillomet-
ric arterial stiffness measurement for cardiovascular 
risk stratifi cation due to its easier methodology com-
pared to ultrasonography and applanation tonometry. 
Arterial stiffness is an important predictor of cardio-
vascular disease, events, mortality and morbidity, and 
total mortality [1]. Arterial stiffness refl ects the true 
damage on the arterial wall on account of several car-
diovascular risk factors [2]. In contrast to classical 
biomarkers like mean arterial pressure or glycaemia, 
arterial stiffness does not fl uctuate over the age range, 
but is increasing continuously instead [2]. 
 The  ‘ gold-standard ’ for measuring arterial stiff-
ness non-invasively is the carotid-femoral PWV [1]. 
Applanation tonometry is the most widely used 
method to assess carotid-femoral PWV. Here the 
pulse waveform is obtained by measuring the blood 
pressure locally at the carotid artery and at the fem-
oral artery with a tonometer. However, tonometric 
methods of assessing arterial stiffness are highly 
dependent on the quality of the measurement associ-
ated with the observer ’ s skills based on extensive 
measurement training [3]. Valid arterial stiffness 
measures are needed for large clinical trials, as well 
as for daily clinical use that are highly reproducible 
to give a meaningful prediction of the underlying 
cardiovascular risk at an early stage. 
 The reproducibility and validity of the oscillo-
metrically measured arterial stiffness indices 
Scandinavian Journal of Clinical & Laboratory Investigation, 2015; 75: 170–176
ISSN 0036-5513 print/ISSN 1502-7686 online © 2015 Informa Healthcare
DOI: 10.3109/00365513.2014.993692
 Arterial stiffness reproducibility  171
cardio-ankle vascular index (CAVI) and brachial-
ankle pulse wave velocity (baPWV) has not been 
shown in Caucasian populations. Several studies on 
Asian populations have proven CAVI ’ s clinical use-
fulness [4 – 15] and reproducibility [4,16 – 18] in 
healthy persons and patients. CAVI has been shown 
to be less affected by blood pressure at the time of 
measurement compared to baPWV [19]. There are 
also several Asian studies showing clinical associa-
tions of baPWV with CV risk factors and cardiovas-
cular disease, as well as baPWV as a predictor of 
future cardiovascular events, mortality and subclini-
cal target organ damage [20]. A meta-analysis sum-
marized that an increase in baPWV by 1 m/s is 
associated with a 13% risk increase of cardiovascular 
mortality [20]. However, there is lack of evidence 
concerning the reproducibility of CAVI and baPWV 
for arterial stiffness assessment in larger samples of 
Caucasians. Only one study with a small sample 
( n    7) showed a low variability of 2.9% expressed as 
coeffi cient of variation (CV) for CAVI on a week-to-
week basis in Caucasians [18]. Therefore we ana-
lyzed the clinical reproducibility of the arterial 
stiffness indices CAVI, baPWV and peripheral aug-
mentation index (pAI) obtained simultaneously 
based on a blood-cuff method in a larger study pop-
ulation of Caucasian individuals participating in the 
Swiss Cohort Study on Air Pollution and Lung and 
Heart Diseases in Adults (SAPALDIA). 
 Material and methods 
 Study design and subjects 
 SAPALDIA is a multi-center cohort study with eight 
distinct geographic areas covering the environmental 
and demographic diversity of Switzerland (Aarau, 
Basel, Davos, Gen è ve, Lugano, Montana, Payerne, 
Wald) [23,24]. SAPALDIA was initiated in 1991 to 
investigate the association of air pollution and lung 
diseases among randomly selected adults (18 – 60 
years,  n    9651). The second follow-up (SAPALDIA 3) 
focuses more precisely on cardiovascular health 
assessment. Thus, besides sonographic measurement 
of the carotid-intima media thickness (CIMT) [25 – 27], 
the CAVI, baPWV and pAI were assessed as early 
arterial stiffness and atherosclerosis markers. Data 
collection was fi nished in 2011. The respective Swiss 
cantonal ethical committees have granted ethical 
approval. Participants gave written informed consent 
to participate in the study. 
 Arterial stiffness measurement 
 Arterial stiffness by CAVI, baPWV and pAI was mea-
sured in 3025 subjects of the SAPALDIA 3 cohort. 
In a representative subsample ( n    105) of SAPAL-
DIA 3, we assessed reproducibility of these three 
non-invasive oscillometric arterial stiffness indices. 
We measured arterial stiffness twice at 3 – 5 min inter-
vals on each of two separate days within 3 months 
(Figure 1). 
 CAVI, baPWV, and pAI were measured simulta-
neously using a VaSera VS-1500N vascular screening 
system (Fukuda Denshi, Tokyo, Japan) with the study 
participant being in supine position after 15 min of 
rest. The underlying methodology was extensively 
explained elsewhere [4]. CAVI and baPWV are 
directly associated with the stiffness of the arteries 
and cardiovascular risk. Blood cuffs were placed at 
each upper arm and above each ankle. The cuffs were 
kept at 30 – 50 mmHg to reduce the effect of cuff 
pressure. Electrocardiogram leads at each wrist and 
a phonocardiogram on the sternal border in the sec-
ond intercostal space were applied to detect the ini-
tial notch of the pulse wave at the heart and the 
ankle. Thereby the time delay of the pulse wave from 
the heart to the ankle was determined by a foot-to-
foot-method as the sum of the difference between the 
transmission time of the pulse waves to the brachium 
and the transmission time of the same waves to the 
ankle, and the time difference between the second 
heart sound on the phonocardiogram and the notch 
of the brachial pulse wave [12,16,28]. Vascular length 
(L) between the heart valve and the ankle artery is 
indirectly calculated from the individual height of the 
patient using the formula: 
 L    0.77685    height  – 1.7536 [cm] (according 
to the manufacturer). 
 The PWV is calculated by dividing the arterial 
length by the time delay of the pulse wave. CAVI is 
then mathematically derived from Bramwell-Hill ’ s 
equation and the stiffness parameter  ß with an inclu-
sion of the PWV. 
 The pAI of the VaSera VS-1500N device is calcu-
lated as the ratio between the systolic pressures at the 
peak of the tidal wave and the peak of the percussion 
wave obtained from the right brachial pulse 
wave (according to the operation manual from the 
Figure 1. Study fl ow chart.
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manufacturer, Ver.04). Therefore the obtained pAI 
refl ects the ratio of the second pressure wave peak to 
the fi rst assessed from the right brachial artery 
expressed in percent. That is to say that pAI stands 
for the augmentation of the pressure pulse that occurs 
due to refl ections of the forward travelling pulse wave 
at sites of impedance changes in the periphery [29]. 
 Statistical analyses 
 The reproducibility analyses included means of indi-
vidual between-visit coeffi cients of variation (CV) 
and intraclass correlation coeffi cients (ICC) using 
one-way analysis of variance. Mixed linear models 
were applied to produce detailed information on the 
sources of variability of repeated CAVI, baPWV and 
pAI measurements. The models included a fi xed 
effect of time and random effects of subject, mea-
surement day within subject, and fi eldworker. We 
used Bland-Altman plots (BAP) for graphical analy-
ses [30]. For regression analyses, outcome data were 
averaged between left and right, separately for each 
of the two measurement time points of each day. For 
other analyses, averages were taken over all measure-
ments of the respective day. All statistical analyses 
were performed using the statistical software STATA 
(StataCorp LP, Release 12, TX, USA);  p    0.05 was 
regarded as signifi cance level. 
 Results 
 This randomly selected and representative subsam-
ple of the SAPALDIA 3 cohort study included 105 
subjects with a mean age of 63 years, an age range 
of 50 – 79 years and a mean body mass index of 25.5 
(standard deviation [SD], 4.1) kg/m 2 . 55 (52.4%) 
subjects were female. The mean systolic blood pres-
sure was 130.1 (12.9) mmHg and the mean diastolic 
blood pressure 80.0 (8.4) mmHg. 
 The mean of individual CVs of repeated CAVI 
measurements was 4.4%, of baPWV 3.9% and of 
pAI 7.4%. The ICC ranged from 0.6 for pAI to 0.9 
for baPWV (Table I). The mixed linear model 
revealed that the subject accounts for 68.7% of the 
unexplained CAVI variance (80.1% baPWV, 55.0% 
pAI), measurement day within subject for 6.7% and 
the fi eldworker for 5.2%. Residual variance accounted 
for 19.4% in the CAVI model, 4.0% for baPWV and 
16.5% for pAI. 
 The BAP (Figure 2) of repeated CAVI measure-
ments relates the individual CAVI differences between 
the two measurement days to the respective indi-
vidual means. The mean differences with 95% con-
fi dence intervals (CI) in percent of the respective 
mean were for CAVI 1.7% (CI: 0.2%, 3.2%), for 
baPWV 0.9% (CI:    0.4%, 2.3%) and for pAI 0.7% 
(CI:    2.2%, 3.5%). The mean CAVI difference 
between the two measurement days was statistically 
signifi cant ( p    0.02), but neither the baPWV differ-
ence ( p    0.14) nor the pAI difference ( p    0.52) was 
signifi cant. The CAVI and baPWV BAP showed 
homogeneous scatter of individual differences within 
limits of agreement displaying the interval of 1.96 
SD of the measurement differences either side of the 
mean difference in percent of the mean of    13.7% 
to 17.1% for CAVI and    13.1% to 15.0% for 
baPWV. The pAI BAP tended to heterogeneous scat-
ter with higher pAI values at the second measure-
ment day with increasing pAI means. Table II shows 
the means of each measurement day, mean differ-
ences and limits of agreement. 
 Discussion 
 The main study result shows that the oscillometri-
cally measured arterial stiffness indices CAVI and 
baPWV are highly reproducible in Caucasians in a 
cohort setting. The methodology is applicable for 
large clinical trials or cohort studies. The simultane-
ously assessed pAI of the VaSera VS-1500N device 
of Fukuda Denshi (Tokyo, Japan) shows lower repro-
ducibility. 
 A CV of less than 5% is commonly regarded as 
threshold for clinical useful testing in medicine [17]. 
Our mean CVs of CAVI and baPWV were below this 
threshold indicating high reproducibility and appli-
cability of CAVI and baPWV for arterial stiffness 
measurement in Caucasians. Our reproducibility 
 Table I. Intraclass correlation coeffi cients (ICC) and mean coeffi cient of variation (CV) with 95% confi dence interval (CI) and percent 
variance explained by the factors subject, measurement day within subject, fi eldworker and by the residuals. 
ICC (95% CI)
Mean CV [%] 
(95% CI)
Variance [%] explained by
Unexplained 
variance [%]subject measurement day fi eldworker
CAVI 0.80 (0.73 – 0.87) 4.38 (3.67 – 5.09) 68.71 6.71 5.21 19.37
baPWV [m/s] 0.90 (0.87 – 0.94) 3.88 (3.32 – 4.44) 80.13 7.84 8.08 3.95
pAI 0.59 (0.47 – 0.72) 7.35 (6.13 – 8.56) 55.03 28.47    0.01 16.50
SBP [mmHg] 0.69 (0.59 – 0.79) 4.40 (3.64 – 5.16) 64.13 22.48 4.75 8.64
DBP [mmHg] 0.70 (0.61 – 0.80) 4.72 (3.94 – 5.51) 66.65 20.57 3.30 9.48
 CAVI, Cardio-ankle vascular index; baPWV, brachial-ankle pulse wave velocity; pAI, peripheral augmentation index; SBP, systolic blood 
pressure; DBP, diastolic blood pressure. 
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analyses by mean CV and BAP are consistent with 
fi ndings in Asian populations, both in healthy sub-
jects [4] and patients [17]. This is the case even 
though our validation sample was far larger, which 
could increase the variability. The only study in a very 
small Caucasian sample ( n    7) showed a week to 
week CV of 2.9% [18]. In addition to CV, the most 
commonly used statistical measure of reproducibil-
ity, we used ICCs, mixed linear regression models 
and BAPs to overcome drawbacks of single methods 
and to confi rm the statistical analyses as recom-
mended [31]. 
 The CV results are strengthened by the very good 
ICCs of 0.8 for CAVI and 0.9 for baPWV, respec-
tively. The ICC quantifi es reproducibility of repeated 
measurements by refl ecting the proportion of the 
total variability that is attributable to the subject 
[32]. The high proportion of variance on account of 
the subject within the mixed model (CAVI, 68.7%; 
baPWV, 80.1%) is in line with the high ICC value. 
It shows that most of the measurement variance of 
these indices is due to subject specifi c characteristics. 
Since the calculation of the ICC is not accounting 
for covariates like fi eldworker or measurement day 
within subject, the ICCs are slightly higher. Here the 
variances of the covariates accounted for in the mixed 
model are attributed to the subject. The comparably 
high unexplained variance in the model for CAVI of 
19.4% and for pAI of 16.5% (baPWV, 4.0%) signals 
that there is still a considerable amount of uncer-
tainty connected with the statistical modelling of 
CAVI and pAI. In addition the regression analyses 
show that the fi eldworker effect is small with 5.2% 
of the CAVI variance and 8.1% of baPWV. CAVI and 
baPWV measurement involves basic clinical devices 
(blood cuffs, electrocardiogram leads, phonocardio-
gram), which makes it easily applicable. Our data 
show that CAVI and baPWV measurement with the 
VaSera VS-1500N screening system has limited need 
for fi eldworker training in a standardized setting. The 
signifi cant CAVI difference of 0.15 between the fi rst 
and second measurement relates to a proportion of 
only 1.7% of the CAVI mean and only 15% of the 
CAVI SD. From a clinical point of view this differ-
ence can be regarded as non-relevant, since the 
difference is much less than half of one SD [33]. 
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Figure 2. Bland-Altman plots of arterial stiffness indices cardio-
ankle vascular index (CAVI), brachial-ankle pulse wave velocity 
(baPWV) and peripheral augmentation index (pAI) at two different 
measurement days with mean difference as thin black line and 
limits of agreement (mean [2SD]) as dashed black lines.
 Table II. Mean and standard deviation (SD) of CAVI, baPWV and pAI of each measurement day 
(1st/2nd). 
1st mean (SD) 2nd mean (SD) Mean difference (CI) [%] LoA [%]
CAVI 8.52 (1.01) 8.38 (1.10) 1.72 (0.22 – 3.21)    13.67; 17.10
baPWV [m/s] 13.48 (2.13) 13.36 (2.14) 0.94 (   0.42 – 2.30)    13.13; 15.00
pAI 1.06 (0.16) 1.05 (0.18) 0.66 (   2.17 – 3.50)    28.58; 29.91
SBP [mmHg] 131.81 (15.06) 128.34 (12.64) 2.67 (1.10 – 4.24)    13.54; 18.89
DBP [mmHg] 81.11 (9.42) 78.90 (8.63) 2.77 (1.16 – 4.39)    13.89; 19.34
 CAVI, Cardio-ankle vascular index; baPWV, brachial-ankle pulse wave velocity; pAI, peripheral 
augmentation index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LoA, limits of 
agreement. 
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This statistical signifi cance does not affect the very 
good CAVI reproducibility. 
 BAP is the accepted method for reproducibility 
testing of a new measurement in medical science 
graphically [31]. Kubozono et  al. measured CAVI in 
21 Japanese twice within two weeks [16]. Both their 
relative mean CAVI difference (2.4%) and their BAP 
limits of agreement in percent from the mean 
from    14.4% to 20.5% were comparable to our 
study results. The Pearson correlation between the 
two measurements was very strong indeed ( r    0.93, 
 p   0.0001). However, the Pearson correlation coef-
fi cient is not a suffi cient measure of reproducibility 
[30,31]. Linear correlation does not account for sys-
tematic bias in the mean or the dispersion of two 
related measurements nor for differences in scale. It 
is a measure of the strength of linear association of 
two variables rather than of the agreement between 
two measurements [34]. 
 The pAI assessed with the VaSera VS-1500N 
device reveals a distinct lower reproducibility than 
CAVI and baPWV. With an ICC of 0.6, a CV above 
5% (7.4%) and the subject accounting for only 
55.0% of the total measurement variance all of the 
reproducibility measures of pAI ranged below the 
results of CAVI and baPWV. Furthermore, the pAI 
BAP showed an inhomogeneous scatter with 
increasing pAI means and broader limits of agree-
ment. In contrast to the central augmentation index 
used generally [35], the pAI given by the VaSera 
VS-1500N device refl ects vascular stiffness assessed 
peripherally from the right brachial pulse wave 
(according to the operation manual of the manufac-
turer, Ver.04, p. 14 – 6). It can be hypothesized that 
the difference in reproducibility between the three 
indices is related to the variation in the included 
vessel segments. It has also clearly been shown that 
the augmentation index is affected by heart rate 
variation resulting in considerable short-term 
changes [36]. This may also negatively impact on 
the pAI reproducibility. There is no ongoing study 
using the pAI of the VaSera device for pulse wave 
analyses to our knowledge. However, it has been 
shown that pAI is closely related to central AI 
because of the strong link between the late systolic 
peak and central systolic blood pressure [29]. There-
fore, pAI may have further prognostic and thera-
peutic potential concerning central hemodynamics 
[29]. More research on this pAI is needed to inves-
tigate its validity for future clinical use and cardio-
vascular investigations. 
 The strength of this study is the large representa-
tive reproducibility sample, as well as the extensive 
statistical measures investigated. For the fi rst time 
the reproducibility of the arterial stiffness indices 
CAVI and baPWV is analyzed in a larger Caucasian 
sample. The data are derived from a population-
based cohort and each measurement is conducted in 
concordance with a detailed protocol. Furthermore, 
for the purpose of such a methodological study a 
large sample ( n    105) was analyzed compared to 
other reproducibility studies ( n    7 – 35) [4,16 – 18,37]. 
Up to date the carotid to femoral (aortic) PWV is 
still considered the  ‘ gold-standard ’ for arterial stiff-
ness assessment [1]. This measurement has proven 
good reproducibility [37], but has major drawbacks 
in terms of substantial need in fi eldworker training 
and concerning the sensitivity of the measuring site 
at the femoral artery [38]. A limitation of our study 
is the lacking internal comparison with another 
method. However, a previous study showed that 
carotid-femoral PWV assessed with the SphygmoCor 
device (AtCor, Medical Pty Ltd, Sydney, Australia) 
had a nearly twice as high intra-session variability 
expressed as CV (6.1% vs. 3.2%) than for CAVI in 
Caucasians [18]. 
 Conclusions 
 In summary, this study has proven good reproduc-
ibility of the non-invasive, cuff-based arterial stiffness 
indices CAVI and baPWV in a subsample of a 
Caucasian cohort. CAVI measurement is based on 
the easy-to-apply oscillometric measurement of the 
baPWV. Results of the pAI derived from the VaSera 
VS-1500N vascular screening system demonstrated 
to be less reproducible. The reasons for this fi nding 
need further investigation. CAVI and baPWV are 
highly suitable and recommendable for population 
wide studies or cardiovascular risk assessment and 
surveillance on the individual and population level in 
Caucasians. 
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Abstract Associations of physical activity (PA) intensity
with arterial stiffness in older adults at the population level
are insufficiently studied. We examined cross-sectional
associations of self-reported PA intensities with arterial
stiffness in elderly Caucasians of the Swiss Cohort Study
on Air Pollution and Lung and Heart Diseases in Adults.
Mixed central and peripheral arterial stiffness was mea-
sured oscillometrically by the cardio-ankle vascular index
(CAVI) and brachial-ankle pulse wave velocity (baPWV).
The self-reported International Physical Activity Ques-
tionnaire long version was administered to classify each
subject’s PA level. We used univariable and multivariable
mixed linear and logistic regression models for analyses in
1908 persons aged 50 years and older. After adjustment for
several confounders moderate, vigorous and total PA were
inversely associated with CAVI (p = 0.02–0.03). BaPWV
showed negative and marginally significant associations
with vigorous and moderate PA (each p = 0.06), but not
with total PA (p = 0.28). Increased arterial stiffness
(CAVI C 9, upper tertile) was inversely and significantly
associated with vigorous PA [odds ratio (OR) 0.65, 95 %
confidence interval (CI) 0.48–0.88], and marginally sig-
nificantly with total PA (OR 0.76, 95 % CI 0.57–1.02) and
moderate PA (OR 0.75, 95 % CI 0.56–1.01). The odds
ratio for baPWV C 14.4 was 0.67 (95 % CI 0.48–0.93)
across the vigorous PA levels, and was non-significant
across the total (OR 0.91, 95 % CI 0.66–1.23) and mod-
erate PA levels (OR 0.94, 95 % CI 0.69–1.28). In this
general Caucasian population of older adults higher levels
especially of vigorous PA were associated with lower
arterial stiffness. These data support the importance of PA
for improving cardiovascular health in elderly people.
Keywords Arterial stiffness  Cardiovascular disease
prevention  Epidemiology  Physical exercise  Prevention
Background
Physical inactivity is regarded as one of the main risk
factors for both non-communicable diseases in general and
cardiovascular diseases in particular [1]. 6 % of the burden
of disease from coronary heart disease and 9 % of pre-
mature deaths worldwide in 2008 are attributable to
physical inactivity [2]. Adherence to physical activity (PA)
guidelines is suggested to reduce the mortality rate by
25 % [3] and an increase of PA by 10 or 25 % could
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prevent more than 533,000 or 1.3 million deaths, respec-
tively, per year worldwide [2]. A physically active lifestyle
is linked with decreased risk of cardiovascular diseases and
events at all ages through improvements in arterial stiffness
reflecting arterial remodeling [4–6]. Arterial stiffness is a
reversible, non-invasive structural biomarker of potentially
grave cardiovascular modifications and is independently
associated with cardiovascular disease and events [7, 8].
Stiffening of the arteries is closely linked with ageing
related elastin degeneration and collagen proliferation
reflecting vascular ageing [9].
The current European Guidelines on cardiovascular
disease prevention in clinical practice of the European
Society of Cardiology [10] and PA guidelines [11] rec-
ommend a minimum of 150 min per week of at least
moderate intensity for adults to beneficially impact on the
population health and cardiovascular mortality. However,
in larger samples associations between PA intensities and
arterial stiffness have so far mainly been analyzed
regarding central arterial stiffness in adolescents and mid-
dle-aged persons [12–15]. In two population based studies
of older adults walking speed was inversely associated with
central arterial stiffness [16, 17]. Besides, there are only
two medium sized cross-sectional studies showing that PAs
of different intensities are associated with lower central
arterial stiffness in older adults [18, 19].
The cardio-ankle vascular index (CAVI) and brachial-
ankle pulse wave velocity (baPWV) are mixed measures of
central and peripheral arterial stiffness that have mainly
been studied in Asian populations so far [20, 21]. There are
no data on the population level in older adults of the
association between different intensities of PA and arterial
stiffness measured by CAVI and baPWV. Therefore, we
examined associations of self-reported PA intensities with
these arterial stiffness indices in the Swiss Cohort Study on
Air Pollution and Lung and Heart Diseases in Adults
(SAPALDIA).
Methods
Study design and participants
SAPALDIA 3 is the second follow-up assessment of an
ongoing multi-center cohort study including eight distinct
rural and urban areas which represent the environmental
and demographic diversity of Switzerland (Aarau, Basel,
Davos, Geneva, Lugano, Montana, Payerne, Wald) [22,
23]. SAPALDIA was initiated in 1991 to investigate the
association of air pollution and lung diseases among ran-
domly selected adults (18–60 years, N = 9651). SAPAL-
DIA 3 additionally focused on cardiovascular health
assessment and arterial stiffness was measured in 3068
subjects of the cohort aged at least 50 years. The respective
Swiss cantonal ethical committees have granted ethical
approval and participants gave written informed consent.
Arterial stiffness measurement
Mixed central and peripheral arterial stiffness was mea-
sured oscillometrically and simultaneously by CAVI and
baPWV using a non-invasive VaSera VS-1500N vascular
screening system (Fukuda Denshi, Tokyo, Japan). All
measurements were taken in supine position after 10 min
of rest in a quiet room with constant temperature. Blood
cuffs were placed at each upper arm and above each ankle.
ECG electrodes at each wrist and a phonocardiogram on
the sternal border in the second intercostal space were
applied to detect the initial notch of the pulse waves at the
heart and the ankle on average over six heart cycles. The
time delay of the pulse wave from the heart to the ankle
was determined by a foot-to-foot-method. Vascular length
between the heart valve and the ankle artery was estimated
by the VSS-10 software (Fukuda Denshi) using a height
based formula [24]. The PWV is calculated by dividing the
arterial length by the time delay of the pulse wave. CAVI is
then automatically derived from Bramwell-Hill’s equation
and the stiffness parameter b with an inclusion of the PWV
[25]. Therefore, CAVI is less dependent on blood pressure
at the time of measurement than aortic PWV [26] and
baPWV [27]. The average of two consecutive measure-
ments at 3–5 min intervals and of both body sides was
taken for analyses. The CAVI and baPWV reproducibility
was previously shown to be high in this Caucasian cohort
[28]. CAVI reflects arterial stiffness of the aorta and the
iliac, femoral and tibial arteries [25] and baPWV between
the brachial and tibial arteries [29]. Since both of these
indices cover different segments of the arterial tree, they
reflect a combination of central and peripheral arterial
stiffness [20, 21].
Physical activity assessment
The self-reported International Physical Activity Ques-
tionnaire (IPAQ) long version was administered to classify
the PA level in 3072 individuals [30]. The IPAQ long form
asks for the frequency and duration of moderate and vig-
orous PA in different domains performed during the last
7 days (leisure time PA, domestic and gardening (yard)
activities, work-related PA, transport-related PA) [31].
Moderate and vigorous intensities were associated with
harder and much harder breathing, respectively. Minutes
per week of moderate PA (including walking), vigorous PA
and total PA as a sum of minutes per week of moderate and
vigorous PA were calculated following the IPAQ guideli-
nes [31]. They were weighted by their energy cost as
S. Endes et al.
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metabolic equivalents (MET) with one MET equating to
around one kcal/kg/hour, which approximately corresponds
to sitting quietly. This leads to a MET-minutes per week
score reflecting total energy expenditure [32]. Total PA is
therefore a combined measure of amount and intensity of
PA in terms of MET-minutes per week of moderate and
vigorous PA. We calculated levels (‘‘low’’, ‘‘medium’’ and
‘‘high’’) of each category of PA (moderate, vigorous and
total PA). Levels of moderate and total PA were calculated
by tertile classes. Vigorous PA was not categorized in
tertiles due to the clustering of answers (56.8 % of subjects
reported no vigorous PA and 6.2 % reported 960 MET-
min/week of vigorous PA). All subjects without vigorous
PA were assigned to the lowest level of vigorous PA
(N = 1084). Since 118 subjects reported on exactly 960
MET-min/week of vigorous PA corresponding to the
threshold between the medium and high level of vigorous
PA, these subjects were all assigned to the medium level to
achieve the best possible balance of group sizes. Thus, the
chosen categorization of vigorous PA is the best approxi-
mation to a categorization by tertiles as for moderate and
total PA.
Statistical analyses
If not stated otherwise, data are expressed as median (25th
and 75th percentile). Comparisons of the variables of
interest by PA levels were performed by using t test,
nonparametric median test (Kruskal–Wallis test) or v2 test,
as appropriate and age associations by linear regression.
CAVI and baPWV were analyzed as continuous outcomes
and when stated in dichotomized form, with a threshold for
increased arterial stiffness of 9 for CAVI (comparing the
highest to the lower two tertiles) and of 14.4 m/s for
baPWV (comparing the highest to the lower two tertiles),
respectively. We used univariable (Model 1) and multi-
variable mixed linear and logistic regression models for
analyses including a random area effect to account for the
multi-center study setting. In Model 2, the association of
arterial stiffness with PA was adjusted for age and sex and
in Model 3 additionally for body mass index, smoking
status defined as packyears up to SAPALDIA 3, educa-
tional status, mean arterial pressure, heart rate, and medi-
cation. Medication intake was categorized in two classes:
0, no cardiovascular or metabolic disease related medica-
tion; 1, medication for kidney disease, diabetes, hyper-
lipidemia, hypertension, stroke, myocardial infarction,
heart failure, angina and arrhythmia. We a priori defined
and investigated several potentially important interactions
and included the interaction terms age–sex and sex–mean
arterial pressure in the final Model 4 based on the inclusion
criteria p = 0.1. We used backward selection of variables
using the Akaike Information Criterion (AIC) and tested
non-linear terms using residual-versus-predicted-plots to
derive the best fitting model. All statistical analyses were
performed using the statistical software STATA (StataCorp
LP, Release 12, Texas, USA) with p = 0.05 as significance
level.
Results
Subject characteristics
In 1908 out of 3068 individuals data of both arterial stiff-
ness and IPAQ were available. The analytic sample was on
average significantly older (63.3 vs 58 years, p\ 0.001)
and had significantly lower baPWV (13.8 vs 14.1 m/s,
p\ 0.001), body mass index (26.1 vs 26.5 kg/m2,
p\ 0.05), total PA (5279 vs 5810 MET-min/week,
p\ 0.05), vigorous PA (1023 vs 1454 MET-min/week,
p\ 0.001), mean arterial pressure (99.3 vs 100.3 mmHg,
p\ 0.05) and heart rate (61.9 vs 63.1 bpm, p\ 0.05)
compared to the whole arterial stiffness and IPAQ sample
of SAPALDIA 3. CAVI, moderate PA and the number of
smoking packyears were not significantly different. The
main characteristics by vigorous PA levels are listed in
Table 1.
Associations of age and sex with physical activity
and arterial stiffness
A significant sex difference with respect to PA was present
only in vigorous PA with higher values in males
(p\ 0.001) (Supplemental Table S1). There was a signif-
icant age associated decline in total PA for females
(p\ 0.01 oldest to youngest age category), but not for
males (p = 0.71) (Supplemental Table S2). Vigorous PA
decreased significantly in both sexes with increasing age
category (p\ 0.001 oldest to youngest age category).
Moderate PA increased in both sexes from the age of
50-59 years to 60-69 years, significantly only in males
(p\ 0.01; females p = 0.09), and decreased in older par-
ticipants with higher amounts of moderate PA compared to
age 50–59 years significant only in males (p = 0.03), but
not in females (p = 0.53). CAVI and baPWV increased
significantly with age in both sexes (every p\ 0.001);
CAVI on average by 0.9 per decade and baPWV by 1.8 m/
s, respectively (Supplemental Fig. S1). Statistically sig-
nificant gender differences were observed for CAVI in the
age groups 60–69 (p\ 0.001) and 70–81 (p\ 0.01) and
for baPWV in the age groups 50–59 (p = 0.01) and 60–69
(p\ 0.01), with lower values among women (Supple-
mental Fig. S1).
Physical activity is associated with lower arterial stiffness in older adults: results of the…
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Association of physical activity with arterial stiffness
In the univariable analyses the means of CAVI and baPWV
both decreased across levels of moderate, vigorous and total
PA, however significantly only for vigorous PA (every
p\ 0.001), where more than a third of the participants did
not report on any vigorous PA. Tables 2 and 3 show the
regression results for CAVI and baPWV as a function of PA
for each of the four models. In the multivariable analyses of
CAVI there was a significant inverse association of CAVI
with PA after adjustment in Model 2 for total and vigorous
PA comparing the high with the low PA level (each
p = 0.04) and for moderate PA comparing the medium with
the low PA level (p = 0.03), but not between high and low
PA (p = 0.09). This inverse association was strengthened
upon further adjustment in Model 3 with significant asso-
ciations between the high and low PA level for total
(p = 0.03) and vigorous PA (p = 0.02) and marginally
significant for moderate PA comparing medium and low PA
(p = 0.05), but not high and low PA (p = 0.10). Inclusion
of the interaction terms age–sex and sex–mean arterial
pressure in Model 4 further strengthened the associations of
CAVI with the respective PA levels (p = 0.02–0.03).
BaPWV showed negative and marginally significant asso-
ciations with vigorous PA comparing the high with the low
level and with moderate PA comparing the medium with the
low level (each p = 0.06), but not significantly with total
PA after adjustment in Model 3 and 4.
Table 1 Study population main characteristics across vigorous physical activity (PA) levels (N = 1898)
Units Vigorous PA level p
Low (N = 1084) Medium (N = 326) High (N = 488)
Age Years 65.0 (59.0; 70.9) 61.7 (55.8; 66.4) 60.9 (54.7; 66.3) \0.001
baPWV m/s 13.07 (12.27; 15.42) 13.00 (11.48; 14.60) 13.00 (11.48; 14.60) \0.001
CAVI No unit 8.72 (7.93; 9;47) 8.34 (7.64; 9.20) 8.40 (7.69; 9.05) \0.001
Mean arterial pressure mmHg 99 (92; 107) 98 (90; 105) 99 (92; 107) 0.37
Heart rate bpm 62 (56; 69) 59 (54; 64) 60 (54; 65) \0.001
Body mass index kg/m2 26.0 (23.3; 29.1) 25.3 (22.6; 27.5) 25.4 (23.0; 28.3) 0.01
Smoking Packyears 0.4 (0; 20.0) 0 (0; 14.5) 2.0 (0; 20.0) 0.02
Moderate PA MET-min/week 2832 (1356; 5292) 2753 (1449; 5202) 4821 (2588; 8148) \0.001
Vigorous PA MET-min/week 0 (0; 0) 680 (480; 960) 2880 (1860; 4580) \0.001
Total PA MET-min/week 2832 (1356; 5292) 3455 (2130; 6036) 8236 (5384; 11,909) \0.001
N (%) N (%) N (%) p
Medication
0 647 (34.1) 230 (12.1) 337 (17.8) \0.001
1 437 (23.0) 96 (5.1) 151 (8.1)
Medication for
DKidney disease 3 (0.2) 3 (0.2) 0 (0)
Diabetes 2 (0.1) 6 (0.3) 14 (0.7)
Hyperlipidemia 190 (10.0) 42 (2.2) 62 (3.3)
Hypertension 308 (16.2) 70 (3.7) 103 (5.4)
Stroke 17 (0.9) 4 (0.2) 5 (0.3)
Myocardial infarction 20 (1.1) 6 (0.3) 8 (0.4)
Heart failure 8 (0.4) 2 (0.1) 4 (0.2)
Angina pectoris 15 (0.8) 1 (0.1) 9 (0.5)
Arrhythmia 40 (2.1) 8 (0.4) 10 (0.5)
Education
Low 64 (3.4) 10 (0.5) 18 (0.9) 0.15
Middle 700 (36.9) 213 (11.2) 328 (17.3)
High 320 (16.9) 103 (5.4) 142 (7.5)
BaPWV, brachial-ankle pulse wave velocity; CAVI, cardio-ankle vascular index; Education low, primary school; middle, secondary school,
middle school or apprenticeship; high, Technical College or University; Medication 0, no cardiovascular or metabolic disease related medication;
1, medication for kidney disease, diabetes, hyperlipidemia, hypertension, stroke, myocardial infarction, heart failure, angina and arrhythmia;
MET, metabolic equivalent; PA, physical activity. Values are median and 25th, 75th percentile or N (%). Percentages and p values for
comparisons across vigorous PA levels. Percentages may not add up to 100 % due to rounding
S. Endes et al.
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There was a significant positive age–sex (each
p = 0.03) and marginally significant positive sex–mean
arterial pressure interaction (each p = 0.05) in the models
estimating the association between CAVI and PA. With
increasing mean arterial pressure, the sex difference in
CAVI increased, with higher values in males for moderate,
vigorous and total PA (exemplarily for total PA in Sup-
plemental Fig. S2). The interaction terms were not statis-
tically significant in the baPWV models.
The fully adjusted (Model 4) CAVI means decreased
significantly from 8.67 to 8.56 from the high to the low
total PA level, similarly from 8.64 to 8.53 for vigorous PA
and from 8.67 for the low moderate PA level to 8.57 for the
medium moderate PA level (Fig. 1). The fully adjusted
baPWV means decreased non-significantly from 13.78 to
13.65 m/s across total PA levels (from low to medium),
from 13.77 to 13.60 m/s for vigorous PA (from low to
high) and from 13.80 to 13.63 m/s for moderate PA (from
low to medium).
Odds ratios
The marginal probability of CAVI C 9 decreased from
0.37 to 0.31 (p\ 0.01) significantly across vigorous PA
levels with an odds ratio (OR) of 0.65 (95 % Confidence
Interval (CI) 0.48–0.88) for the highest level compared to
the lowest, and marginally significant from 0.37 to 0.33
across total PA levels (p = 0.07, OR 0.76, 95 % CI
0.57–1.02), and from 0.38 to 0.34 across moderate PA
levels (p = 0.06, OR 0.75, 95 % CI 0.56–1.01). These
results are derived from mixed logistic regression analyses
with the same adjustment as in Model 4 (Table 4 and
Supplemental Fig. S3). Similarly, the marginal probability
of baPWV C 14.4 decreased significantly from 0.33 to
0.28 for vigorous PA levels (p = 0.02, OR 0.67, 95 % CI
0.48–0.93), but non-significantly across the total (from 0.33
to 0.32, p = 0.53, OR 0.91, 95 % CI 0.66–1.23) and
moderate PA levels (from 0.33 to 0.32, p = 0.69, OR 0.94,
95 % CI 0.69–1.28).
Fig. 1 Fully adjusted (Model 4) means of cardio-ankle-vascular-index (CAVI) and brachial-ankle pulse wave velocity (baPWV) across total,
vigorous and moderate physical activity (PA) levels. *p\ 0.05 compared to low PA level
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Discussion
The results of this cross-sectional study in a very well
characterized cohort of elderly Caucasian subjects from the
general population suggest that higher levels of self-re-
ported PA are associated with lower arterial stiffness, even
after adjustment for several potential confounders. Espe-
cially vigorous PA was linked with lower arterial stiffness
in this ageing population. These data support the impor-
tance of PA for improving cardiovascular health in elderly
people and suggest that vigorous PA promotion in this age
group may prevent against increased arterial stiffness
resulting from atherosclerotic processes.
Our results are in agreement with previous cross-sec-
tional studies which suggest that higher levels of PA may
have a protective effect on the vascular system [16, 17].
Thereby, it has to be kept in mind, that the effect of PA on
arterial stiffness varies across the arterial tree [15, 33]. In a
comparable cohort of older adults of the Whitehall II study
higher arterial stiffness measured as carotid-femoral PWV
was strongly associated with reduced walking speed and
self-reported physical functioning [16]. Similarly, lower
walking speed was linked with increased carotid-femoral
PWV in a general population aged 70–79 years of the
Health ABC Study, however, this association was depen-
dent on the presence of hypertension and other vascular
risk factors [17]. Aoyagi et al. [33] examined the associa-
tion of habitual PA ([3 metabolic equivalents) measured
by step counts and arterial stiffness in 198 Japanese people
aged 65–84 years . They reported on a beneficial effect of
PA on the stiffening of central arteries, but not on the
peripheral vasculature. Controversial results can be found
regarding the intensity-dependence of this PA effect. In a
medium sized longitudinal study particularly PA at higher
intensity was favorable regarding central and peripheral
arterial stiffness in younger persons [14, 15]. In the only
study analyzing baPWV and PA intensities an increase in
moderate-to-vigorous PA, but not light intensity PA, was
linked with a decrease of baPWV in 274 overweight and
obese young adults longitudinally within 1 year [20]. In
103 postmenopausal women moderate and vigorous PA
was inversely associated with central arterial stiffness [19].
Yet, also long-term maintenance of low intensity PA was
associated with lower central arterial stiffness in older
adults [18].
Intervention studies with rather small sample sizes have
demonstrated that arterial stiffness may be modifiable by
exercise training in older adults [34–36]. A 1 year vigorous
endurance exercise program improved arterial stiffness
indices in twelve persons aged on average 70.3 years, who
were sedentary before [34]. However, a short-term
12 week moderate intensity PA program did not change
arterial stiffness in 113 persons aged 50–80 [37]. Five
recent systematic reviews of intervention studies show
conflicting results concerning the effects of exercise
interventions on arterial stiffness. Two of them found a
significant positive effect of aerobic exercise on arterial
stiffness especially at higher intensity [35, 36], however
neither in pre- and hypertensive [38] nor in middle-aged
and older obese persons [39]. The results regarding resis-
tance training are controversial ranging from negative
effects [40] to beneficial effects depending on the intensity,
muscle groups involved and the movement execution [35,
36]. The discrepancies in these results may be due to
whether or not non-randomized controlled trials have been
included in the reviews, small sample sizes for subgroup
analyses, different arterial stiffness measures, and varying
statistical analyses. Thus, intervention study results show
that there are beneficial effects of exercise training on
arterial stiffness depending on the intensity and modality
[34–37]. Our results show an association in line with these
intervention study effects in terms of a beneficial rela-
tionship between higher amounts of regularly performed
PA, especially at higher intensity, on arterial stiffness in
older adults at the population level.
CAVI and baPWV are valid vascular biomarkers for
non-invasive arterial stiffness assessment and are associ-
ated with cardiovascular disease risk and outcomes [41–
44]. Both CAVI and baPWV have shown good correlations
with central arterial stiffness [29, 45]. In a systematic
review of clinical studies, a 1 m/s reduction in baPWV was
associated with an increase in total cardiovascular events,
cardiovascular mortality, and all-cause mortality by 12, 13,
and 6 %, respectively [43]. CAVI is methodologically
Table 4 Odds ratios (OR) of
cardio-ankle vascular index
(CAVI) C 9 and brachial-ankle
pulse wave velocity
(baPWV) C 14.4 m/s across
moderate, vigorous and total
physical activity (PA)
Variable PA Medium compared to low PA level High compared to low PA level
OR 95 % CI p OR 95 % CI p
CAVI Total 0.87 0.65 1.17 0.36 0.76 0.57 1.02 0.07
Vigorous 0.91 0.65 1.27 0.60 0.65 0.48 0.88 \0.01
Moderate 0.75 0.56 1.01 0.06 0.75 0.56 1.01 0.06
baPWV Total 0.94 0.68 1.29 0.69 0.91 0.66 1.24 0.53
Vigorous 0.93 0.64 1.34 0.69 0.67 0.48 0.93 0.02
Moderate 0.89 0.64 1.22 0.46 0.94 0.69 1.28 0.69
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based on the baPWV measurement with improvements
regarding the correlation with blood pressure [25]. Since
CAVI is mathematically derived from the stiffness
parameter b and a modified Bramwell-Hill equation, CAVI
could be shown to be less dependent on the blood pressure
at the time of measurement compared to baPWV [27].
CAVI includes stiffness of the aorta, femoral artery and
tibial artery [25], whereas baPWV reflects the PWV to the
upper arm and foot ignoring the influence of PWV to the
arm as a possible modifier of the overall stiffness without
precise definition of the distance from the heart to the upper
arm [46]. These differences between CAVI and baPWV
might explain that both indices do not show exactly the
same results concerning their association with PA. How-
ever, they point to consistent conclusions towards lower
arterial stiffness with higher PA.
CAVI and baPWV were on average 0.10 and 0.16 m/s,
respectively, lower in persons of the high PA level com-
pared to the low PA level across moderate, vigorous and
total PA in the fully adjusted Model 4. Thereby, it has to be
kept in mind that moderate and total PA levels have been
generated according to tertiles of MET-min/week, while
this was not possible for vigorous PA where more than a
third of subjects (N = 1084) did not report on any vigor-
ous. In this general population aged 50–81 years, CAVI
increased significantly on average by 0.87 per decade and
baPWV by 1.84 m/s (see Supplemental Fig. S1). There-
fore, higher levels of PA were associated with a favorable
decrease of CAVI corresponding to around 1.1 years and
for baPWV to 0.9 years of age related decrease in arterial
stiffness independent of the main confounding factors. This
strengthens the evidence that PA can be implemented in
cardiovascular health guidelines to counteract the vascular
aging process and prevent early vascular aging as sug-
gested by Nilsson et al. [9]. Nevertheless, due to the cross-
sectional design of this study causality and reverse
causality concerning PA and arterial stiffness cannot be
answered. Up-to-date there are no studies on sedentary
behavior and systemic arterial stiffness, however sitting
time has been shown to be related to higher wave reflec-
tions [47], augmentation index [48] and carotid arterial
stiffness [49].
Presently, there are no comparable IPAQ data for a
Swiss population based cohort. According to the Euro-
barometer 64.3 our study sample of the Swiss general
population of older adults would rank as one of the most
active European nations (median total PA 3971 MET-
minutes/week) [50]. This is in line with reports that 73 %
of Swiss adults meet the current PA guidelines according to
the recent Swiss health survey [51] and is consistent with
the 2014 Swiss report on sports activity, in which
Switzerland ranks 2nd behind Sweden in a European
comparison [52, 53]. However, only 43 % of our ageing
population reported on vigorous PA. This part of the
population showed a beneficial inverse association of vig-
orous PA with arterial stiffness compared to subjects
without vigorous PA. This result indicates that population
based PA interventions and guidelines for older adults
should incorporate and promote vigorous PA to improve
cardiovascular health.
Self-reported medication is commonly used for assess-
ing disease in epidemiological studies and is related to
diagnosed disease as shown for diabetes [54]. Assessment
of disease by self-report of medication may be prone to
information bias due to non-reporting leading to misclas-
sification. However, it can be assumed that this would be
nondifferential misclassification without affecting the
estimates in this cohort study [55]. Besides, medical
treatment is commonly based on clear disease indications
and it has been shown, that self-reported medical history is
accurately related to cardiovascular and metabolic disease
[56, 57]. Furthermore, patients’ self-reported cardiovascu-
lar and diabetic medication use has been found to be reli-
able [58].
Study limitations
This is a cross-sectional study, which does not enable
inferring a causal association between PA and arterial
stiffness in these adults aged at least 50 years. Reporting
bias might have affected the self-reported PA assessment.
However, the IPAQ has been developed and validated by
Craig et al. [30] as a cross-national monitoring tool of PA
and physical inactivity for adults aged 15–69 years and
represents a feasible, reliable and valid measurement
instrument of PA. While the IPAQ is prone to over-esti-
mating PA especially in adults aged C65 years [59], this is
less the case for vigorous PAs such as structured sports or
exercise activities [60], which showed the strongest asso-
ciation with arterial stiffness in our study. Due to logistic
and financial reasons, objective PA measurements could
not be implemented in the current study.
Conclusions
In summary, PA of higher intensity was independently
associated with lower mixed central and peripheral arterial
stiffness in this cross-sectional analysis of a cohort of older
adults. The probability of having increased arterial stiffness
was lower in more physically active persons. Regular
vigorous PA may counteract vascular aging and, thus,
reduce the population risk of cardiovascular disease and
events. It is highly recommended to further strengthen the
significance of vigorous PA in cardiovascular health
guidelines in these age groups.
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Supplemental figures 
 
Fig. S1 Box plots of cardio-ankle-vascular-index (CAVI) and brachial-ankle pulse wave velocity 
(baPWV) by sex and age. Box represents 25th percentile (lower edge), median (middle bar) 
and 75th percentile (upper edge). Whiskers show the extent of the rest of the data; points 
indicate outliers. 
 
Fig. S2 Fully adjusted (Model 4) means of cardio-ankle-vascular-index (CAVI) over mean 
arterial pressure by sex and total physical activity (PA) levels (low, medium, high).
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Fig. S3 Marginal probability of cardio-ankle vascular index (CAVI) >=9 and brachial-ankle 
pulse wave velocity (baPWV) >=14.4 m/s across total, vigorous and moderate physical 
activity (PA) levels. * p < 0.05 compared to low PA level. 
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Supplemental tables 
Supplemental Table S1. Study population main characteristics by sex. 
 Units N Male (N=923) Female (N=985) P-value 
Age Years 1908 63.9 (57.7; 69.0) 62.6 (56.3; 68.8) 0.17 
baPWV m/s 1907 13.55 (12.19; 15.27) 13.24 (11.89; 14.84) <0.05 
CAVI no unit 1908 8.74 (7.88; 9;44) 8.46 (7.75; 9.20) <0.001 
Mean arterial pressure  mmHg 1906 100 (93; 108) 97 (90; 105) <0.001 
Heart rate  Bpm 1904 61 (55; 67) 61 (56; 67) 0.38 
Body mass index kg/m2 1908 26.6 (24.4; 29.3) 24.5 (21.9; 27.8) <0.001 
Smoking packyears 1896 4 (0; 24) 0 (0; 12) <0.001 
Medication 
0 
1 
2  
 1908 N (%) 
533 (57.7) 
292 (31.6) 
98 (10.6) 
N (%) 
699 (71.0) 
241 (24.5) 
45 (4.6) 
<0.001 
Education 
Low 
Middle 
High 
 1908 N (%) 
27 (2.9) 
538 (58.3) 
358 (38.8) 
N (%) 
66 (6.7) 
712 (72.3) 
207 (21.0) 
<0.001 
Moderate PA MET-min/week 
1908 3066 (1634; 5978) 3447 (1688; 6095) 0.32 
Low N (%)  296 (32.1) 294 (29.8)  
Medium N (%)  317 (34.3) 338 (34.3)  
High N (%)  310 (33.6) 353 (35.8)  
Vigorous PA MET-min/week 
1898 0 (0; 1680) 0 (0; 960) <0.001 
Low N (%)  466 (50.7) 618 (63.1)  
Medium N (%)  168 (18.3) 158 (16.1)  
High N (%)  285 (31.0) 203 (20.7)  
Total PA  MET-min/week 
1908 3948 (2066; 7818) 3975 (1968; 6997) 0.32 
Low N (%)  301 (32.6) 316 (32.1)  
Medium N (%)  289 (31.3) 346 (35.1)  
High N (%)  333 (36.1) 323 (32.8)  
BaPWV, brachial-ankle pulse wave velocity; CAVI, cardio-ankle vascular index; Education low, primary school; 
middle, secondary school, middle school or apprenticeship; high, Technical College or University; Medication 0, 
no medication intake, 1, hyperlipidemia, kidney disease, hypertension, arrhythmia medication, 2, diabetes, 
myocardial infarction, heart insufficiency, stroke medication; MET, metabolic equivalent; PA, physical activity. 
Values are median and 25th, 75th percentile or N (%). 
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Supplemental Table S2. Moderate, vigorous and total physical activity (PA) by age and sex. 
  Male (N=923) P-value Female (N=985) P-value 
 Unit 50-59 years 
60-69 
years 
70-81 
years 
 50-59 
years 
60-69 
years 
70-81 
years 
 
Moderate 
PA 
MET-
min/week 
2643 
(1200; 
5362) 
3436 
(1881; 
6059) 
3199 
(1645; 
6582) 
0.03 3294 
(1778; 
5784) 
3603 
(1830; 
6264) 
3449 
(1215; 
5814) 
0.53 
Vigorous 
PA 
MET-
min/week 
720 (0; 
1920) 
0 (0; 
1800) 
0 (0; 
840) 
<0.001 0 (0; 
1440) 
0 (0; 
720) 0 (0; 0) 
<0.001 
Total PA MET-min/week 
3666 
(1728; 
7818) 
4442 
(2330; 
7947) 
3946 
(1853; 
7629) 
0.71 4158 
(2136; 
7636) 
4080 
(2160; 
7050) 
3642 
(1245; 
6204) 
<0.01 
MET, metabolic equivalent; PA, physical activity. Values are median and 25th, 75th percentile. 
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Abstract
Background: longitudinal analyses of physical activity (PA) and arterial stiffness in populations of older adults are scarce. We
examined associations between long-term change of PA and arterial stiffness in the Swiss Cohort Study on Air Pollution and
Lung and Heart Diseases in Adults (SAPALDIA).
Methods: we assessed PA in SAPALDIA 2 (2001–03) and SAPALDIA 3 (2010–11) using a short questionnaire with a cut-off
of at least 150 min of moderate-to-vigorous PA per week for sufﬁcient activity. Arterial stiffness was measured oscillometrically
by means of the brachial-ankle pulse wave velocity (baPWV) in SAPALDIA 3. We used multivariable mixed linear regression
models adjusted for several potential confounders in 2,605 persons aged 50–81.
Results: adjusted means of baPWV were signiﬁcantly lower in persons with sufﬁcient moderate-to-vigorous PA (i) in
SAPALDIA 2 but not in SAPALDIA 3 (P = 0.048) and (ii) in both surveys (P = 0.001) compared with persons with insufﬁ-
cient activity in both surveys. There was a signiﬁcant interaction between sex and the level of change in PA concerning baPWV
(P = 0.03). The triples of parameter estimates describing the association between level of PA change and baPWV were not sig-
niﬁcantly different between the two sex-speciﬁc models (P= 0.07).
Conclusions: keeping up or adopting a physically active lifestyle was associated with lower arterial stiffness in older adults after a
follow-up of almost a decade. Increasing the proportion of older adults adhering to PA recommendations incorporating also vig-
orous PA may have a considerable impact on vascular health at older age and may contribute to healthy ageing in general.
Keywords: arterial stiffness, cardiovascular disease, longitudinal, physical activity, pulse wave velocity, older people
Introduction
Early vascular ageing is a major determinant of increased
cardiovascular (CV) risk [1]. Structural changes of the arterial
system related to advanced ageing such as accelerated thickening
of the arterial wall, degeneration of elastin and collagen pro-
liferation are associated with higher arterial stiffness [2]. The
velocity of the pulse waves propagating along the arterial wall
is a measure of stiffening of the vasculature and increased
CV risk [3]. Increased arterial stiffness was found to be inde-
pendently associated with increased CV risk and CV events, as
well as all-cause and CV mortality [4, 5]. Furthermore, arterial
stiffness is an important surrogate end point of CV disease,
because it reﬂects not only target organ damage but also
110
pathological processes and underlying risk factors connected
with vascular ageing [3, 5].
Lack of physical activity (PA) is a well-documented risk
factor for CV disease [6, 7] and one of the main components
of the global burden of disease [8]. PA has been shown to be
a modiﬁable lifestyle factor with the potential to decelerate
vascular ageing and arterial stiffness in short-term interven-
tional studies up to 16 weeks including persons aged 18–72
[9]. A physically active lifestyle throughout life has protective
effects on the vasculature and the risk of CV events also in
older adults with accelerated vascular modiﬁcations [10]. In
cross-sectional population-based studies of older adults, PA
at both light and moderate-to-vigorous intensity was beneﬁ-
cially associated with lower arterial stiffness compared with
inactive persons [11–13].
There are no longitudinal population-based studies of PA
and arterial stiffness measured as brachial-ankle pulse wave
velocity (baPWV) in older adults. baPWV is correlated with
higher risk of CV events and all-cause mortality [14]. In 274
overweight young adults, a 1-year increase in moderate PA
was associated with lower baPWV, suggesting a reduction of
future CV risk [15]. On the basis of this lack of longitudinal
evidence in ageing populations, the present study aimed at
examining the associations of long-term PA and change of
PA with arterial stiffness in a cohort of community-dwelling
adults aged 50–81. The main question was whether even older
adults beneﬁt from adopting a physically active lifestyle in
terms of lower arterial stiffness and CV risk in the long term.
Methods
Study design and participants
The Swiss Cohort Study on Air Pollution and Lung and
Heart Diseases in Adults (SAPALDIA) is an ongoing multi-
centre cohort study initiated in 1991 among randomly
selected adults (18–65 years, n = 9,651) [16]. The present
analyses include all participants who gave information on
their PA behaviour in SAPALDIA 2 (year 2001–03) and
SAPALDIA 3 (year 2010–11) and participated in the arterial
stiffness measurements in SAPALDIA 3 (n= 2,605). Partici-
pants gave written informed consent, and the respective Swiss
cantonal ethical committees had granted ethical approval.
Arterial stiffness measurement
Arterial stiffness was measured oscillometrically in SAPALDIA
3 by the baPWV using a VaSera VS-1500N vascular screening
system (Fukuda Denshi, Tokyo, Japan). The reproducibility
of this measurement has been shown to be high with a mean
coefﬁcient of variation of 3.9% in the studied population
[17]. All measurements were performed in a quiet room with
constant temperature in supine position after 10 min of rest.
A detailed description of this measurement has been
reported previously [17]. In brief, blood cuffs were placed at
each upper arm and above each ankle. ECG electrodes at
each wrist and a phonocardiogram on the sternal border in
the second intercostal space were attached. PWV was
calculated automatically by the VSS-10 software (Fukuda
Denshi) by dividing the arterial length between the sites of
interest on the basis of a height-based formula by the time
delay of the pulse wave determined by a foot-to-foot
method.
Physical activity assessment
The same short self-reported PA questionnaire was adminis-
tered to classify the participants’ PA level in SAPALDIA 2
and SAPALDIA 3 [18]. Four questions were asked regarding
the frequency and duration of PA per week. PA associated
with getting a bit out of breath was categorised as moderate
intensity PA and with getting out of breath and sweating as
vigorous intensity PA. We calculated minutes per week of
moderate and vigorous PA and summed these two to moderate-
to-vigorous PA, whereby minutes derived from vigorous PA
were counted twice [19]. Participants with at least 150 min/week
of moderate-to-vigorous PA or at least 1 h of vigorous PA
were categorised as active, both in SAPALDIA 2 and in
SAPALDIA 3, and participants with less as inactive [19]. The
participant’s change of PA from SAPALDIA 2 to SAPALDIA 3
was categorised as follows: (i) as remaining inactive if the partici-
pant was inactive in both assessments, (ii) as becoming inactive
if active in SAPALDIA 2 but inactive in SAPALDIA 3,
(iii) as becoming active if inactive in SAPALDIA 2 but active
in SAPALDIA 3 and (iv) as remaining active if active in
SAPALDIA 2 and 3.
Co-variates
Age at the time of the SAPALDIA 3 baPWV assessment and
sex were taken as primary co-variates. Change of body mass
index (BMI [kg/m2]) was calculated as BMI of SAPALDIA 3
minus BMI of SAPALDIA 2. Heart rate, diastolic and systolic
blood pressure were measured in sitting position after 10 min
of rest in SAPALDIA 2 and 3 (Omron 705IT, Omron
Healthcare, Japan). Mean arterial pressure was calculated as
mean arterial pressure = [(2 × diastolic blood pressure) +
systolic blood pressure]/3. Medication was assessed by a self-
administered questionnaire in SAPALDIA 3 and coded as 0,
for no medication intake; 1, for hyperlipidaemia, kidney disease
and hypertensive medication; 2, for diabetes, arrhythmia, myo-
cardial infarction, heart failure and stroke medication.
Socioeconomic status was assessed by the maximal level of edu-
cation in SAPALDIA 2 and 3 (low: primary school; middle: sec-
ondary school, middle school or apprenticeship; high: Technical
College or University). Pack-years of cigarettes smoked were cal-
culated in SAPALDIA 2 and 3.
Statistical analyses
Unless stated otherwise, data are expressed as mean (standard
deviation [SD]). Sex differences in the variables were assessed
using t-tests or non-parametric Wilcoxon–Mann–Whitney tests
as appropriate. We analysed the association between long-term
change in PA from SAPALDIA 2 to SAPALDIA 3 and arterial
stiffness in SAPALDIA 3 using multivariable mixed linear re-
gression models. Based on the literature and previous
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analyses in this cohort, we pre-selected potential confound-
ing co-variates. Co-variates were considered as potential con-
founders if the P-value of their association with the respective
outcome was <0.2. We used backward selection of variables
using the Akaike Information Criterion (AIC) and tested non-
linear terms to derive the best ﬁtting model. We tested a set of
interaction terms between PA, age, sex and mean arterial pres-
sure to be included in the ﬁnal model if P< 0.1. The fully
adjusted model included age, sex, mean arterial pressure,
heart rate, change of BMI, pack-years of cigarettes smoked,
educational level, medication intake and an interaction term
between change of PA and sex as ﬁxed effects, and study area
as random effect to account for the multi-centre study setting.
Chi-square tests were used to compare effect estimates of
sex-stratiﬁed analyses. All statistical analyses were performed
using the statistical software STATA (StataCorp LP, USA)
with P < 0.05 deﬁning statistical signiﬁcance.
Results
The mean follow-up time was 8.3 (SD 0.5) years. The ﬁnal
analytic sample consisted of 2,605 participants with complete
data. In SAPALDIA 3, the cohort was on average 63.4 (SD
8.0) years old with 50.7% of them being females, mean BMI
26.3 (SD 4.3) kg/m2, had a mean arterial pressure of 99.7
(SD 11.5) mmHg and a mean baPWVof 13.8 (SD 2.5) m/s.
Among them, 74.0% were sufﬁciently active with at least
150 min of moderate-to-vigorous PA in SAPALDIA 2 and
75.1% in SAPALDIA 3. The main characteristics by sex and
PA level for SAPALDIA 2 and 3 are listed in Tables 1 and 2.
The mean of minutes per week of moderate PA was
signiﬁcantly higher by 23.9% in SAPALDIA 3 than in
SAPALDIA 2 (median 180 [inter-quartile range 60, 360]
versus 180 (60, 420) min/week, P< 0.001). Vigorous PA
decreased signiﬁcantly in all participants on average by 18%
from SAPALDIA 2 to 3 (median 30 [inter-quartile range 0,
150] versus 30 (0, 60) min/week, P< 0.001). BMI (mean 25.7
[SD 4.0] versus 26.3 [SD 4.3] kg/m2) and mean arterial pres-
sure (mean 96.2 (SD 12.9) versus 98.1 (SD 12.1) mmHg (each
P< 0.001) increased signiﬁcantly in both sexes from
SAPALDIA 2 to 3. Mean heart rate decreased from 70.0 (SD
10.2) to 69.2 (SD 10.3) bpm (P< 0.001).
baPWV was lower in persons with sufﬁcient PA in one of
the two or both SAPALDIA follow-ups compared with per-
sons with insufﬁcient PA in both assessments. In the entire
cohort, covariate-adjusted means of baPWV were signiﬁcantly
lower in persons with sufﬁcient moderate-to-vigorous PA (i)
in SAPALDIA 2 but not in SAPALDIA 3 (P= 0.048) and (ii)
in both surveys (P= 0.001) compared with persons with insuf-
ﬁcient activity in both surveys (Figure 1).
There was a signiﬁcant interaction between sex and the
level of change in PA concerning baPWV (P= 0.03). The fully
covariate-adjusted means of baPWV were signiﬁcantly lower
in men becoming active (13.8 m/s, P= 0.04) and in men
remaining active (13.8 m/s, P= 0.01) compared with men
remaining inactive (14.3 m/s). In females with sufﬁcient activ-
ity in SAPALDIA 2 but not in SAPALDIA 3 (13.6 m/s,
P= 0.02) and in females remaining active (13.7 m/s, P= 0.03),
the fully covariate-adjusted means of baPWV were signiﬁcantly
lower compared with females remaining inactive (13.9 m/s).
Analyses stratiﬁed by sex conﬁrmed these results. The triples
of parameter estimates describing the association between
level of PA change and baPWV were not signiﬁcantly differ-
ent between the two sex-speciﬁc models (P = 0.07).
Discussion
Key findings
In this longitudinal cohort study of older adults, adoption or
maintenance of a physically active lifestyle over an average
time of 8.3 years was associated with lower arterial stiffness
in males and in females later in life. As our analyses were
adjusted for several potential confounders, this is suggestive
of an independent association. In the total study population,
individuals with insufﬁcient PA in both surveys had higher
CV risk in terms of higher arterial stiffness compared with
persons with sufﬁcient PA in at least one of the two surveys.
Previous cross-sectional studies of adults aged 60 years
and older have shown that a higher amount of regular PA of
light and moderate-to-vigorous intensity was associated with
lower aortic stiffness measured as carotid-femoral pulse wave
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Main characteristics by sex and moderate-to-vigorous physical activity (PA) level in SAPALDIA 2
Units Female (n = 1,316) P value Male (n = 1,289) P value
Inactive Active Inactive Active
n (%) 377 (28.6) 939 (71.4) 299 (23.2) 990 (76.8)
Age Mean (SD) years 54.7 (7.7) 55.5 (8.2) 0.10 55.4 (7.7) 55.0 (8.0) 0.49
BMI Mean (SD) kg/m2 25.3 (4.4) 24.7 (4.2) <0.05 27.0 (3.3) 26.4 (3.4) <0.05
MAP Mean (SD) mmHg 92.4 (11.8) 92.3 (12.5) 0.85 100.8 (11.8) 99.8 (12.5) 0.20
Heart rate Mean (SD) bpm 71.1 (9.5) 70.2 (9.6) 0.12 71.3 (10.2) 68.8 (10.8) <0.001
Smoking Median (p25, p75) pack-years 1 (0, 18) 0.4 (0, 17) 0.65 3.8 (0, 21) 0 (0, 16) 0.005
Education n (%)
Low 39 (9) 55 (6) 0.30 20 (5) 22 (2)
Middle 307 (71) 651 (74) 221 (60) 534 (58)
High 85 (20) 179 (20) 126 (35) 366 (40) <0.05
Moderate PA Median (p25, p75) min/week 15 (0, 60) 240 (120, 420) <0.001 5 (0, 60) 225 (120, 420) <0.001
Vigorous PA Median (p25, p75) min/week 0 (0, 0) 60 (0, 150) <0.001 0 (0, 0) 60 (30, 150) <0.001
BMI, body mass index; MAP, mean arterial pressure; p25, 25th percentile; p75, 75th percentile. P values relate to sex-specific differences between active and inactive persons.
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velocity [11, 12]. In addition, physical functioning in terms of
walking speed was inversely related to aortic stiffness in older
adults of the Whitehall II Study in a cross-sectional analysis
[20]. The American Heart Association deﬁned regular PA of
at least 150 min of at least moderate intensity PA per week
as one component of a so-called ideal CV health behaviour
[21]. In a 4- to 5-year follow-up among 505 Caucasian
persons with a mean age of 61.6 years, adherence to a life-
style complying with all of the components of an ideal CV
health was associated with signiﬁcantly lower carotid-femoral
pulse wave velocity compared with persons with a maximum
of two of these CV health components [22]. The independ-
ent contribution of long-term PA and change of PA apart
from other health behaviours was not assessed in this study.
There is one longitudinal interventional study in 198 Japanese
aged 65–84 years, which showed that maintenance of a physic-
ally active lifestyle over 1 year with a step count of 6,600 steps/
day and/or a total activity duration of 16 min/day at
moderate-to-vigorous intensity was signiﬁcantly associated
with lower stiffness of central arteries compared with less active
persons [23]. This has so far not been shown in a population-
based longitudinal cohort study such as SAPALDIA.
The signiﬁcant sex difference in baPWV is supposed to
reﬂect the cardio-protective effect of hormonal levels, espe-
cially oestrogen through vasodilation and reduction of vascu-
lar tone [24]. Oestrogen enhances nitric oxide production by
stimulation of endothelial nitric oxide synthase stimulation
inducing vasodilation as the main suggested pathway [25].
Besides, oestrogen has been beneﬁcially linked with reduc-
tions in blood pressure and deceleration of age-associated ar-
terial stiffness in postmenopausal women [26]. It is suggested
that the effect of oestrogen is inﬂuenced by age, with lower
protective effect of oestrogen on the vasculature with longer
time from menopause due to lower levels of oestrogen and
number of oestrogen receptors [27]. The mostly postmeno-
pausal females of our study population showed beneﬁcial
associations of long-term PA with arterial stiffness. The
effect estimates were not signiﬁcantly different between sup-
posedly pre- and postmenopausal women, when taking into
account age in SAPALDIA 2 and 3. Nevertheless, the incon-
sistent results within the females becoming active compared
with males need further investigation.
Longevity has been found to be strongly associated with a
healthy lifestyle in a population-based prospective study in
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2.Main characteristics by sex and moderate-to-vigorous physical activity (PA) level in SAPALDIA 3
Units Female (n = 1,316) P value Male (n = 1,289) P value
Inactive Active Inactive Active
n (%) 371 (28.2) 945 (71.8) 277 (21.5) 1,012 (78.5)
Age Mean (SD) years 63.8 (8.5) 63.5 (7.8) 0.59 62.8 (8.4) 63.7 (7.7) 0.08
BMI Mean (SD) kg/m2 26.0 (4.9) 25.2 (4.5) <0.05 27.6 (4.0) 27.0 (3.6) <0.05
baPWV Mean (SD) m/s 13.8 (2.6) 13.7 (2.4) 0.56 14.2 (2.6) 13.9 (2.4) 0.11
MAP Mean (SD) mmHg 95.7 (12.3) 96.2 (12) 0.45 100.3 (11.4) 100.3 (11.9) 0.93
Heart rate Mean (SD) bpm 70.5 (10.1) 69.0 (9.3) <0.05 70.9 (10.4) 68.2 (11.2) <0.001
Smoking Median (p25, p75) pack-years 0.2 (0, 16.8) 0 (0, 11) <0.05 3.8 (0, 30.5) 5 (0, 26) 0.73
Medication n (%)
0 259 (64) 655 (72) <0.05 168 (51) 561 (58)
1 113 (28) 204 (22) 115 (35) 275 (29)
2 31 (8) 54 (6) 45 (14) 125 (13) <0.05
Education n (%)
Low 46 (11) 48 (5) <0.05 16 (5) 26 (3)
Middle 281 (70) 677 (74) 189 (58) 566 (59)
High 76 (19) 188 (21) 123 (37) 369 (38) <0.05
Moderate PA Median (p25, p75) min/week 0 (0, 60) 270 (180, 420) <0.001 0 (0, 60) 300 (180, 540) <0.001
Vigorous PA Median (p25, p75) min/week 0 (0, 0) 60 (0, 150) <0.001 0 (0, 0) 60 (30, 150) <0.001
BMI, body mass index; MAP, mean arterial pressure; Medication 0, for no medication intake; 1, for hyperlipidaemia, kidney disease, hypertension and arrhythmia
medication; 2, for diabetes, myocardial infarction, heart failure and stroke medication. p25, 25th percentile; p75, 75th percentile. P values relate to sex-specific
differences between active and inactive persons.
Figure 1. Fully co-variate-adjusted means of baPWVacross dif-
ferent levels of change in moderate-to-vigorous physical activity
(PA) from SAPALDIA 2 to 3, by sex. Underlying models
included age, change of body mass index, mean arterial pres-
sure, heart rate, education, medication, pack-years of cigarettes
smoked and an interaction term between sex and change of PA
as ﬁxed effects and study area as random effect. *Statistically
signiﬁcant compared with remaining inactive.
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males with a mean age of 72 years [28]. Accordingly, in this
study, older males with sufﬁcient PA had an almost 30% lower
mortality risk and a probability of 54% to live up to the age of
90 years if they were also non-smokers, non-diabetic, normo-
tensive and had a normal weight proﬁle at the age of 70 years.
Furthermore, a recent systematic review has shown that an
increase in baPWV by 1 m/s is not only associated with in-
creased risk of CV events and CV mortality (12 and 13%, re-
spectively), but also with a 6% increase in all-cause mortality
[14]. Building on this, our study results strengthen the evidence
that adoption of a physically active lifestyle has the potential to
beneﬁcially inﬂuence the vasculature in terms of lower arterial
stiffness also in later life. This may reduce the risk of CV disease
also in older adults having become physically active later in life,
with positive effects on mortality and longevity.
Some study limitations need to be considered. Arterial
stiffness measurement was only available in SAPALDIA 3.
PA has not been assessed objectively because of logistic and
ﬁnancial reasons. However, the used short questionnaire is a
valid instrument for population-wide PA assessments [18].
Attrition and selection bias might have affected the analyses,
since only persons with full data on PA, arterial stiffness and
co-variates were included in this study. However, the analysed
sample was not different on average in terms of baPWV,
BMI, mean arterial pressure and vigorous PA compared with
the rest of the SAPALDIA 3 sample. The analysed sample
was signiﬁcantly older, smoked more and had lower mean
arterial pressure and more moderate PA.
Conclusions and implications
In summary, this is the ﬁrst longitudinal population-based
cohort study showing that keeping up or adopting a physically
active lifestyle was associated with lower arterial stiffness in
older adults after a follow-up of almost a decade. These ﬁnd-
ings represent a useful basis for generating hypothesis that
should be tested in large randomised controlled trials concern-
ing the long-term effects and underlying pathways of PA, exer-
cise training and long-term change towards a physically active
lifestyle on arterial stiffness in older adults.
Key points
• Long-term physical activity was associated with reduced ar-
terial stiffness.
• Adopting a physically active lifestyle was beneﬁcial regarding
arterial stiffness and cardiovascular risk also in older adults.
• RCTs on the long-term effects and underlying pathways
of physical activity on arterial stiffness in older adults are
recommended.
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Chapter 7 Main Results 
7.1 Aim 1: Measuring Characteristics of Arterial Stiffness Indices (CAVI, baPWV) in a 
Caucasian Cohort 
The first aim of the PhD thesis was to determine the measuring characteristics in terms of 
the reproducibility of the novel arterial stiffness measures CAVI and baPWV in Caucasians 
aged at least 50 years of the SAPALDIA cohort. These two arterial stiffness indices are 
derived from an oscillometric measurement with the VaSera VS-1500N vascular screening 
system. This work resulted in one publication in the Scandinavian Journal of Clinical & 
Laboratory Investigation showing the high reproducibility of these indices.1 The mean 
coefficient of variation for CAVI was 4.4% and for baPWV 3.9%. The intraclass correlation 
coefficient was 0.8 for CAVI and 0.9 for baPWV. The mixed linear model revealed that 68.7% 
of the CAVI and 80.1% of the baPWV variance was accounted for by the subject, 5.2%/8.1% 
by the fieldworker, 6.7%/7.8% by variation between measurement days, and 19.4%/4% by 
measurement error. Bland-Altman plots showed no particular dispersion patterns. This could 
be shown for the first time in a representative subsample of a Caucasian cohort, since both 
of these newly emerging arterial stiffness indices reflecting early CVD risk have so far mainly 
been studied in Asian populations56 or only in small studies with Caucasians.91 Valid markers 
of CVD are essential and highly important for CVD risk stratification on the population level.  
Furthermore, we have analyzed associations of CAVI and baPWV with age and sex as the 
main determinants of arterial stiffness in the SAPALDIA cohort to prove the high quality of 
these indices. CAVI and baPWV linearly increased with age, CAVI on average by 0.9 per 
decade and baPWV by 1.8 m/s. Statistically significant gender differences were observed for 
CAVI in the age groups 60-69 and 70-81 years and for baPWV in the age groups 50-59 and 
60-69 years, with lower values among women. These results could be integrated in the 
second manuscript published in the European Journal of Epidemiology.2 
7.2 Aim 2: Cross-Sectional Association of Physical Activity and Arterial Stiffness 
In the second aim we focused extensively on analyzing associations between physical activity 
and arterial stiffness in the SAPALDIA cohort of older adults from a cross-sectional point of 
view. During the data collection of SAPALDIA 3 the IPAQ has been consulted to classify the 
subjects’ physical activity level. We hypothesized that insufficient physical activity is 
associated with increased arterial stiffness assessed by CAVI and baPWV. We found that in 
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this general Caucasian population of older adults higher levels especially of vigorous physical 
activity were associated with lower arterial stiffness reflecting lower cardiovascular risk. 
After adjustment for several confounders moderate, vigorous and total physical activity 
were inversely associated with CAVI. baPWV showed negative and marginally significant 
associations with vigorous and moderate physical activity, but not with total physical 
activity. Increased arterial stiffness (CAVI ≥ 9, upper tertile) was inversely and significantly 
associated with vigorous physical activity (odds ratio (OR) = 0.65, 95% confidence interval 
(CI) 0.48–0.88), and marginally significantly with total physical activity (OR 0.76, 95% CI 0.57–
1.02) and moderate physical activity (OR 0.75, 95% CI 0.56–1.01). The odds ratio for 
baPWV ≥ 14.4 m/s was 0.67 (95% CI 0.48–0.93) across the vigorous physical activity levels, 
and was non-significant across the total (OR 0.91, 95% CI 0.66–1.23) and moderate physical 
activity levels (OR 0.94, 95% CI 0.69–1.28). These data support the importance of physical 
activity for improving cardiovascular health in older adults. These results have been 
published in the European Journal of Epidemiology.2  
7.3 Aim 3: Longitudinal Association of Physical Activity and Arterial Stiffness 
To add on this from a longitudinal point of view we have extensively worked on the third aim 
of this PhD thesis analyzing the association between change in physical activity between the 
first and second follow-up of SAPALDIA (SAPALDIA 2 to 3) and CVD risk using baPWV as 
marker in multilevel models including several confounding factors. We hypothesized that an 
increase in physical activity between SAPALDIA 2 and 3 was associated with lower 
cardiovascular risk assessed by arterial stiffness. This is the first longitudinal population 
based cohort study showing that keeping up or adopting a physically active lifestyle was 
associated with lower arterial stiffness in older adults after a follow-up of almost a decade. 
In the entire study population adjusted means of baPWV were significantly lower in persons 
with sufficient moderate-to-vigorous physical activity a) in SAPALDIA 2 but not SAPALDIA 3 
and b) in both surveys when compared to persons with insufficient physical activity in both 
surveys. In sex specific analyses it has been shown that in sufficiently active males and 
females in both surveys baPWV was lower compared to insufficiently active persons. 
Besides, the fully covariate-adjusted means of baPWV were significantly lower in men 
becoming active (13.8 m/s, P=0.04) compared to men remaining inactive (14.3 m/s), 
whereas significantly lower in females with sufficient physical activity in SAPALDIA 2 but not 
in SAPALDIA 3 (13.6 m/s, P=0.02) compared to females remaining inactive (13.9 m/s). 
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Increasing the proportion of older adults adhering to physical activity recommendations 
incorporating also vigorous physical activity may have a considerable impact on vascular 
health at older age and may contribute to healthy ageing in general. These findings will 
strengthen physical activity recommendations within CVD prevention guidelines in older 
adults with respect to the prevention of manifest CVD and related health outcomes. A 
manuscript presenting these findings has been published in the journal Age and Ageing.3 
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Chapter 8 Discussion and Synthesis 
This PhD thesis has been conducted to analyze of the association between physical activity 
assessed by the IPAQ and a short physical activity questionnaire as a preventive life style 
component of aggressive decrease of atherosclerotic modifiers (ADAM)55 and arterial 
stiffness in a Caucasian cohort aged at least 50 years (N=3026). We have found that physical 
activity is cross-sectionally and in the long-term beneficially associated with arterial stiffness 
and, thus, lower cardiovascular risk. In this cohort of older adults a physically active lifestyle 
incorporating vigorous physical activity may have a significant effect on population health. 
The analyses have been based on the evaluation of the measuring characteristics of the 
oscillometric arterial stiffness indices CAVI and baPWV for the first time performed in a 
Caucasian cohort. We have shown that CAVI and baPWV are highly reproducible and easy-
to-apply for cardiovascular risk assessments in Caucasians. 
8.1 Aim 1: Measuring Characteristics of Arterial Stiffness Indices (CAVI, baPWV) in a 
Caucasian Cohort 
The reproducibility of clinical measurements is an essential and crucial feature for clinical 
and scientific use. The reproducibility of the arterial stiffness indices CAVI and baPWV has so 
far only been shown in Asian populations75,86,88 and in a small study with Caucasians (N=7).91 
Therefore we have evaluated the reproducibility of CAVI and baPWV in a representative 
subsample of the SAPALDIA 3 cohort of Caucasian adults aged 50-81 years. We could show 
that both CAVI and baPWV are highly reproducible arterial stiffness indices also in a 
Caucasian population. The methodology is applicable for large clinical trials or cohort 
studies. The peripheral augmentation index simultaneously assessed with the VaSera 
vascular screening system had distinct lower reproducibility. These results show that CAVI 
and baPWV are reliable and easy-applicable non-invasive vascular biomarkers of arterial 
stiffness that can be used for population wide cardiovascular screening. The extensive 
statistical analyses besides the large representative sample of a cohort is a major strength of 
this reproducibility study compared to other studies using mostly the coefficient of variation 
as a statistical measure of reproducibility.75,88,91 We could confirm the high reproducibility by 
using intraclass correlation coefficients and Bland-Altman-plots. Furthermore, the high 
proportion of variance on account of the subject within the mixed model (CAVI, 68.7%; 
baPWV, 80.1%) shows that most of the measurement variance of these indices is due to 
subject specific characteristics. Since, in addition, the fieldworker effect was small with 5.2% 
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of the CAVI variance and 8.1% of baPWV we can conclude that arterial stiffness 
measurement with the VaSera VS-1500N screening system has limited need for fieldworker 
training in a standardized setting and is highly reproducible. This is mainly because CAVI and 
baPWV measurement involves basic clinical devices (blood cuffs, electrocardiogram leads, 
phonocardiogram), which makes it easily applicable also for large scale CVD risk assessments 
or routine screenings in Caucasian populations. 
8.2 Aim 2: Cross-Sectional Association of Physical Activity and Arterial Stiffness 
The second aim of this PhD thesis was targeted at the analyses of the cross-sectional 
association between physical activity and arterial stiffness reflecting CVD risk in multilevel 
models including several confounding factors. Physical activity is regarded as an important 
health promotion measure with protective impact on the cardiovascular system and, thus, as 
one component of aggressive decrease of atherosclerotic modifiers (ADAM).55 The main 
focus of the second aim was the question how a physically active lifestyle is cross-sectionally 
associated with arterial stiffness in the SAPALDIA cohort. Up-to-date this question has been 
insufficiently studied in older adults in population based studies. Furthermore, there is no 
comparable cohort in which a measure of arterial stiffness could be analyzed in association 
with a detailed questionnaire of physical activity like the IPAQ. We found that adjusted for 
several potential confounders higher levels of physical activity are associated with lower 
cardiovascular risk in terms of lower arterial stiffness measured with CAVI and baPWV. 
Thereby, the strongest associations were evident for higher amounts of physical activities 
performed with more vigorous intensity. These results support the importance of physical 
activity for improving cardiovascular health in older people and suggest that vigorous 
physical activity promotion in this age group may prevent against increased arterial stiffness 
resulting from atherosclerotic modifications.  
Our study results are in line with other cross-sectional analyses that have, however, used 
cfPWV as an outcome.99,100 Since arterial stiffness is differently affected by physical activity 
across the arterial tree,98,101 our study adds significant novel evidence concerning the 
beneficial association of physical activity with mixed measures (central and peripheral) of 
arterial stiffness (CAVI and baPWV). Our study results are also in agreement with the current 
state of research of intervention studies concerning this topic and provide scientific support 
from a population study perspective. Two systematic reviews have recently shown that 
aerobic exercise especially at higher intensities beneficially affects arterial stiffness.95,96  
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CAVI and baPWV did not show fully agreeing results concerning their association with levels 
of moderate, vigorous and total physical activity. Even if the tendencies of both outcome 
associations point to consistent conclusions toward lower arterial stiffness with more 
physical activity, the disagreement needs further investigation. CAVI and baPWV are 
currently used as combined measures of central and peripheral arterial stiffness.77,114 Since 
CAVI also correlated well with intima media thickness (IMT) and plaque score (still pending 
for Caucasians) reflecting carotid and coronary atherosclerosis, CAVI is suggested to 
represent systemic arterial stiffness.115 Very recently CAVI has been shown to be associated 
with carotid atherosclerosis similar to cfPWV and baPWV in 500 Caucasians aged 35-74 
years.116 CAVI and baPWV have been proven to be valid vascular biomarkers for non-invasive 
arterial stiffness assessment associated with cardiovascular disease risk and 
outcomes,62,115,117,118 and with central arterial stiffness.74,83 Despite, the interpretation of the 
results concerning the association between physical activity and arterial stiffness has to be 
performed against the background that the effect of physical activity on arterial stiffness 
varies across the arterial tree.98,101 Furthermore, CAVI is derived from PWV measurements, 
by using a mathematical transformation with inclusion of the stiffness parameter β and a 
modification of the Bramwell-Hill equation.75 These methodological differences of CAVI and 
baPWV should be investigated in more detail in view of associations with physical activity. 
8.3 Aim 3: Longitudinal Association of Physical Activity and Arterial Stiffness 
Within aim 3 we have found that long-term maintenance or adoption of a physically active 
lifestyle in a Caucasian cohort of adults aged 50-81 years was associated with lower arterial 
stiffness after almost a decade. These results strengthen the cross-sectional analyses and 
support the finding that physical activity is cross-sectionally and longitudinally beneficially 
associated with arterial stiffness in the general Caucasian population of older adults and, 
thus, with decelerated vascular ageing and lower cardiovascular risk. This has so far not been 
shown in a comparable population based cohort such as SAPALDIA. Our result is of particular 
interest since arterial stiffness is progressively increasing with age. Furthermore, it is 
important to show this beneficial association of physical activity with arterial stiffness in 
older adults, because it can be assumed that with ageing structural and functional 
components of the arteries are less susceptible to beneficial modifications such as 
decelerated stiffening as presented in our study population or to positive effects on vascular 
endothelial dysfunction.119 The found association between physical activity and arterial 
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stiffness was present in males and females concerning the comparison between remaining 
active individuals from SAPALDIA 2 to 3 with individuals remaining inactive. Beyond that and 
in contrast to the cross-sectional analyses without sex specific associations, there were 
differences between males and females in the longitudinal analyses: Female individuals 
becoming inactive and male individuals becoming active in SAPALDIA 3 had also significantly 
lower arterial stiffness in SAPALDIA 3. This finding points to the assumption that a physically 
active lifestyle at any point in life has a beneficial effect on arterial stiffness later in life. In 
older adults there is only one longitudinal study over one year in 198 Japanese aged 65-84 
years similarly showing a beneficial association of higher levels of moderate-to-vigorous 
physical activity of at least 16 min/day compared to inactive individuals with stiffness of 
central arteries.98 This is very comparable to the 15 min/day of moderate intensity physical 
activity found to be associated with 14% reduced mortality risk.22 In our study population 
individuals remaining active had a median of 61 min/day more moderate-to-vigorous 
physical activity compared to individuals remaining inactive (median 0 min/day). Even if 
these results are not fully comparable due to different outcomes and methodological 
inconsistencies further investigations are warranted to shed light on the differences in the 
amount of moderate-to-vigorous physical activity and its association with arterial stiffness in 
the long-term. 
Both the IPAQ for extensive physical activity assessment and the arterial stiffness 
measurements by CAVI and baPWV have been applied for the first time in SAPALDIA within 
the second follow-up. The promising results of this beneficial cross-sectional association of 
physical activity with arterial stiffness have the major potential of being baseline findings for 
longitudinal arterial stiffness outcome analyses with the change of physical activity assessed 
with IPAQ in different intensities and domains as primary predictor in the third follow-up 
(SAPALDIA 4). These upcoming analyses will shed more light on the associations between 
physical activity and cardiovascular risk and target organ damage in a highly representative 
population based cohort of ageing adults. 
This PhD thesis focused on arterial stiffness and vascular ageing in view of physical activity or 
more so physical inactivity or sedentary behavior as a potential risk factor. Within this 
context the EVA-ADAM concept by Nilsson et al. sets the framework for physical activity 
potentially being one aggressive decrease of atherosclerotic modifier (ADAM) targeted at 
early vascular ageing (EVA).55 A quote by the physician Sir William Osler from 1898 
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underlines the importance of lifelong vascular health on the basis of genetic determinants 
and lifestyle influences for healthy ageing in terms of longevity: 
“Longevity is a vascular question, which has been well expressed in the axiom 
that man is only as old as his arteries. To a majority of men death comes 
primarily or secondarily through this portal. The onset of what may be called 
physiological arterio-sclerosis depends, in the first place, upon the quality of 
arterial tissue which the individual has inherited, and secondly upon the amount 
of wear and tear to which he has subjected it.” (Sir William Osler, 1898)120 
Physical activity and exercise training are nowadays regarded as lifestyle components with 
potential beneficial effects on vascular ageing and stiffening and reduction of cardiovascular 
risk.15–18,94,121 Especially aerobic exercise as an intentional and structured unit of physical 
activity has been recently highlighted as a “’first line’ strategy for prevention and treatment 
of arterial ageing and a vital component of a contemporary public health approach for 
reducing the projected increase in population CVD burden.”122 On the molecular basis this 
may be due to reductions in oxidative stress, fibrosis and advanced glycation end-products, 
and maintenance of endothelial function and nitric oxide bioavailability.122 From this 
perspective, the physical activity-arterial stiffness relationship may positively contribute to 
the beneficial association between physical activity and longevity. In this regard, longevity 
has been proven to be strongly associated with a healthy lifestyle in a population based 
prospective study (males, mean age 72 years).123 Thereby, older adults with sufficient 
physical activity according to current guidelines had an almost 30% lower mortality risk and 
a probability of 54% to live up to the age of 90 years if they were also non-smoker, and had a 
normal diabetic, hypertonic and weight profile at the age of 70 years. In a recent large 
pooled cohort analysis from six prospective cohorts in 654’827 adults aged mostly at least 40 
years it was found that after a median follow-up of 10 years a minimum amount of light 
intensity physical activity in terms of up to 75 minutes of brisk walking per week was 
associated with a 1.8 years longer life expectancy compared to inactive individuals.124 
Similarly, adhering to current physical activity recommendations was associated with 3.4 
years of longer life expectancy, increasing up to 4.2 years in individuals with approximately 
300 minutes of moderate intensity physical activity (e.g. brisk walking). Adding to this, our 
study results strengthen the importance of a physically active lifestyle also in older adults 
with significant beneficial effects on the CVD risk and healthy vascular ageing potentially 
positively contributing to longevity. Further investigations are recommended focusing on the 
interrelations of physical activity with arterial stiffness and longevity, since arterial stiffness 
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represents a measure of the cumulative effect of cardiovascular risk factors such as 
insufficient physical activity on the vasculature with ageing.55 Up-to-date, there are no 
longitudinal cohort study results concerning physical activity, arterial stiffness and longevity 
in ageing populations. 
8.4 Strengths and Limitations 
A major strength of this PhD thesis is that the data are derived from a nearly 25 year 
prospective population based Swiss cohort meeting highest standards of data collection and 
data management. Therefore, the performed association analyses are related to a detailed 
characterized Caucasian cohort with the possibility to control for several potential 
confounders. Based on this the study population of this PhD thesis is large enough to give 
highly relevant conclusions for public health. The IPAQ used for the physical activity 
assessment is a cross-national monitoring tool of physical activity for adults and has been 
shown to be a feasible, reliable and valid measurement instrument of physical activity in 
several countries.105 From this it follows that the produced data are easily comparable to 
other cohorts studying physical activity. The IPAQ not only allows duration and intensity but 
also domain related analyses of physical activity and, thus, gives the opportunity to study 
physical activity behavior in more detail. There is no other Caucasian cohort of older adults 
providing population based data on the association between long-term change in physical 
activity and oscillometrically measured arterial stiffness. 
At this point also some study limitations need to be considered. Even if the IPAQ is a valid 
instrument for population wide physical activity monitoring, it is a subjective method and is 
prone to over-estimation of physical activity especially in adults aged ≥65 years. However, it 
has been shown that vigorous physical activities are less affected by this reporting bias also 
in older adults,125 which showed the strongest association with arterial stiffness in this PhD 
thesis. Objective physical activity measurements such as accelerometer are increasingly used 
in research. However, logistic and financial reasons have not allowed implementing such 
objective measures of physical activity in the large sized cohort study SAPALDIA. Due to the 
same reason the reproducibility study of CAVI and baPWV could not be performed in 
comparison to the gold-standard measurement cfPWV. As pointed out in the publication1 
the reproducibility expressed as coefficient of variation of CAVI and baPWV is very 
comparable to cfPWV. Arterial stiffness has been measured for the first time in the second 
follow-up of SAPALDIA, wherefore longitudinal outcome analyses of the change of physical 
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activity on the change of arterial stiffness from SAPALDIA 2 to 3 could not be performed. 
Selection and healthy survivor bias might have affected the analyses, since only persons with 
full data on physical activity, arterial stiffness and covariates were included in this PhD 
thesis. Yet, the analyzed sample was not significantly different in the main variables of 
interest compared to the total SAPALDIA cohort.  
8.5 Significance and Conclusions 
This PhD thesis addresses one of the main questions in health-enhancing physical activity 
and public health research, which are the associations of chronic physical activity with the 
pathophysiologic processes underlying cardiovascular morbidity and mortality. In view of the 
world-wide research on CVD and health promotion measures, a highly important public 
health impact of this study may arise from the usage of oscillometrically measured arterial 
stiffness indices such as CAVI and baPWV as early, subclinical arteriosclerosis markers and 
the exploration of potential risk factors such as physical inactivity. Risk stratification is 
essential for goal-oriented and population wide primary and secondary prevention. Early 
detection of CVD and cardiovascular risk factors is crucial besides promotion of prevention 
and early treatment for diminishing the increasing public health and economic impact of 
CVD. This PhD thesis significantly contributes to the understanding of the association of 
physical activity as an anti-atherosclerotic modifier with arterial stiffness and, thus, CVD risk. 
Physical activity assessed with the long version of the IPAQ offered the unique opportunity 
to analyze the association with arterial stiffness down to intensity and duration as well as 
energy expenditure of physical activity. For the first time we have been able to show that a 
long-term physically active lifestyle over a period of almost a decade or the adoption of 
more physical activity especially of vigorous intensity is associated with lower arterial 
stiffness and, therefore, lower cardiovascular risk in middle-aged and older adults. In 
conclusion this PhD thesis adds highly significant evidence to an up-to-date public health 
research question to that effect that increasing the proportion of older adults adhering to 
physical activity recommendations incorporating also vigorous physical activity may have a 
considerable impact on vascular health in ageing populations and may contribute to healthy 
ageing in general.   
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Chapter 9 Perspectives 
In the following chapter three projects will be put in perspective to this PhD thesis that are 
all highly relevant for upcoming analyses. 
9.1 Associations of Physical Activity with Central Arterial Stiffness and Hemodynamics 
Central arterial (aortic) stiffness and central hemodynamics are considered to be important 
determinants of improved cardiovascular risk stratification with major potential for public 
health related examinations.15,126 This is because central hemodynamic indices reflect the 
true load of genetic and lifestyle influences on inner organs and the vascular system.8 Due to 
the amplification of the pressure waveform propagating along the arterial tree on the basis 
of reflections and increasing arterial stiffness in the periphery central blood pressure cannot 
be inferred by peripheral blood pressure.15 Central systolic blood pressure varies extensively 
from brachial systolic blood pressure and also within one individual at all age groups.127 
Against this background growing evidence has accumulated in recent years suggesting that 
central blood pressure may be a better predictor of cardiovascular risk and future 
cardiovascular events compared to brachial blood pressure and may reduce hypertension 
misclassification.128 It is for this reason that besides invasive methods for assessing central 
hemodynamics and aortic stiffness, unsuitable for population examinations, non-invasive 
methods such as applanation tonometry and transfer functions for estimations on the basis 
of peripheral pressures have been developed and validated.15,127 Transfer functions based on 
oscillometric measurements of brachial blood pressure have the advantage of being less 
operator dependent compared to tonometer assessments at the carotid.127 Building on this 
we have analyzed the feasibility of the ARCSolver algorithm109 to retrospectively derive 
central hemodynamics and aortic stiffness parameters from cuff-based blood pressure 
measurements. This has been done in cooperation with the working group of Dr. S. 
Wassertheurer (Cardiovascular Diagnostics, AIT Austrian Institute of Technology GmbH) in a 
separate study (N=68, mean age 51±18 years) based on a dataset of a previous study.91 The 
ARCSolver method is a mathematical procedure for the calculation of aortic stiffness and 
central hemodynamic measures from peripheral pulse waves and blood pressure 
measurements at the brachial artery using a common occlusive cuff.109 The ARCSolver 
algorithm has been validated invasively and non-invasively.129–131 Within this work we could 
show that it is feasible to retrospectively apply the ARCSolver algorithm to oscillometrically 
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measured pulse wave signals in order to derive aortic stiffness and central hemodynamics. 
These promising results have been published in the journal Blood Pressure Monitoring (see 
Appendix B).110 This successful work is the basis for upcoming analyses of aortic stiffness and 
central hemodynamics in SAPALDIA. It opens the perspective for promising future outcome 
and association analyses within this very well characterized cohort and beyond in other 
studies. Thereby it will be of specific interest to analyze whether and how physical activity is 
cross-sectionally and a physically activity lifestyle in the long-term is associated with central 
hemodynamics and aortic stiffness in older adults.  
9.2 Domain-Specific Associations of Physical Activity with Arterial Stiffness and 
Hemodynamics 
Furthermore, as pointed out by Hallal et al. domain specific analyses of physical activity are 
highly important to support public health actions in view of increasing physical activity and 
decreasing sedentary behavior.9 The IPAQ applied in SAPALDIA 3 assesses physical activity 
domain specifically: leisure time, domestic and gardening activities, work-related, transport-
related. This will allow us to analyze associations of physical activity performed in different 
domains with central and peripheral hemodynamics and arterial stiffness. Thereby, for 
example the question will be of interest whether active transportation in comparison to 
leisure time physical activity has the potential of being beneficially associated with lower 
cardiovascular risk. 
9.3 Air Pollution as a Modifier of the Association Between Physical Activity and Arterial 
Stiffness/ Hemodynamics 
As highlighted in the introduction, environmental influences are highly important 
determinants of physical activity,27 with air pollution being the main environmental 
determinant being studied in SAPALDIA using high quality, Swiss wide data.103,104 Both, high 
amounts of physical activity and low air pollution exposure are recommended by several 
global health institutions for the prevention of cardiovascular disease.5,94,132,133 Strong 
epidemiologic evidence exists suggesting that air pollution is negatively associated with 
cardiovascular mortality and morbidity.132,134 Short and long-term air pollution exposure is 
linked with coronary artery disease, heart failure and stroke.132 A very recent expert position 
paper points out the high importance of the associations between air pollution, CVD and 
global health.132 Subclinical vascular modifications are thought to mediate in part the 
pathophysiological effect of air pollution on CVD.132 In this connection mainly atherosclerosis 
Perspectives 
70 
measured as carotid-intima media thickness has been studied.132 However, atherosclerosis is 
closely related to stiffening of the arteries in the initial stage.50 Up-to-date associations 
between air pollution and arterial stiffness have been insufficiently studied in themselves135 
and were never studied in the context of chronic physical activity and different physical 
activity domains. Studying the interaction between physical activity and air pollution is not 
only justified from the perspective of physical activity recommendations in different 
environmental contexts, but is also justified against the current biological understanding of 
physical activity and air pollution effects on atherosclerotic pathophysiology. Both, physical 
inactivity and air pollution have been associated with systemic low grade inflammation and 
oxidative stress, both risk factors for endothelial dysfunction, atherosclerosis and CVD.133,136 
Physical inactivity7 and air pollution133,137 are both positively associated with blood pressure 
increase. In addition there is synergy at the level of pathophysiology, because physical 
activity leads to a higher and potentially deeper inhalation of air pollutants through elevated 
breathing rates, which could elevate local respiratory and systemic inflammation.138,139 
Nevertheless, being physically active compared to resting in a polluted environment was 
found to be associated with lower systolic blood pressure regardless of the level of 
pollution.140 In contrast, short-term exposure to traffic-related air pollution through physical 
activity was negatively associated with arterial stiffness in a small experimental study.141 
Besides, in a cross-over study among 53 healthy women exposure to traffic-related air 
pollution through cycling activity led to an acute increase in systolic blood pressure.142 Apart 
from these studies, the associations between physical activity and air pollution have so far 
mainly been studied concerning lung function and exercise performance, and there is limited 
evidence concerning interactions with the cardiovascular system.143 Despite presenting 
several severe cardiovascular risks associated with acute and long-term air pollution 
exposure a current expert position paper recommends physical exercise and being physically 
active together with avoiding major traffic roads.132 However, there is lack of evidence on 
how the associations between physical activity performed in different domains of daily living 
and cardiovascular risk markers especially concerning aortic stiffness and central 
hemodynamics are modified by air pollution on the population level. Therefore, in upcoming 
analyses building on this PhD thesis we will focus on the research question whether and how 
physical activity recommendations need to be refined towards the prevention of 
atherosclerosis and CVD by a) studying cross-sectional and longitudinal associations of 
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different physical activity domains (e.g. leisure time vs. transport-related physical activity) 
with central and peripheral arterial stiffness and hemodynamics including aortic stiffness 
derived with a novel transfer algorithm (ARCSolver) on the population level, and by b) 
assessing modifying effects of air pollution on the physical activity/ arterial stiffness/ 
hemodynamics associations towards context and environment specific physical activity 
recommendations. Thereby it will be of interest whether the respiratory and cardiovascular 
health state influences the association between chronic physical activity and cardiovascular 
risk markers and the potential modification by long-term ambient and traffic-related air 
pollution. 
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Aerobic, resistance and combined exercise training on arterial stiffness
in normotensive and hypertensive adults: A review
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Abstract
Exercise training has different effects on arterial stiffness according to training modalities. The optimal exercise modality for
improvement of arterial function in normotensive and hypertensive individuals has not been well established. In this review,
we aim to evaluate the effects of aerobic, resistance and combined aerobic and resistance training on arterial stiffness in
individuals with and without hypertension. We systematically searched the Pubmed and Web of Science database from 1985
until December 2013 for relevant randomised controlled trials (RCTs). The data were extracted by one investigator and
checked by a second investigator. The training effects on arterial stiffness were estimated using weighted mean differences of
the relative changes (%) with 95% confidence intervals (CIs). We finally reviewed the results from 17 RCTs. The available
evidence indicates that aerobic exercise tends to have a beneficial effect on arterial stiffness in normotensive and
hypertensive patients, but does not affect arterial stiffness in patients with isolated systolic hypertension. Resistance exercise
has differing effects on arterial stiffness depending on type and intensity. Vigorous resistance training is associated with an
increase in arterial stiffness. There seem to be no unfavourable effects on arterial stiffness if the training is of low intensity, in
a slow eccentric manner or with lower limb in healthy individuals. Combined training has neutral or even a beneficial effect
on arterial stiffness. In conclusion, our review shows that exercise training has varying effects on arterial stiffness depending
on the exercise modalities.
Keywords: Exercise, cardiovascular, health, ageing, lifestyle
Introduction
Arterial stiffness is as an emerging biomarker in
the assessment of vascular health (Laurent, Alivon,
Beaussier, & Boutouyrie, 2012). Arterial stiffness
increases with advancing age in healthy normotensive
adults (Vaitkevicius et al., 1993) and hypertensive
patients (London, Marchais, & Safar, 1989). Large
artery stiffening is independently associated with
cardiovascular events and all-cause mortality (Karras
et al., 2012; Vlachopoulos, Aznaouridis, & Stefanadis,
2010; Vlachopoulos, Aznaouridis, Terentes-Printzios,
Ioakeimidis, & Stefanadis, 2012). Hypertension has
become the leading cause of cardiovascular disease
and all-cause mortality (Chow et al., 2013; Danaei
et al., 2011; Kearney et al., 2005). The relationship
between hypertension and arterial stiffness may be
bi-directional (Franklin, 2005). In contrast to con-
ventional understanding, a recent study showed that
aortic stiffness may be a precursor of hypertension,
rather than being the result of high blood pressure
(Kaess et al., 2012). Given that arterial stiffness is a
precursor of hypertension, lowering blood pressure
alone is not enough to decrease cardiovascular
risk. Therefore, lifestyle modifications aiming at the
reduction of arterial stiffness are of great clinical
importance.
Exercise training is an important component of
lifestyle modification. There are two major types of
exercise, aerobic and resistance exercise training.
Aerobic exercise training has been defined by the
American College of Sports Medicine (ACSM) as
any activity that involves major muscle groups and is
continuous and rhythmical in nature (Garber et al.,
2011). Resistance exercise training is defined as any
activity that involves brief, repeated execution of
voluntary muscle contractions against a load that is
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greater than those normally encountered in activities
of daily living (Lee & Carroll, 2007).
Although the blood pressure lowering effect of
exercise training has been widely accepted (Cornelis-
sen & Smart, 2013), the effect of exercise training on
the vascular system is not fully clarified. Previous
studies showed that an active lifestyle with regular
physical activity is associated with reductions in
cardiovascular disease risk in healthy individuals and
patients with cardiovascular disease (Hakim et al.,
1999; Mons, Hahmann, & Brenner, 2014; Sesso,
Paffenbarger, & Lee, 2000). However, the extreme
daily strenuous physical activity may increase cardio-
vascular mortality in patients with coronary heart
disease in a reverse J-shaped association (Mons
et al., 2014).
When examining the time course of exercise-
induced change on vasculature, shear stress flow-
mediated vasodilatation (FMD) was initially altered,
followed by other functional and structural adapta-
tions. Arterial compliance is the ability of an artery to
expand and recoil during cardiac contraction and
relaxation, while arterial stiffness is the inverse
(Nichols, O’Rourke, Hartley, & McDonald, 1998).
Arterial stiffness is determined by the functional
(endothelium, smooth muscle cells) and structural
components (elastin, collagen and connective tissue).
It is a function of the structure of an artery and may be
modified more rapidly or slowly depending on which
component is influenced by exercise training (Green
et al., 2013; Green, Spence, Halliwill, Cable, &
Thijssen, 2011; Tinken et al., 2010). However, the
studies investigating the effect of exercise training on
arterial stiffness were less uniform. Previous cross-
sectional studies showed that aerobic training is
associated with improved arterial stiffness (Otsuki
et al., 2006; Sugawara et al., 2006; Tanaka et al.,
2000), whereas resistance training is associated with
an increase of arterial stiffness (Bertovic et al., 1999;
Miyachi et al., 2003; Otsuki et al., 2006). However,
the combination of aerobic and resistance training in
rowers showed either no change (Kawano et al., 2012;
Petersen et al., 2006) or improved arterial stiffness
(Cook et al., 2006). These cross-sectional studies
showed inconsistent results, but they do not suggest
cause and effect between exercise and the change of
arterial stiffness. Conclusive explanations for the un-
derlying mechanisms are still lacking and the true
relationship should be further analysed and confirmed
in randomised controlled trials (RCTs). Thus, the aim
of this review is to summarise the current evidence
based on RCTs regarding the effect of exercise
training with a duration >4 weeks on arterial stiffness
in normotensive and hypertensive individuals.
Methods
Search methods
We systematically searched for RCTs investigating
the effect of exercise training on arterial compliance
published from 1985 to December 2013 in the
PubMed and Web of Science database. Search terms
included “aerobic training” OR “endurance training”
OR “resistance training” OR “strength training” OR
“weight training” OR “eccentric training” OR “con-
centric training” OR “exercise” AND “vascular stiff-
ness” OR “arterial stiffness” OR “arterial compliance”
OR “arterial stiffening”. Abstract, case reports and
articles not in English were not considered. The
reference lists of published articles and reviews on the
topic were checked to identify other eligible studies.
Criteria for study selection
Definition of hypertension. The definition of hyperten-
sion is based on recommendations by the American
Joint National Committee (JNC) on Prevention,
Detection, Evaluation, and Treatment of High
Blood Pressure. According to the JNC-7 report
(2003): prehypertension is defined as SBP ranging
from 120–139 mmHg and/or DBP 80–89 mmHg.
Hypertension is defined as SBP ≥ 140 mmHg and/or
DBP ≥ 90 mmHg. Isolated systolic hypertension
(ISH) is defined as an elevated SBP of >140 mmHg
with a normal (<80 mmHg) DBP (Chobanian
et al., 2003).
Types of studies
We included RCTs that involved a non-exercise
control group (parallel design) or a non-exercise
control phase (cross-over design). The study sub-
jects enrolled should be either healthy normotensive
individuals or hypertensive patients without any
significant comorbidities.
Types of interventions
RCTs prescribing aerobic or resistance or combined
exercise training of at least 4 weeks were included as
follows: (1) Aerobic exercise versus non-exercise
control group/phase; (2) Resistance exercise versus
non-exercise control group/phase; (3) Combined
exercise (aerobic exercise plus resistance exercise)
versus non-exercise control group/phase; (4) Aer-
obic, resistance exercise versus non-exercise control
group/phase; (5) Aerobic, combined exercise versus
non-exercise control group/phase; (6) Resistance,
combined exercise versus non-exercise control
group/phase; (7) Aerobic, resistance, combined exer-
cise versus non-exercise control group/phase.
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Types of outcome measures
There are various techniques for assessing arterial
stiffness. We included studies using regional and local
arterial stiffness measured as primary or secondary
outcome in our review. In particular these were as
follows: central arterial stiffness measured as carotid-
femoral pulse wave velocity (cfPWV), carotid arterial
compliance and carotid β-stiffness index; peripheral
arterial stiffness measured as carotid-radial pulse wave
velocity (crPWV), femoral-ankle pulse wave velocity
(faPWV), femoral-dorsalis pedis pulse wave velocity
(fdPWV); systemic arterial stiffness measured as
brachial-ankle pulse wave velocity (baPWV) and
cardio-ankle vascular index (CAVI). Standardised
reference values have recently been published by the
“Reference Values for Arterial Stiffness Collabora-
tion” (Mattace-Raso et al., 2010). A higher value of
pulse wave velocity, β-stiffness index, CAVI or lower
value of arterial compliance denotes a stiffer artery.
An increase in cfPWV and baPWV by 1 m/s has been
shown to increase cardiovascular mortality by 15%
(Vlachopoulos et al., 2010) and 13% (Vlachopoulos
et al., 2012), respectively.
Quality assessment
The quality of the included studies was assessed
using the Jadad scale (Jadad et al., 1996), giving one
point each for descriptions of randomisation, blind-
ing, dropouts and appropriateness of randomisation
and blinding. Blinding of the investigator adminis-
tering the intervention and of the participants per-
forming the exercise is almost impossible in exercise
intervention trials. Therefore, the Jadad scale was
slightly modified by giving one point for proper
blinding of the outcome assessor. Since all studies
had to be RCTs according to the inclusion criteria,
the range of the Jadad score for the included studies
in this review was one to five, with higher scores
reflecting superior quality.
Data extraction
The following data were extracted: first author, year
of publication, type of study design, characteristics of
the study population (health status, age, sex), train-
ing programme (duration, frequency, intensity),
study sample size, parameters of arterial stiffness,
intervention effects (weighted mean difference of
relative change with a 95% CI) and Jadad score.
The training intensity of aerobic exercise was indi-
cated as heart rate reserve (HRR), maximum heart
rate (HRmax) or maximal oxygen consumption
(VO2max). The intensity of aerobic exercise was
defined as follows: moderate, 40–59% heart rate
reserve = 64–76% maximal heart rate = 46–63%
maximal oxygen uptake; vigorous, 60–89% heart
rate reserve = 77–95% maximal heart rate = 64–
90% maximal oxygen uptake (Garber et al., 2011).
The training intensity of resistance exercise was
indicated as a percentage of 1 RM (one repetition
maximum). The intensity was defined as follows:
light, < 50% 1RM; moderate, 50–69% 1RM; vigor-
ous, 70–84% 1RM (Garber et al., 2011). The
primary outcome was resting arterial stiffness in the
supine position.
Data synthesis
To summarise the effects of exercise training on
arterial stiffness, we estimated the weighted mean
differences (WMD) of the relative changes (%) with
95% CIs. We used relative changes in our analysis
because the RCTs reviewed had used different
arterial stiffness measures and units. The relative
change in each group was calculated by subtracting
the baseline value (Meanpre) from the post interven-
tion value (Meanpost), divided by the baseline value
and multiplied by 100% {Meanrc = [(Meanpost–
Meanpre)/Meanpre] ×100%}; Variances were calcu-
lated from the standard deviation (SD) of the
changes in the intervention and control group. If
the SD of the change was not available, the formula
SDc =√ [(SDpre)2 + (SDpost)2 − 2 × corr(pre, post) ×
SDpre × SDpost] was used for the calculation, for
which we assumed a conservative correlation coeffi-
cient of 0.5 between the initial and final values
(Cornelissen, Fagard, Coeckelberghs, & Vanhees,
2011; Follmann, Elliott, Suh, & Cutler, 1992).
Statistical analysis was performed using the software
Review Manager (RevMan 5.1; Cochrane Collab-
oration, Oxford, United Kingdom).
Results
Our literature search revealed 228 potentially relev-
ant records, of which 36 met our inclusion criteria
for outcome variables. Excluding 19 trials with non-
random allocation to control group, the remaining
17 RCTs were included in the final analysis. Four
RCTs consisted of two studies, therefore, 21 studies
were separately reviewed (6 aerobic exercises, 11
resistance exercises and 4 combined aerobic plus
resistance exercises). A flow chart of studies identi-
fied, included and excluded is shown in Figure 1. All
studies used parallel group design except for one
study using cross-over design. The characteristics
and quality assessment of the included RCTs are
shown in Table I.
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Aerobic exercise and arterial stiffness
Results. We investigated 6 RCTs on the effect of
aerobic training on arterial stiffness, involving 8
comparisons and 215 participants. The average age
of the participants ranged from 18 to 72 years and
29.3% were male. Training duration varied from 8
to 16 weeks. Training frequency amounted to 2–3
weekly sessions. Training duration per session aver-
aged 30–45 min. Intensity ranged from 50–90%
VO2max, 50– 85% HRmax or 50–80% HHR. Four
of these studies had a Jadad score of ≥3. The
combined relative changes in arterial stiffness are
reported in Table II.
Two RCTs have measured the changes in arterial
stiffness in the context of aerobic training in normo-
tensive young (Ciolac et al., 2010) and middle-aged
individuals (Yoshizawa et al., 2009). No RCT was
available in the older adults above 60 years old.
Combining the data of interval and continuous
training, aerobic exercise was associated with a
significant reduction in cfPWV by −7.0% (95% CI,
−11.3%, −2.6%) in young individuals (Ciolac et al.,
2010). Similar result was shown in the middle-aged
adults [−6.7% (95% CI, −10.6%, −2.8%)] (Yoshi-
zawa et al., 2009). Comparing the exercise modality
of continuous and interval training, the authors
showed that vigorous interval training was associated
with a significant reduction in cfPWV by −7.5%
(95% CI, −13.2%, −1.8%), however, the improve-
ment in arterial stiffness with continuous training
was not significant (Ciolac et al., 2010). Regarding
the training intensity, combining the data of con-
tinuous aerobic exercise (Yoshizawa et al., 2009) and
interval aerobic exercise (Ciolac et al., 2010), the
vigorous training was associated with a significant
improvement in cfPWV by −7.0 (95% CI, −10.2%,
−3.8%). However, the improvement of arterial stiff-
ness following moderate continuous aerobic exercise
was not significant (Ciolac et al., 2010). All remain-
ing RCTs in this review investigated hypertensive
patients with inconsistent results. Three RCTs
showed the changes in arterial stiffness in the context
of aerobic training in mixed hypertension. In young
prehypertensive individuals, peripheral arterial stiff-
ness was significantly reduced [−10.3% (95% CI,
−18.4%, −2.2%)] after moderate interval training;
however, the central arterial stiffness did not change
apparently (Beck, Martin, Casey, & Braith, 2013). In
middle-aged hypertensive patients, combining the
data of continuous and interval aerobic exercise,
vigorous aerobic exercise did not change the central
Figure 1. Flow chart of studies identiﬁed, included and excluded.
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Table I. Characteristics of the included RCTs: aerobic, resistance and combined exercise training
Study Design Participant
Age
(years) Sex Exercise Weeks
Frequency/
week
Min/
session Intensity
N1
(Intervention)
N2
(Control) Outcome
Mean difference
(% change; 95% CI)
Jadad
score
Trails including AE
Yoshizawa
et al. (2009)
Parallel Normotensive 47 ± 2 Female Cycle
ergometer
12 3 30 60–70% VO2max 12 12 cfPWV −6.74 (−10.64, −2.84) 2
Ciolac
et al. (2010)
Parallel Normotensive females
with hypertensive patients
25.0 ± 4.4 Female Treadmill
walking/
running
16 3 40 80–90% VO2max
interval training
16 12 cfPWV −7.5 (−13.21, −1.79) 3
50–60% VO2max
continuous training
16 −6.2 (−12.83, 0.43)
Beck
et al. (2013)
Parallel Prehypertensive 18–35 Both Treadmill
walking/
running
8 3 45 65–85% HRmax 13 15 crPWV −9.8 (−19.97, 0.37) 3
cfPWV −1.00 (−8.52, 6.52)
fdPWV −11.1 (−24.58, 2.38)
Madden
et al. (2009)
Parallel Hypertension,
Hypercholesterolemia
71.4 ± 0.7 Both Treadmilland
cycle ergometer
12 3 40 60−75% HRR 17 17 Radial PWV −29.2 (−33.54, −24.86) 4
Femoral PWV −18.3 (−21.85, −14.75)
Guimarães
et al. (2010)
Parallel Hypertension 45 ± 9 Both Treadmill 16 2 40 50−80%
HRRinterval
training
26 13 cfPWV −8.6 (−19.35, 2.15) 4
26 −4.6 (−16.53, 7.33)
Ferrier
et al. (2001)
Cross-
over
Isolated systolic
hypertension
64 ± 7 Both Cycle
ergometer
8 3 40 65% HRmax 10 10 cfPWV 0 (−16.5, 16.5) 1
fdPWV 2.10 (−16.25, 20.45)
Trials including RE
Yasuda
et al. (2013)
Parallel Healthy 61–84 Both Lower limb 12 2 NG 20–30% 1RM 9 10 CAVI 1.2 (−11.38, 13.78) 1
Okamoto et al.
(2008a)
Parallel Healthy 19.4 ± 0.2 Male Whole body 8 2 NG 40% 1RM 10 9 baPWV −6.6 (−13.45, 0.25) 1
Okamoto
et al. (2011)
Parallel healthy 18.5 ± 0.5 Both Whole body 10 2 NG 50% 1RM 13 13 baPWV −8.4 (−18.59, 1.79) 3
Kawano
et al. (2006)
Parallel Healthy 20 ± 1 Male Whole body 16 3 45 50% 1RM 12 16 Carotid
arterial
compliance
20.0 (7.0, 33.0) 2
Femoral
arterial
compliance
−22.5 (−51.38, 6.38)
Yoshizawa
et al. (2009)
Parallel Healthy 47 ± 2 Female Whole body 12 2 NG 60% 1RM 11 12 cfPWV −5.14 (−9.8, −0.48) 2
Beck
et al. (2013)
Parallel Prehypertensive 18–35 Both Whole body 8 3 45 60% 1RM 15 15 crPWV −10.5 (−20.20, −0.80) 3
cfPWV −2.0 (−9.05, 5.05)
fdPWV −7.9 (−15.26, −0.54)
Cortez-Cooper
et al. (2008)
Parallel Healthy 52 ± 2 Both Whole body 13 3 30–45 70% 1RM 13 12 cfPWV −4.91 (−16.10, 6.28) 2
Okamoto
et al. (2006)
Parallel Healthy 18.9 ± 0.3 Female Upper limb,
eccentric
8 3 NG 100% 1RM 10 9 baPWV −3.1 (−6.38, 0.18) 3
19.1 ± 0.3 Female Upper limb,
concentric
NG 80% 1RM 10 10.4 (7.12, 13.68)
Okamoto et al.
(2008b)
Parallel Healthy 19.6 ± 0.4 Male Whole body,
eccentric
10 2 NG 80% 1RM 10 10 baPWV −5.55 (−10.37, −0.73) 3
19.2 ± 0.3 Male Whole body,
concentric
NG 10 8.75 (3.93, 13.57)
Okamoto
et al. (2009)
Parallel Healthy 20.2 ± 0.4 Both Upper limb 10 2 NG 80% 1RM 10 10 baPWV 12.18 (5.58, 18.78) 2
20.0 ± 0.5 Lower limb NG 10 −1.42 (−8.02, 5.18)
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Table I (Continued)
Study Design Participant
Age
(years) Sex Exercise Weeks
Frequency/
week
Min/
session Intensity
N1
(Intervention)
N2
(Control) Outcome
Mean difference
(% change; 95% CI)
Jadad
score
Miyachi
et al. (2004)
Parallel Healthy 20–38 Male Whole body 16 3 45 80% 1RM 14 14 Carotid
arterial
compliance
29.88 (14.17, 45.59) 3
Femoral
arterial
compliance
0.00 (−40.34, 40.34)
Trials including COMB
Stewart
et al. (2005)
Parallel Mild hypertension 55–75 Both RE + AE one
training session
24 3 RE:
NGAE:
45
50% 1RM,
60–90% HRmax
40 42 cfPWV 10.5 (−9.08, 30.08) 2
Kawano
et al. (2006)
Parallel Healthy 21 ± 1 Male RE + AE one
training session
16 3 75 80% 1RM,
60% HRmax
11 16 Carotid
arterial
compliance
−12.5 (−26.32, 1.32) 2
Femoral
arterial
compliance
12.2 (−15.57, 39.97)
Cortez-Cooper
et al. (2008)
Parallel Healthy 52 ± 2 Both RE and AE
separate days
13 3 60–90 70% 1RM,
60–75% HRmax
12 12 cfPWV −4.91 (−15.65, 5.83) 2
Figueroa
et al. (2011)
Parallel Healthy 47–68 Female RE + AE one
training session
12 3 40 60% 1RM,
60% HRmax
12 12 baPWV −6.98 (−11.34, −2.62) 1
RE, resistance training; AE, aerobic training; COMB, combined aerobic and resistance training; VO2max, maximal oxygen consumption; HRmax, maximal heart rate; HRR, heart rate reserve; NG, not
given in the study; 1RM, one repetition maximum; CAVI, cardio-ankle vascular index; baPWV, brachial ankle pulse wave velocity; cfPWV, carotid femoral pulse wave velocity; crPWV, carotid radial
pulse wave velocity; fdPWV, femoral ankle pulse wave velocity; CI, confidence interval; − [Mean difference (% change)], decrease of arterial stiffness or increase of arterial compliance; + [Mean
difference (% change)], increase of arterial stiffness or decrease of arterial compliance.
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Table II. Combined relative changes in arterial stiffness after aerobic training
Arterial
stiffness Study
N1
(intervention)
N2
(Control) Outcome
Combined relative change (%)
of arterial stiffness (95% CI)
Normotensive individuals (2 RCTs)
Intensity
Moderate Central Ciolac et al. (2010) 16 12 cfPWV −6.2 (−12.8, 0.43)
Peripheral No data available
Vigorous Central Yoshizawa et al. (2009) and Ciolac et al. (2010) 28 24 cfPWV −7.0 (−10.2, −3.8)
Peripheral No data available
Age
Young (18–39 years) Central Ciolac et al. (2010) 32 24 cfPWV −7.0 (−11.3, −2.6)
Peripheral No data available
Middle-aged (40–59 years) Central Yoshizawa et al. (2009) 12 12 cfPWV −6.7 (−10.6, −2.8)
Peripheral No data available
Old (>60 years) Central No data available
Peripheral No data available
Modality
Continuous Central Ciolac et al. (2010) 16 12 cfPWV −6.2 (−12.8, 0.4)
Peripheral No data available
Interval Central Ciolac et al. (2010) 16 12 cfPWV −7.5 (−13.2, −1.8)
Peripheral No data available
Mixed hypertension individuals (3 RCTs)
Intensity
Moderate Central Beck et al. (2013) 13 15 cfPWV −1.0 (−8.5, 6.5)
Peripheral Beck et al. (2013) 26 30 crPWV, fdPWV −10.3 (−18.4, −2.2)
Vigorous Central Guimarães et al. (2010) 52 26 cfPWV −6.8 (−14.8, 1.2)
Peripheral Madden et al. (2009) 34 34 Radial PWV, femoral PWV −23.7 (−34.4, −13)
Age
Young (18–39 years) Central Beck et al. (2013 13 15 cfPWV −1.0 (−8.5, 6.5)
Peripheral Beck et al. (2013) 26 30 crPWV, fdPWV −10.3 (−18.4, −2.2)
Middle-aged (40–59 years) Central Guimarães et al. (2010) 52 26 cfPWV −6.8 (−14.8, 1.2)
Peripheral No data available
Old (>60 years) Central No data available
Peripheral Madden et al. (2009) 34 34 Radial PWV, femoral PWV −23.7 (−34.4, −13)
Modality
Continuous Central Guimarães et al. (2010) 26 13 cfPWV −4.6 (−16.5, 7.3)
Peripheral Madden et al. (2009) 34 34 Radial PWV, femoral PWV −23.7 (−34.4, −13)
Interval Central Beck et al. (2013) and Guimarães et al. (2010) 39 28 cfPWV −3.8 (−11, 3.4)
Peripheral Beck et al. (2013) 26 30 crPWV, fdPWV −10.3 (−18.4, −2.2)
Isolated systolic hypertension individuals (1 RCT)
Central Ferrier et al. (2001) 10 10 cfPWV 0 (−16.5, 16.5)
Peripheral fdPWV 2.10 (−16.3, 20.5)
Moderate intensity, 40–59% heart rate reserve = 64–76% maximal heart rate = 46–63% maximal oxygen uptake; Vigorous intensity, 60–89% heart rate reserve = 77–95% maximal heart rate = 64–90%
maximal oxygen uptake; cfPWV, carotid femoral pulse wave velocity; crPWV, carotid radial pulse wave velocity; fdPWV, femoral ankle pulse wave velocity; CI, confidence interval; − [Combined relative
change of arterial stiffness], decrease of arterial stiffness or increase of arterial compliance; + [Combined relative change of arterial stiffness], increase of arterial stiffness or decrease of arterial
compliance.
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arterial stiffness significantly (Guimarães et al.,
2010). In older hypertensive patients, the vigorous
aerobic exercise affected the peripheral arterial stiff-
ness favourably with a combined reduction of radial
PWV and femoral PWV by −23.7% (95% CI,
−34.4%, −13%) (Madden, Lockhart, Cuff, Potter, &
Meneilly, 2009). However, moderate aerobic exercise
training did not result in a change of arterial stiffness
in patients with isolated systolic hypertension (Ferrier
et al., 2001).
Discussion. There is a general agreement that acute
aerobic exercise leads to both local (exercising limbs;
Kingwell, Berry, Cameron, Jennings, & Dart, 1997)
and systemic changes in arterial stiffness (Ranadive
et al., 2012). Analogously, for medium to long-term
exercise training, similar effects could be speculated.
Our results demonstrate that aerobic exercise train-
ing reduced arterial stiffness in healthy normotensive
(Ciolac et al., 2010; Yoshizawa et al., 2009) and
hypertensive patients (Beck et al., 2013; Guimarães
et al., 2010; Madden et al., 2009). However, aerobic
exercise failed to alter large arterial stiffness in
older populations with isolated systolic hypertension
(Ferrier et al., 2001). The central and peripheral
arterial stiffness may differ in response to aerobic
exercise. In healthy individuals, central arterial stiff-
ness following aerobic exercise decreased significantly
(Ciolac et al., 2010; Yoshizawa et al., 2009). In
hypertensive patients, aerobic exercise reduced the
peripheral arterial stiffness (Beck et al., 2013; Madden
et al., 2009); however, the central arterial stiffness did
not change significantly (Beck et al., 2013; Guimarães
et al., 2010). Since most of the RCTs investigated the
association between exercise training and only one
arterial stiffness parameter at one segment of the
artery, whether the adaptations differ for central and
peripheral arterial stiffness in normotensive and hyper-
tensive is largely unknown and should be investigated
in future studies. Further, comparing exercise modal-
ities, vigorous interval training was shown to be
superior to traditional moderate continuous training
in reducing arterial stiffness in normotensive popula-
tions at risk for future cardiovascular events (Ciolac
et al., 2010). However, whether high intensity interval
training is well tolerated in hypertensive patients is
unknown. Interval training with a lower intensity (50–
80% HRR) caused a small and non-significant
improvement in cfPWV, but the difference of cfPWV
at baseline level in the interval training group (9.44 ±
0.91 m/s) and control group (10.23 ± 1.82 m/s) leaves
a doubt, as to whether the drop in cfPWV (0.41 m/s)
following interval training was due to a superior
intervention effect compared to the controls (Guimar-
ães et al., 2010). Further, the lower intensity (50–80%
HRR) assigned to the hypertensive patients may also
contribute to the blunted reduction of arterial stiffness
in hypertensive patients (Guimarães et al., 2010).
Therefore, further studies are required to confirm
that high intensity interval training is superior to
traditional moderate continuous training in reducing
arterial stiffness in hypertensive patients. Age alone
increased arterial stiffness even in the well-trained
individuals (Cameron, Rajkumar, Kingwell, Jennings,
& Dart, 1999; Tanaka et al., 2000). Furthermore, the
increase of arterial stiffness was more pronounced
in hypertensive patients (Vaitkevicius et al., 1993;
Wallace et al., 2007). Thus, to determine the effect
of aerobic exercise in populations whose arterial
stiffness has some alteration is of great clinical
importance. The previous thought of a point of no
return might be changed by the encouraging results in
older hypertensive patients (Madden et al., 2009).
However, the low responsiveness of patients with
isolated systolic hypertension to exercise, which may
be due to an irreversible level of arterial stiffness
(Tanaka & Safar, 2005), implied that aerobic training
initiated at a younger age may be more effective. In
addition, since arterial stiffening seems to precede
hypertension (Kaess et al., 2012), studies in normo-
tensive individuals with increased arterial stiffness are
warranted in order to show a direct preventive effect of
aerobic exercise training on the artery. Finally, differ-
ent muscle contractions in aerobic training may
contribute differently on arterial stiffness. It has been
shown that aerobic exercise training (running) involves
both eccentric (knee extensors) and concentric con-
tractions (ankle plantar flexors) (Bijker, Groot, &
Hollander, 2002). However, no study so far has
addressed the question of whether concentric and
eccentric muscle contractions in aerobic exercise
training contribute to different effects on arterial
stiffness.
Resistance exercise and arterial stiffness
Results. We identified 11 randomised controlled
trials investigating the effect of resistance training
on arterial stiffness, involving 14 study groups and
287 participants totally. The average age of the study
groups ranged from 18 to 84 years, 56% of the
participants were male. Only one trial was conducted
in prehypertensive patients (Beck et al., 2013).
Training duration varied from 8 to 16 weeks,
training frequency averaged 2–3 weekly sessions
and intensity ranged from 20–100% of 1RM. Four
studies reported the duration per session which
averaged 30–45 min (Beck et al., 2013; Cortez-
Cooper et al., 2008; Kawano, Tanaka, & Miyachi,
2006; Miyachi et al., 2004). Of these 11 studies, only
5 had a Jadad score of ≥3 (Beck et al., 2013; Miyachi
et al., 2004; Okamoto, Masuhara, & Ikuta, 2006,
2008b, 2011). The combined relative changes in
arterial stiffness are reported in Table III.
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Table III. Combined relative changes in arterial stiffness after resistance training
Arterial stiffness Study
N1
(intervention)
N2
(Control) Outcome
Combined relative change (%) of
arterial stiffness (95% CI)
Normotensive individuals (10 RCTs)
Intensity
Light Central Kawano et al. (2006) 12 16 Carotid arterial
compliance
20.0 (7.0, 33.0)
Peripheral Kawano et al. (2006) 12 16 Femoral arterial
compliance
−22.5 (−51.4, 6.4)
Systemic Okamoto et al. (2011), Okamoto et al. (2008a) and Yasuda
et al. (2013)
32 32 baPWV, CAVI −5.7 (−10.9, −0.6)
Moderate Central Cortez-Cooper et al. (2008) and Yoshizawa et al. (2009) 24 24 cfPWV −5.1 (−9.4, −0.8)
Peripheral No data available
Systemic No data available
Vigorous Central Miyachi et al. (2004) 14 14 Carotid arterial
compliance
29.9 (14.2, 45.6)
Peripheral Miyachi et al. (2004) 14 14 Femoral arterial
compliance
0 (−40.3, 40.3)
Systemic Okamoto et al. (2006), Okamoto et al. (2008b) and
Okamoto et al. (2009)
60 58 baPWV 3.1 (1.4, 4.8)
Age
Young (18
−39 years)
Central Kawano et al. (2006) and Miyachi et al. (2004) 26 30 Carotid arterial
compliance
24.0 (14.0, 34.0)
Peripheral Kawano et al. (2006) and Miyachi et al. (2004) 26 30 Femoral arterial
compliance
−14.9 (−38.3, 8.6)
Systemic Okamoto et al. (2006), Okamoto et al. (2008a), Okamoto et al.
(2008b), Okamoto et al. (2009) and Okamoto et al. (2011)
83 80 baPWV 1.1 (−4.5, 6.7)
Middle-aged
(40−59 years)
Central Cortez-Cooper et al. (2008) and Yoshizawa et al. (2009) 24 24 cfPWV −5.1 (−9.4, −0.8)
Peripheral No data available
Systemic No data available
Old (>60
years)
Systemic Yasuda et al. (2013) 9 10 CAVI 1.2 (−11.4, 13.8)
Muscle contraction types
Eccentric Systemic Okamoto et al. (2006) and Okamoto et al. (2008b) 20 19 baPWV −3.9 (−6.6, −1.2)
Concentric Okamoto et al. (2006) and Okamoto et al. (2008b) 20 19 baPWV 9.9 (7.2, 12.6)
Muscle groups
Lower limb Systemic Okamoto et al. (2009) and Yasuda et al. (2013) 19 20 baPWV, CAVI −1.0 (−5.7, 3.6)
Upper limb Systemic Okamoto et al. (2009) 10 10 baPWV 12.2 (5.6, 18.8)
Prehypertensive patients (1 RCT)
Intensity Central Beck et al. (2013) 15 15 cfPWV −2 (−9.1, 5.1)
Moderate Peripheral crPWV, fdPWV −8.9 (−14.7, −3)
Intensity “light”, <50% 1RM; Intensity “moderate”, 50–69% 1RM; Intensity “vigorous”, 70–84% 1RM; baPWV, brachial ankle pulse wave velocity; CAVI, cardio-ankle vascular index; cfPWV,
carotid femoral pulse wave velocity; crPWV, carotid radial pulse wave velocity; fdPWV, femoral ankle pulse wave velocity; CI, confidence interval; − [Combined relative change of arterial stiffness],
decrease of arterial stiffness or increase of arterial compliance; + [Combined relative change of arterial stiffness], increase of arterial stiffness or decrease of arterial compliance.
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Light resistance training (≤50%1RM) induced a
significant pooled reduction of systemic arterial
stiffness measured in baPWV and CAVI of −5.7%
(95% CI, −10.9%, −0.6%) in 32 participants in
comparison with 32 controls combining 3 studies
(Okamoto, Masuhara, & Ikuta, 2008a; Okamoto
et al., 2011; Yasuda et al., 2013). However, a relative
low intensity of 50% 1RM decreased the carotid
arterial compliance by 20% (95% CI, 7.0%, 33%)
without changing the femoral arterial compliance
(Kawano et al., 2006). Moderate resistance training
(>50–70% 1RM) was associated with a reduction of
cfPWV by −5.1% (95% CI, −9.4%, −0.8%) in
healthy young and middle-age individuals (Cortez-
Cooper et al., 2008; Yoshizawa et al., 2009). In
contrast, high intensity and concurrent high-volume
resistance training was found to have unfavourable
effects on arterial stiffness. A training at an intensity
of ≥80%1RM, resulted in an increase of central
arterial stiffness by 29.9% (95% CI, 14.2%, 45.6%)
(Miyachi et al., 2004) and baPWV by 3.1% (95%
CI, 1.4%, 4.8%) (Okamoto et al., 2006, 2008b;
Okamoto, Masuhara, & Ikuta, 2009) without chan-
ging the peripheral arterial stiffness (Miyachi et al.,
2004). We further summarised the responses to
resistance training in different age groups. In young
individuals, resistance training was associated with
an increase of central arterial stiffness of 24% (95%
CI, 14.0%, 34.0%) (Kawano et al., 2006; Miyachi
et al., 2004), but was not associated with changes in
peripheral (Kawano et al., 2006; Miyachi et al.,
2004) and systemic arterial stiffness (Okamoto et al.,
2006, 2008a, 2008b, 2009, 2011). In middle-aged
adults, two RCTs showed that resistance training
was associated with a reduction of central arter-
ial stiffness by −5.1% (95% CI, −9.4%, −0.8%)
(Cortez-Cooper et al., 2008; Yoshizawa et al., 2009).
The only existing RCT in older adults showed that
light resistance training (20–30% 1RM) with lower
limb did not affect the systemic arterial stiffness
measured as CAVI (Yasuda et al., 2013). Compar-
ing eccentric and concentric training, eccentric
exercise led to a relative change by −3.9% in arterial
stiffness (95% CI, −6.6%, −1.2%) and concentric
exercise increased arterial stiffness of 9.9% (95% CI,
7.2%, 12.6%) (Okamoto et al., 2006, 2008b). Most
of the studies examined dynamic resistance training
involving major muscular groups of both the upper
and lower limbs. Comparing exercise using upper
limb with lower limb, upper limb exercise led to a
12.2% (95% CI, 5.6%, 18.8%) increase of baPWV
(Okamoto et al., 2009), while lower limb exercise
had not affected the systemic arterial stiffness
(baPWV and CAVI)(Okamoto et al., 2009; Yasuda
et al., 2013). To our knowledge, the only existing
RCT in a small number of prehypertensive patients
reported that a 8-week moderate (60% 1RM) whole
body resistance training reduced peripheral arterial
stiffness (combined crPWV and fdPWV) by −8.9%
(95% CI, −14.7%, −3%). However, central arterial
stiffness (cfPWV) did not change (Beck et al., 2013).
Discussion. Resistance training has been recom-
mended as an important component in a compre-
hensive exercise programme by the American College
of Sports Medicine in recent years (American College
of Sports Medicine, 2009). However, these recom-
mendations were primarily based on its favourable
effects on muscular strength (Feigenbaum & Pollock,
1999). Few recommendations with respect to resist-
ance training and cardiovascular function exist so far.
Current evidence suggests that low to moderate
intensity resistance training does not result in arterial
stiffening measured as carotid-femoral pulse wave
velocity (cfPWV) (Cortez-Cooper et al., 2008;
Yoshizawa et al., 2009), femoral ankle pulse wave
velocity (faPWV) (Yoshizawa et al., 2009) or cardio-
ankle vascular index (CAVI) (Yasuda et al., 2013).
This is in line with the beneficial blood pres-
sure adaptation to moderate resistance training
(Cornelissen et al., 2011). On the other hand, our
results show that high intensity and concurrent high-
volume resistance training was found to be asso-
ciated with an increase of arterial stiffness (Miyachi
et al., 2004; Okamoto et al., 2006, 2008b, 2009).
This is consistent with previous studies reporting
blood pressure elevation after vigorous resistance
training (MacDougall, Tuxen, Sale, Moroz, & Sut-
ton, 1985; Palatini et al., 1989). However, there may
be a neutral effect of high intensity resistance
training on central arterial stiffness as shown in
obese normotensive young men (Croymans et al.,
2014). Even a favourable effect on arterial stiffness
has been shown for resistance training in a slow
eccentric manner (Okamoto et al., 2006, 2008b) or
with the lower limbs, although intensity was high
(Okamoto et al., 2009). In addition, a non-rando-
mised controlled study showed that progressive
high-intensity resistance training without volume
increase did not alter arterial stiffness (Casey, Beck,
& Braith, 2007). Further, resistance training in
young individuals was associated with an increase
of central and systemic arterial stiffness, but not
peripheral arterial stiffness. However, this was not
the case in middle-aged and older adults. One
explanation for the divergent effects following
eccentric and concentric training could possibly be
due to the difference in actively contracting muscle
mass, which is lower in eccentric training than
concentric training (Komi, Linnamo, Silventoinen, &
Sillanpää, 2000; Linnamo, Moritani, Nicol, & Komi,
2003; Madeleine, Bajaj, Søgaard, & Arendt-Nielsen,
2001). The greater amount of active muscle mass in
concentric resistance training may cause a stronger
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vasopressor response, which again increases the
strain on the arteries. Further, compared to eccentric
training, concentric training results in a greater
increase in blood pressure (Okamoto et al., 2006),
which may be associated with a stiffening of the
arterial wall (London & Guerin, 1999). The differ-
ence in upper limb and lower limb might be
explained by higher heart rates (Pivarnik, Grafner, &
Elkins, 1988) and higher blood pressure levels
(Volianitis & Secher, 2002) induced by upper limb
exercises compared to lower limb exercises with the
same workload. However, not all RCTs with mul-
tiple exercise interventions defined the workloads of
eccentric versus concentric exercise or upper versus
lower limb exercise to be equivalent for comparison
of training effect on arterial stiffness. The results are
thus, less convincing. Furthermore, it is of clinical
importance to investigate the effects of resistance
training on arterial stiffness in hypertension. Note-
worthy, the only existing RCT in prehypertensive
patients showed that moderate resistance training
improved peripheral arterial stiffness (Beck et al.,
2013). Further studies are warranted for precise
resistance exercise recommendations for hypertens-
ive patients.
Traditional resistance training generally consists of
muscular contractions performed at a relatively slow
speed. This is different to emerging novel types of
resistance training with higher velocity and lower
intensity, which may result in differing effects on
arterial stiffness. In high-velocity resistance training
in which the concentric phase is performed as
quickly as possible, force can be produced very fast.
This aspect of power production is important in
activities of daily living, especially with respect to fall
prevention (Orr et al., 2006; Sayers & Gibson,
2014). It has been shown that high-velocity resistance
training causes a greater increase in muscle power
than low-velocity resistance training (Fielding et al.,
2002). However, no study exists on the effect of high-
velocity resistance training on arterial stiffness. Com-
pared to lower velocity, higher velocity resistance
movements with a quick concentric phase might
have a smaller impact on arterial stiffness because of
a smaller vasopressor response. In view of an ageing
population with an increasing prevalence of hyperten-
sion (Kearney et al., 2005), and the progressive
reduction in muscular power (Reid & Fielding,
2012) and strength (Doherty, 2003), there is an
urgent clinical need to define the optimal type of
resistance exercise training. The ideal resistance
training should provide muscular benefits without
health hazards to the vasculature. At best, the
individualised resistance training programme has a
destiffening effect on the arteries.
Combined aerobic/resistance exercise and arterial stiffness
We included four RCTs on the effect of combined
aerobic and resistance exercise training on arterial
stiffness in our analysis. These trials involved 8 study
groups and 157 participants. Within the 4 studies,
the average age of the study groups ranged from 20
to 75 years and 31% of the participants were male.
Only one trial was conducted in patients with
untreated milder forms of hypertension (Stewart
et al., 2005). Training durations varied from 12 to
24 weeks, training frequency amounted to 3 weekly
sessions, the training intensity ranged from 50–80%
of 1RM and 60–90% HRmax and training duration
per session averaged 40–90 min.
The resistance exercises were either directly fol-
lowed by the aerobic exercise within one training
session (Figueroa, Park, Seo, Sanchez-Gonzalez, &
Baek, 2011; Kawano et al., 2006; Stewart et al.,
2005) or on alternating days (Cortez-Cooper et al.,
2008). Combined training either had a small or no
positive effect on arterial stiffness, suggesting that
combined exercise may be of particular relevance for
the prevention of sarcopenia in elderly population
without arterial stiffening. Aerobic following resist-
ance training in the same exercise session may
favourably affect arterial stiffness, but could decrease
the gain in muscular strength (Kawano et al., 2006;
Sale, Jacobs, MacDougall, & Garner, 1990). The
mammalian target of the rapamycin complex 1
(mTORC1), known as a protein complex that
controls protein synthesis, and thus, is important
for regulating muscle mass, was induced by resist-
ance training and can be down-regulated by aerobic
training (Ogasawara, Sato, Matsutani, Nakazato, &
Fujita, 2014). Therefore, in order to minimise the
attenuation of strength gain, resistance and aerobic
training should preferably be performed on alternat-
ing days (Kawano et al., 2006; Sale et al., 1990).
However, the portion, intensity and sequence of the
aerobic and resistance exercise components in the
combined exercise programme may all contribute to
the discrepancy of the results. Another aspect worth
consideration is the good health status in the studies
included in our analysis, whereby the results cannot
be generalised to other populations. Furthermore,
none of the 4 studies included had a Jadad score of
≥3, and thus, all were of lower study quality. Thus,
there is an evident need for additional studies on the
effect of combined aerobic and resistance training on
arterial stiffness in normotensive and hypertensive
individuals.
Limitations
There are some limitations that have to be consid-
ered. First, we included only the RCTs using the
Arterial stiffness in normotensive and hypertensive adults 453
regional and local arterial stiffness parameters men-
tioned above. The estimates in this study should be
interpreted with caution when compared to other
arterial stiffness parameters. Second, we only eval-
uated studies which reported precise data of change
in arterial stiffness in both intervention and control
group. Therefore, the estimates were synthesised
from the limited data in studies published in English
language, and we cannot fully exclude publication
bias. Furthermore, the poor methodological quality
of some included trials should be acknowledged. We
assessed the quality of the included studies using
Jadad scale, but we have not excluded the RCTs
with a Jadad score <3. We reported all the RCTs
that we found according to our inclusion criteria.
The existing evidence does not allow firm conclu-
sions. The interpretation is hampered by the use of
different measures of arterial stiffness, varying exer-
cise programmes (modality, duration, intensity and
frequency), different population-based variables
(age, health status) and several confounding factors
(e.g. exercise induced weight loss, daily physical
activity, diet, medication).
Conclusions
The available evidence indicates that aerobic exer-
cise training is more likely to have a beneficial effect
on arterial stiffness in normotensive and hypertensive
patients, but does not affect arterial stiffness in
patients with isolated hypertension. Resistance exer-
cise seems to have no adverse effect on arterial
stiffness if the training is of low intensity, in a slow
eccentric manner or with lower limb in healthy
individuals. However, intensive concentric resistance
exercise increases arterial stiffness in healthy indivi-
duals, and thus, should be avoided in populations
with an increased cardiovascular risk. Combined
training with resistance training first, followed by
endurance training, has neutral or even beneficial
effects on arterial stiffness based on limited number
of studies available.
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Objectives A number of operator-independent
oscillometric devices to measure hemodynamics and
arterial stiffness became available recently, but some and in
particular VaSera VS-1500 do not provide estimates of
aortic pressures and aortic pulse wave velocity (aPWV).
The aim of this work was the retrospective application of the
ARCSolver algorithm to pulse wave signals acquired with
the VaSera VS-1500 device to estimate central systolic
blood pressure (cSBP) and aPWV.
Materials and methods ARCSolver estimates of cSBP
and aPWV, on the basis of brachial cuff measurements, were
compared pair-wise with results from the tonometric
SphygmoCor device in 68 individuals (mean age
51±18 years). We used variation estimates, correlation
coefficients, age group-related t-tests, and the
Bland–Altman method to analyze the reproducibility and
agreement of the two methods.
Results cSBP reproducibility expressed as variability was
14.9% for ARCSolver and 11.6% for SphygmoCor. PWV
reproducibility was better for ARCSolver, with a variation
estimate of 6.5%, compared with 20.9% using SphygmoCor.
The mean cSBP difference was 0.5 mmHg (SD 6.9 mmHg)
and 0.32m/s (SD 1.20m/s) for PWV, respectively. The age-
related differences between ARCSolver and SphygmoCor
are in line with previous studies. Bland–Altman plots
showed considerable agreement between the two methods
without signs of systematic bias.
Conclusion These results show that the combined
application of the ARCSolver method with the VaSera
VS-1500 device is feasible and the results are comparable
with tonometric determination of cSBP and aPWV. This
successful application of the ARCSolver may potentially
help to improve cardiovascular risk stratification and
prevention at an early stage in a community setting. Blood
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Introduction
Aortic hemodynamics and arterial stiffness are considered to
be important determinants of improved cardiovascular risk
stratification [1,2]. To date, the usability of available devices
seemed to be a drawback for the routine use of arterial
stiffness surrogates. However, a number of cuff-based
operator-independent devices from various manufacturers
became available recently [3,4] featuring central hemody-
namics and pulse wave velocity (PWV). Furthermore, spe-
cific algorithms [5–7] used to estimate arterial stiffness
surrogates have been shown to be applicable to measure-
ment signals derived from different devices [8].
Beyond traditional indices of arterial stiffness, new
parameters, such as brachial to ankle pulse wave velocity
[9] or the cardio-ankle vascular index (CAVI) [10], have
emerged within the last few years. These methods
typically use two to four cuffs applied to the extremities,
which promise simple and unbiased data assessment.
However, such solutions do not provide estimates of
aortic pressures and aPWV. Therefore, the aim of this
work was the retrospective application of algorithms
estimating arterial stiffness surrogates to pulse wave sig-
nals acquired with the VaSera VS-1500 device and a pair-
wise comparison with tonometrically acquired measures
of arterial stiffness.
Materials and methods
Study population
We included 68 of a total of 75 individuals in these
analyses with valid measures of PWV and pulse wave
analysis (PWA), who were participating in an arterial
stiffness diurnal variation study described previously
[11]. Two individuals dropped out and five had to be
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excluded because of insufficient measurement quality:
one VaSera measurement with more than one unit dif-
ference between the two consecutive measurements,
three SphygmoCor measurements with SDs higher than
10%, and one ARCSolver PWA because of insufficient
recording quality. Recruitment resulted from poster
advertisement in our outpatient clinic. Inclusion criteria
were age between 18 and 80 years and being either
healthy or having a medical history of coronary heart
disease, hypertension, or previous stroke. Acute illness or
acute infections were the exclusion criteria. Twenty-five
individuals had heart disease under clinically stable
conditions without clinical signs of peripheral arterial
occlusive disease (Table 1). According to medical history,
physical examination, and resting ECG, 50 participants
did not have cardiovascular disease and diabetes. The
Ethics Committee of the University of Basel granted
ethical approval for this study. Participants provided
written informed consent to participate in the study.
Method of investigation
Arterial stiffness was measured using two devices: the
SphygmoCor (AtCor Medical Pty Ltd, West Ryde, New
South Wales, Australia) and a VaSera VS-1500 vascular
screening system (Fukuda Denshi Co. Ltd, Tokyo,
Japan) applying the ARCSolver algorithm retrospectively
[7]. Measurements were performed at 09:00, 13:00, and
17:00 h within 1 day. For the present analyses, the data at
13:00 h were taken. All measurements were performed
following a standardized protocol by one observer in a
quiet room with a temperature of 22–24°C and complied
with international recommendations [12]. After resting
for at least 10 min, two to three measurements were
obtained with each device (VaSera and SphygmoCor) at
5 min intervals in a supine position. The order of the
measurements was randomized. The measurements were
obtained under fasting conditions with the participants
being asked to refrain from caffeine intake, alcohol
intake, smoking, and exercise for at least 12 h.
SphygmoCor measurements
The carotid-femoral pulse wave velocity (cfPWV) was
measured using the SphygmoCor device. Pulse waves were
recorded using a single high-fidelity applanation tonometer
(Millar Instruments, Houston, Texas, USA) at the right
carotid artery and the right femoral artery. ECG was used to
synchronize the carotid and femoral pulse wave times and
to derive the transit time using a foot-to-foot method with
an intersecting tangent algorithm. The transit distance was
measured superficially with a tape measure by subtracting
the distance from the carotid measuring site to the supras-
ternal notch from the distance between the suprasternal
notch and the femoral measuring site [13]. cfPWV was
calculated by dividing the time delay of the pulse wave
between the two measuring sites by the transit distance (in
meters per second). Two consecutive cfPWV measure-
ments had to be within 1.5m/s with an SD of less than 10%
to be included in the analyses [14]. For pulse wave cali-
bration, blood pressure (BP) was measured at the right
upper arm using an Omron M9 Premium device (Omron
Healthcare, Kyoto, Japan). Furthermore, the SphygmoCor
software allows the calculation of central hemodynamic
parameters from pulse waves measured at the carotid artery
using a generalized transfer function. In contrast to
recordings taken at the radial artery, the transfer function
applied for recordings from the carotid artery uses a differ-
ent calibration method, as described in the ‘SphygmoCor
Research Applications Manual’. The central systolic blood
pressure (cSBP) was estimated using this procedure by
calibrating the aortic pulse wave, derived by the generalized
transfer function, with the brachial diastolic and mean
pressure. The mean pressure was calculated by adding the
brachial diastolic pressure and 0.4 times the brachial pulse
pressure measured by the Omron device [15,16]. In accor-
dance with the ‘SphygmoCor Research Applications
Manual’, the calibration was modified to diastolic and mean
pressure and a PWA was created using the carotid pressure
waveform and the carotid transfer function.
VaSera measurements
The VaSera device is commonly used to assess arterial
stiffness by means of the CAVI. CAVI is based on the
oscillometric measurement of the PWV from the heart to
the ankle [10]. We, however, used the VaSera device to
apply the ARCSolver method to derive central hemo-
dynamic estimates on the basis of peripheral pulse waves,
recorded at the brachial artery. Common BP cuffs were
placed above each ankle and at each upper arm. The
cuffs were kept at 30–50 mmHg to reduce the effect of
cuff pressure. ECG leads were attached at each wrist and
a phonocardiogram on the sternal border in the second
intercostal space. On the basis of the peripheral record-
ings, PWA was performed using the ARCSolver to derive
aPWV and cSBP. CAVI measurements were considered
to have acceptable quality when the difference between
the two measurements was less than 1 U.
ARCSolver
The ARCSolver method (AIT Austrian Institute of
Technology GmbH, Vienna, Austria) is a mathematical
Table 1 Baseline characteristics
Men/women [n (%)] 30 (44)/38 (56)
Hypertensive cardiomyopathy 9
Previous myocardial infarction 13
Previous stroke 2
Compensated heart failure 1
Age (years) 51 (18)
Height (cm) 170.7 (8.9)
Weight (kg) 68.8 (14.9)
SBP (mmHg) 115.1 (12.6)
DBP (mmHg) 96.3 (8.3)
Heart rate/min 58.1 (9.0)
Values are either absolute numbers, percentage, or mean (SD).
DBP, diastolic blood pressure; SBP, systolic blood pressure.
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procedure for the calculation of central aortic hemodynamic
measures, for example aPWV and cSBP, from peripheral
pulse waves and BP measurements at the brachial artery
using a common occlusive cuff [5]. In its original config-
uration, the measurement starts with a conventional oscil-
lometric BP measurement, followed by a 10 s continuous
recording with a constant cuff pressure at the diastolic BP
level using conventional BP cuffs [17]. As described by
Wassertheurer et al. [7], these recordings are digitized and a
multistep processing algorithm is applied. The first step
consists of the separation of the continuous measurement
into single pressure waves and the verification of their
plausibility by testing the position of their minima and
corresponding wavelengths. During the second stage,
artifacts are detected by comparing all pressure waves with
each other. Aortic pulse waves are calculated by a general
transfer function on the basis of the modification of a cer-
tain frequency range in the recorded peripheral pressure
waves. In the third step, the coherence of the measured
parameters is verified by comparing the inflection point of
each pulse wave with their average inflection point.
Finally, on the basis of these calculations, the central
hemodynamic parameters cSBP, aPWV, and others are
estimated.
ARCSolver for VaSera measurements
As stated above, the VaSera device performs continuous
cuff measurements of pulse waves on several sites of the
human body. The ARCSolver is capable of calculating
central hemodynamic values using peripheral pulse wave
measurements. Therefore, these two systems can be
combined easily using the VaSera device for data acqui-
sition and the ARCSolver method for parameter estima-
tion. Only small adaptations had to be made to
compensate for the differences in sampling frequency
(100 Hz for ARCSolver, 1000 Hz for VaSera) and sam-
pling duration (10 s for ARCSolver, 5 s for VaSera).
Therefore, the measured signal was downsampled and
doubled in duration when transferred from VaSera to
ARCSolver. The VaSera device provides measurements
from four sites of the body: left and right ankle and left
and right upper arm. As the ARCSolver needs recordings
from the brachial artery, the measurements at the ankle
were not taken into further consideration. For this work,
the pulse waves at the left upper arm were chosen for
evaluation by the ARCSolver as this is the common
location for oscillometric PWA [18]. However, for reasons
of comparability and compatibility, these pulse waves
were calibrated using the same diastolic and mean BP
values as used for the SphygmoCor device, that is mea-
sured at the right upper arm by an Omron device.
Statistics
If not stated otherwise, data are expressed as mean (SD)
and are normally distributed. We used the Bland–Altman
method to analyze the agreement between the two
methods and for graphical representation [19]. Pearson’s
linear correlation coefficient was calculated for correlation
analyses. T-tests were applied for examination of age
group-related differences between the measurements.
Furthermore, box plots were used to visualize the dis-
tribution of the values grouped by age and measurement
methods.
Reproducibility of the methods was quantified as varia-
tion estimate, as described by Bland and Altman [19]. It
is calculated by using twice the SD of the differences
between two consecutive measurements at the same
time point and the same participant, and presented as
percentage of the overall average of all measurements in
all participants [19]. The scientific computing environ-
ment MATLAB 7.5 (The Mathworks Inc., Natick,
Massachusetts, USA) was used for statistical analyses. A
P-value of less than 0.05 was considered statistically
significant.
Results
Clinical parameters of the cohort
We analyzed measurements of 68 individuals in this
study, 38 women and 30 men. The mean age of the
participants was 51 years, with an SD of 18 years, ranging
from 21 to 79 years. The mean systolic BP was
115.1 mmHg (SD 12.6 mmHg) and the mean diastolic BP
was 69.3 mmHg (SD 8.3 mmHg). Further baseline values
are listed in Table 1. A sensitivity analysis showed no
difference in the results when analyzing data from a
different time point than 13:00 h (data not shown).
Reproducibility of measurements
The variation estimate as a measure of reproducibility of
the cSBP readings resulted in 11.6% for the SphygmoCor
method and 14.9% for ARCSolver. For the cfPWV mea-
sured using SphygmoCor, the reproducibility was 20.9%
and for the aPWV calculated by the ARCSolver, the
reproducibility was 6.5%. The mean SD of consecutive
measurements of the cSBP was 3.8mmHg (SD 3.2mmHg)
for SphygmoCor and 3.6mmHg (SD 4.2mmHg) for
ARCSolver. For the cfPWV measured using SphygmoCor,
the mean SD was 0.40m/s (SD 0.39m/s) and for the aPWV
calculated by the ARCSolver the mean SD was 0.11m/s
(SD 0.12m/s).
Comparison of cSBP
The mean cSBP results were 112.5 mmHg (SD
13.8 mmHg) for SphygmoCor and 112.0 mmHg (SD
13.9 mmHg) for ARCSolver. The mean differences were
0.5 mmHg (SD 6.9 mmHg). The results correlated
strongly, showing a Pearson’s linear correlation coeffi-
cient of R= 0.88 (P< 0.001). Bland–Altman plots in Fig. 1
show the per-subject differences, with a very low Pearson
R coefficient of 0.02 between differences and means [20].
Furthermore, the cohort was divided into six age groups
with 10-year intervals (Fig. 2). The differences in the two
methods did not show any relation to age, whereas the
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absolute values and their spread increased with age for
both calculation methods. The difference in the age
group 70–79 years was found to be significant (P< 0.05),
whereas the differences in all the other age groups were
not significant.
Comparison of PWV
Similar to cSBP, PWV was acquired with the ARCSolver
using measurements from VaSera and were compared with
measurements of cfPWV acquired with the SphygmoCor
device. Again, at least two consecutive recordings were
evaluated for each instant. The mean results were 7.25m/s
(SD 1.66m/s) for SphygmoCor and 7.57m/s (SD 2.25m/s)
for ARCSolver. The mean difference was 0.32m/s (SD
1.20m/s). Pearson’s linear correlation coefficient for these
results was R= 0.85 (P< 0.001). Figure 3 shows the
Bland–Altman analysis of these differences, with a Pearson
R coefficient of 0.51 between differences and means [20].
Again, we investigated the results of the PWV grouped by
age. The results are presented in Fig. 4 and show a strong
correlation with age. The difference between the two
methods varied with age, with a tendency toward higher
values for the VaSera and ARCSolver method in participants
older than 50 years of age. For younger participants, the
PWV readings from SphygmoCor were higher than those of
VaSera and ARCSolver. Furthermore, these differences
were found to be significant (P<0.05) for the age groups
20–29, 30–39, 60–69, and 70–79 years, as listed in Table 2.
Discussion
Our study shows considerable agreement of oscillometrically
measured cSBP and acceptable agreement of aPWV by the
ARCSolver method, combined with a VaSera VS-1500 vas-
cular screening system, with the noninvasive gold-standard
tonometric SphygmoCor device. Central SBP varies exten-
sively from brachial SBP and also within one individual at all
age groups [21]. In recent years, growing evidence has
suggested that central BP may be a better predictor of car-
diovascular risk compared with brachial BP, and may reduce
hypertension misclassification [22]. However, measurement
of central BP with a tonometer relies very much on the skills
and training of the operator and is rather unsuitable for large-
scale assessments [21]. The assessment of central pressure
and wave reflection by the ARCSolver algorithm has been
Fig. 1
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validated invasively and noninvasively [3,18,23]. It has also
been shown that it is a reproducible and feasible method in
a laboratory [7,18,24] and community setting [17]. The
aPWV estimation of the ARCSolver has been proven to
have very good accuracy both in noninvasive [18] and in
invasive comparisons [25]. The ARCSolver aPWV method
is also applicable and robust in large-scale, community-based
studies [26]. We can now successfully apply the ARCSolver
algorithm to a different oscillometric arterial stiffness mea-
surement device.
The reproducibility of measurement is influenced by several
factors. It depends on the physiologic variability of the para-
meters, the effect of the investigator, and the stability of the
measurement method. As theminimization of the physiologic
variability is addressed by study protocols ensuring constant
and equal conditions for each measurement, the remaining
variability can be attributed to the operability and stability of
the methods. In our study, the short-term, within-session
reproducibility of the cSBP and aPWV measurement is high
and very acceptable for clinical practice with a low SD of the
differences [27–29] and low variation estimates [7,18]. This
result is also in line with the previously shown low day-to-day
variation in the same study population of the parameters
CAVI and cfPWV [11]. Furthermore, the results are similar
for both devices, with a considerably lower variation estimate
for the ARCSolver compared with SphygmoCor. This shows
that the ARCSolver method combined with a VaSera device
is comparable in terms of reproducibility to a commonly used
tonometric measurement.
The SD as a measure of variability of the cSBP mean
difference (6.9 mmHg) is similar to previous studies
comparing the ARCSolver method in noninvasive and
invasive settings [3,7,23,30]. This SD and the mean dif-
ference of 0.5 mmHg are well below the threshold of ±5
(8 SD) mmHg recommended by the Association for the
Advancement of Medical Instrumentation [27]. Even
though the mean difference is very low, it may partly
have resulted from different measuring sites as
SphygmoCor measures at the carotid artery, but the
ARCSolver estimation refers to central BP on the basis of
brachial measurements. Furthermore, the carotid transfer
function implemented in the SphygmoCor software has
not been approved for clinical use in the USA, as
described in the ‘SphygmoCor Research Applications
Manual’, which can be considered a limitation to our
study. The Bland–Altman plot, however, shows no sign
Fig. 4
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Table 2 Mean (SD) values for path length and delta t for SphygmoCor measurements, comparison of PWV, and differences by age groups
Age group
(years) N
Mean (SD) path length
SphygmoCor (mm)
Mean (SD) delta t
SphygmoCor (ms)
Mean (SD) cfPWV
SphygmoCor (m/s)
Mean (SD) aPWV VaSera
and ARCSolver (m/s)
Mean (SD) difference
(m/s) P-value
20–29 15 421 (28) 76 (6.8) 5.44 (0.45) 4.76 (0.31) −0.68 (0.57) 0.0001
30–39 8 450 (31) 73 (5.1) 6.07 (0.35) 5.44 (0.31) −0.63 (0.45) 0.0028
40–49 6 447 (25) 69 (9.4) 6.43 (0.97) 6.34 (0.79) −0.08 (0.61) 0.7499
50–59 8 465 (24) 64 (8.7) 7.33 (0.88) 7.68 (0.36) 0.35 (0.72) 0.2122
60–69 18 453 (27) 58 (7.3) 7.92 (1.11) 8.96 (0.70) 1.04 (1.18) 0.0017
70–79 13 443 (31) 46 (6.5) 9.41 (1.23) 10.67 (0.70) 1.25 (1.20) 0.0027
aPWV, aortic pulse wave velocity; cfPWV, carotid-femoral pulse wave velocity; PWV, pulse wave velocity.
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of a homogenous scattering pattern toward the mean or
difference of both methods, which reflects good
agreement.
The mean difference between the ARCSolver aPWV
and cfPWV of SphygmoCor of 0.32 m/s (SD 1.20 m/s) is
very consistent with previous comparisons, both invasive
[25,31] and noninvasive [18]. The mean difference can
be considered as excellent and the SD as acceptable
according to the ARTERY Society validation guidelines
[20]. Accordingly, the Bland–Altman plot shows very
good agreement as there is no sign of systematic bias
between the two methods. The Pearson R coefficient of
0.51 in the Bland–Altman plot can be attributed to the
age-related cross-over effect described below.
The age group analyses show that cfPWV and aPWV
measured with the SphygmoCor and ARCSolver, respec-
tively, reflect the expected age-dependent increase. We also
observed a slight exponential increase in aPWV with
increasing age as found with both MRI and tonometrically
measured aPWV [32] and in a community setting [26]. This
is a crucial feature of the method as age is the main deter-
minant of vascular modification besides BP [1,33]. In con-
trast to our cSBP results, the PWV difference between the
two methods is inconsistent over the age range. The
observed cross-over effect of the PWV difference at the
middle age is in line with previous findings; tonometrically
measured cfPWV has been shown to overestimate aortic
stiffness in younger individuals and to underestimate this in
older individuals compared with direct invasive assessment
[31,34]. This effect is because of the increasing cfPWV
travel distance with age, especially within the aortic arch [32,
34], and the significant decrease in the difference in travel
time between aPWV and cfPWV [34,35]. This also explains
the systematic, and for four age groups, significant difference
between the twomethods. Nevertheless, tonometric cfPWV
and aPWV measured invasively and using MRI have shown
good agreement [31,32]. Comparably, the ARCSolver aPWV
correlated well with invasively measured aPWV [31].
Conclusion
These study results establish considerable agreement
between cSBP and acceptable agreement between
aPWV measured with the ARCSolver method combined
with an oscillometric PWA device and the tonometric
SphygmoCor device. This suggests that the ARCSolver
algorithm can be applied successfully to other devices to
estimate aortic stiffness and aortic hemodynamics, which
may improve cardiovascular risk assessment and preven-
tion at an early stage. Moreover, further studies can also
benefit from the ARCSolver’s capabilities to carry out
wave separation analysis and the determination of other
central hemodynamics parameters.
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